Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3000570	f-elast1	ug/g (ug/g)	6772	9441	2.14%
3000570	f-elast1	— (—)	5595	6801	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Persons encountering health services for specific procedures and health care

2882

7705

2.30

321.69

1.5

1.4

254.87

289.20

ug/g

10.87

1759

4266

Diabetes, insulin treatment (Kela reimbursement)

2763

7390

2.32

314.63

1.5

1.4

242.87

289.17

ug/g

22.45

1691

4224

Other symptoms and signs involving the digestive system and abdomen

631

1220

5.52

311.25

1.5

1.3

269.62

284.48

ug/g

0.89

384

720

Intestinal infectious diseases

3409

7752

2.58

307.65

1.5

1.4

269.47

278.24

ug/g

1.20

1990

4420

General symptoms and signs

2945

5659

2.67

307.65

1.4

273.12

282.82

ug/g

1.29

1682

3217

Collagenous colitis

627

859

8.55

307.65

1.6

1.4

268.99

288.93

ug/g

1.28

408

483

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2765

8275

2.37

307.65

1.5

1.4

262.69

280.35

ug/g

3.89

1685

4677

Adenocarcinoma and ductal carcinoma of pancreas

437

253

25.66

307.65

1.6

1.4

131.41

293.20

ug/g

21.36

231

149

Fever of other and unknown origin

1654

4789

3.18

307.65

1.5

1.4

244.61

277.74

ug/g

7.01

969

2724

GASTRO-related operations

2080

2695

3.98

307.65

1.5

1.2

273.18

315.31

ug/g

11.16

1160

1452

Noninfective enteritis and colitis

1846

5099

3.82

307.65

1.5

1.4

272.79

278.77

ug/g

0.53

1124

2888

Tramadol

2473

4800

3.28

307.65

1.5

1.4

264.17

286.76

ug/g

4.83

1482

2668

Other diseases of biliary tract

602

649

10.90

307.65

1.6

1.3

164.45

303.44

ug/g

32.67

350

372

Cholelithiasis, broad definition with cholecystitis

2375

5740

2.87

307.65

1.5

1.3

268.88

312.83

ug/g

13.85

1415

3238

Noninfectious colitis NAS

685

1274

5.91

307.65

1.5

1.4

270.64

285.32

ug/g

0.89

443

713

Any gastric operation

2080

2695

3.98

307.65

1.5

1.2

273.18

315.31

ug/g

11.16

1160

1452

Opioids

2526

5142

2.61

307.65

1.5

1.4

271.56

289.53

ug/g

3.31

1456

2814

Oxycodone

1403

3297

4.06

307.65

1.5

1.4

220.39

274.26

ug/g

15.62

867

1872

Abdominal and pelvic pain

2958

4364

3.51

307.65

1.5

1.3

269.27

283.61

ug/g

2.04

1698

2521

Examination and observation for other reasons

1887

3017

3.75

307.65

1.4

273.13

268.46

ug/g

0.36

1118

1741

Other soft tissue disorders, not elsewhere classified

2525

6175

2.46

307.65

1.5

1.4

284.30

272.67

ug/g

1.68

1424

3524

Intestinal malabsorption

627

384

24.14

307.65

2.2

1.4

144.36

295.56

ug/g

28.78

405

222

Diseases of oesophagus, stomach and duodenum

3536

6914

3.17

307.65

1.5

1.4

273.67

274.73

ug/g

0.09

2032

3959

Intestinal infectious diseases

2677

8685

2.40

307.65

1.5

1.4

267.97

280.04

ug/g

1.68

1600

4913

Diarrhoea and gastroenteritis of presumed infectious origin

2065

7263

2.64

307.65

1.5

1.4

269.16

280.15

ug/g

1.14

1229

4071

Malignant neoplasm of pancreas

791

559

19.33

307.65

1.6

1.4

154.62

283.83

ug/g

29.68

470

341

Chronic pancreatitis

2034

876

37.11

307.65

1.9

1.3

114.66

309.70

ug/g

122.31

1242

509

Other diseases of pancreas

744

598

15.76

307.65

1.8

1.2

177.07

306.85

ug/g

34.52

495

348

Diseases of the digestive system

1784

5131

3.65

307.65

1.7

1.4

222.13

277.11

ug/g

19.70

1093

2999

Insulin, intermediate and long-acting

1918

6069

3.22

307.65

1.6

1.4

217.55

279.37

ug/g

30.18

1181

3537

Malignant neoplasm of pancreas, including Hilmo

964

748

17.27

307.65

1.5

1.4

154.10

289.05

ug/g

41.83

577

456

Irritable bowel syndrome

1731

2059

9.42

307.65

1.5

1.4

315.04

276.51

ug/g

8.18

950

1171

Pain in joint

1496

2880

3.41

307.65

1.5

1.4

287.26

275.15

ug/g

1.15

825

1681

Gastrointestinal diseases

1384

1250

5.69

307.65

1.4

1.2

292.72

334.96

ug/g

6.49

733

671

Diverticular disease of intestine

2173

4134

3.48

307.65

1.4

273.40

266.77

ug/g

0.64

1292

2435

Cholelithiasis

2251

5664

2.82

307.65

1.5

1.3

269.06

312.59

ug/g

16.97

1336

3194

Insulin, fast-acting or short human

1365

3993

3.60

307.65

1.6

1.4

214.13

282.27

ug/g

24.71

842

2301

Insulin, combination of fast acting with intermediate-acting or long-acting

2049

6508

2.99

307.65

1.6

1.4

217.54

280.49

ug/g

33.36

1255

3785

Gastro-oesophageal reflux disease

2141

6246

3.07

307.65

1.5

1.4

285.80

272.08

ug/g

2.06

1196

3623

Disorders of gallbladder, biliary tract and pancreas

4273

6122

4.66

307.65

1.6

1.3

220.59

314.07

ug/g

99.19

2588

3453

Adenocarcinoma of pancreas

305

201

21.11

307.65

1.6

1.4

142.45

296.41

ug/g

16.03

166

120

Malaise and fatigue

1570

4024

3.26

307.65

1.5

1.4

265.81

272.69

ug/g

0.56

936

2308

Insulin medication

2048

5651

3.18

307.65

1.6

1.4

217.54

285.23

ug/g

36.61

1255

3248

Other functional intestinal disorders

1969

3467

5.62

307.65

1.5

1.4

273.77

269.94

ug/g

0.27

1138

2002

Other noninfective gastroenteritis and colitis

1290

2482

5.69

307.65

1.5

1.4

271.68

280.02

ug/g

0.65

820

1417

Alcohol-induced chronic pancreatitis

489

554

10.70

307.65

1.7

1.4

162.37

274.29

ug/g

17.15

260

337

Constipation

2982

7081

3.03

307.65

1.5

1.4

272.38

275.08

ug/g

0.26

1774

4060

Acute pancreatitis

1252

1522

9.36

307.65

1.7

1.3

214.23

309.88

ug/g

24.10

761

887

Insulin, fast-acting

1361

3760

3.82

307.65

1.6

1.4

213.33

287.81

ug/g

28.51

839

2164

Acute pancreatitis (for exclusion)

1252

2029

6.98

307.65

1.7

1.4

214.23

275.71

ug/g

10.87

761

1199

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2633

6748

2.41

307.65

1.5

1.4

244.12

292.61

ug/g

24.02

1609

3833

Anaemias

817

629

8.94

307.65

1.5

1.3

254.84

348.82

ug/g

15.86

503

317

Symptoms and signs involving the digestive system and abdomen

2978

4365

3.53

307.65

1.5

1.3

267.87

283.61

ug/g

2.38

1727

2521

Other diseases of intestines

3713

5370

4.09

307.65

1.4

282.97

277.10

ug/g

0.67

2083

3048

Malignant neoplasm of digestive organs

1549

3433

3.78

307.65

1.5

1.4

192.54

282.86

ug/g

45.30

984

2027

Diarrhoea and gastroenteritis of presumed infectious origin

2935

7887

2.52

307.65

1.5

1.4

274.39

278.72

ug/g

0.40

1698

4487

Symptoms and signs concerning food and fluid intake

593

880

7.52

307.65

1.5

1.4

286.47

281.95

ug/g

0.16

345

514

Nausea and vomiting

1015

1968

5.35

307.65

1.5

1.3

260.11

286.01

ug/g

2.92

615

1161

Codeine

2308

5089

2.52

306.84

1.4

283.45

288.87

ug/g

0.44

1381

2794

Pain in throat and chest

2241

5483

2.51

304.94

1.5

1.4

282.57

269.31

ug/g

1.88

1268

3141

Headache

1742

5203

2.75

303.79

1.4

292.18

283.90

ug/g

0.76

945

2939

Other antidepressants

2662

5915

2.36

302.07

1.4

277.49

271.77

ug/g

0.53

1497

3481

Mood disorders, excluding more controls

2506

6503

2.36

296.27

1.4

283.92

270.91

ug/g

1.64

1387

3811

Infections, IBD-co-morbidities

547

601

6.85

294.76

1.5

1.3

264.83

275.22

ug/g

0.40

329

355

Diabetes mellitus

2685

7036

2.28

294.04

1.5

1.4

246.73

294.55

ug/g

23.24

1619

3948

Benign neoplasm of colon, rectum, anus and anal canal

1924

6790

2.55

291.21

1.5

1.4

271.40

265.61

ug/g

0.57

1175

3983

Medical observation and evaluation for suspected diseases and conditions

1690

3040

2.91

287.87

1.5

1.4

284.94

267.99

ug/g

1.61

954

1750

Hernia of abdominal wall, postoperative

555

1022

5.71

287.68

1.6

1.3

274.00

303.36

ug/g

1.21

344

581

Diabetes, varying definitions

2660

7048

2.26

286.09

1.5

1.4

245.78

294.80

ug/g

24.24

1603

3956

Weight loss

534

987

6.06

280.78

1.5

1.4

292.40

276.99

ug/g

0.75

312

566

Pain (limb, back, neck, head abdominally)

1695

3026

2.87

279.70

1.5

1.4

273.80

275.68

ug/g

0.11

965

1760

Functional dyspepsia

906

2519

3.78

278.88

1.5

1.4

295.40

276.24

ug/g

1.79

500

1452

First line medication for Crohn's disease

2812

7041

2.20

278.23

1.4

272.66

282.05

ug/g

1.29

1607

3992

Autoimmune diseases excluding thyroid diseases

2675

6653

2.24

276.13

1.5

1.4

265.75

280.36

ug/g

2.57

1602

3748

Abnormal weight loss

507

911

6.28

275.24

1.5

1.4

293.34

277.85

ug/g

0.71

292

518

Abnormalities of breathing

2258

5611

2.39

274.14

1.4

291.97

270.93

ug/g

3.95

1250

3204

Diabetes medication

2687

7378

2.21

273.45

1.5

1.4

244.71

294.19

ug/g

24.63

1625

4155

Pain in limb

2128

6052

2.41

272.63

1.5

1.4

278.18

271.74

ug/g

0.65

1200

3452

Paralytic ileus and intestinal obstruction

779

1999

4.08

268.12

1.5

1.4

233.83

271.22

ug/g

4.36

492

1198

Metabolic disorders

2498

6972

2.24

264.13

1.5

1.4

263.23

281.04

ug/g

2.94

1515

3976

Autoimmune diseases excluding thyroid diseases, strict definition

2567

6450

2.22

261.06

1.5

1.4

265.77

279.60

ug/g

2.28

1543

3634

Type 1 diabetes

833

2300

3.79

258.03

1.7

1.4

217.49

296.92

ug/g

22.48

554

1290

Depression or dysthymia

1748

3740

2.64

256.30

1.5

1.4

277.79

262.44

ug/g

1.47

986

2239

Other bacterial diseases

2515

7946

2.18

255.01

1.5

1.4

238.54

285.65

ug/g

21.91

1513

4560

Implicit Sepsis

2069

6852

2.34

254.46

1.5

1.4

258.01

277.22

ug/g

3.78

1265

3972

Depression

2492

7955

2.17

251.48

1.4

284.74

275.74

ug/g

0.95

1357

4614

Implicit Sepsis

2194

7257

2.27

249.21

1.5

1.4

260.09

278.92

ug/g

3.84

1337

4193

Low back pain

1949

6003

2.39

249.08

1.5

1.4

278.82

271.35

ug/g

0.75

1101

3456

Persons encountering health services in other circumstances, wide

2950

7458

2.08

248.71

1.5

1.4

273.12

275.92

ug/g

0.26

1688

4294

Inflammatory bowel disease treatment related agents

2868

7883

2.08

246.89

1.4

279.51

275.54

ug/g

0.40

1629

4491

Mood [affective] disorders

2642

8288

2.11

245.92

1.4

285.21

274.40

ug/g

1.32

1453

4811

Mood disorders

2645

8297

2.11

245.08

1.4

285.30

274.28

ug/g

1.36

1454

4814

Dysphagia

721

1873

4.03

244.20

1.6

1.3

273.62

277.78

ug/g

0.20

428

1131

Anxiety disorders, excluding more controls

2102

6076

2.30

241.94

1.4

292.81

275.22

ug/g

2.24

1144

3557

Benign neoplasm: Colon

1611

6373

2.50

238.94

1.5

1.4

268.69

263.50

ug/g

0.45

991

3751

Cholecystectomy

1960

7593

2.29

235.57

1.5

1.4

270.25

274.08

ug/g

0.32

1174

4375

Condition for Implicit Sepsis (Organ dysfunction codes)

2306

7469

2.18

235.32

1.5

1.4

265.69

281.20

ug/g

2.80

1402

4251

Other medical care

1351

4633

2.72

234.86

1.4

209.94

274.16

ug/g

23.54

831

2651

Budesonide

580

1328

4.69

234.73

1.5

1.4

280.47

279.78

ug/g

0.03

351

765

Other disorders of fluid, electrolyte and acid-base balance

1028

3256

3.15

234.45

1.5

1.4

234.51

273.13

ug/g

7.01

644

1913

Other bacterial diseases

2577

7982

2.09

233.42

1.5

1.4

246.07

288.37

ug/g

18.13

1556

4537

Benzodiazepine use

2575

8715

2.08

233.30

1.4

277.15

274.86

ug/g

0.17

1449

5041

Type 2 diabetes

2451

6807

2.15

232.82

1.5

1.4

251.86

292.63

ug/g

15.85

1462

3834

Endocrine, nutritional and metabolic diseases

1825

3787

2.49

232.37

1.5

1.3

272.52

301.88

ug/g

5.78

1055

2047

ILD medications: prednisolone, methylprednisolone, prednisone

2711

7503

2.06

229.19

1.4

276.59

276.22

ug/g

0.03

1531

4286

Recurrent or chronic depression

1053

2410

3.16

227.49

1.4

288.41

279.30

ug/g

0.41

567

1409

All kidney diseases

2491

8356

2.08

226.30

1.5

1.4

259.85

283.95

ug/g

6.43

1533

4675

Dorsalgia

2414

6132

2.15

225.00

1.4

282.00

272.38

ug/g

1.19

1323

3516

Cholangitis (primary sclerosing, PSC)

317

430

8.26

224.82

1.6

1.3

178.38

319.47

ug/g

18.36

188

250

Alcohol use disorder, Swedish definition

1500

5654

2.51

223.40

1.5

1.4

240.68

272.48

ug/g

5.82

841

3303

Alcohol-induced acute pancreatitis

273

321

10.36

221.40

1.8

1.4

166.53

272.85

ug/g

9.93

163

188

Renal tubulo-interstitial diseases

2255

8112

2.12

218.21

1.5

1.4

253.31

280.75

ug/g

7.69

1390

4570

Certain infectious and parasitic diseases

2342

5528

2.16

217.29

1.5

1.4

269.51

290.90

ug/g

4.44

1368

3063

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

740

881

4.30

217.16

1.4

1.3

294.74

288.21

ug/g

0.27

405

489

Condition for Implicit Sepsis (Organ dysfunction codes)

2192

7391

2.14

215.69

1.5

1.4

260.46

280.39

ug/g

4.23

1330

4263

Bacterial infection, other or unspecified

1614

5855

2.40

215.21

1.5

1.4

236.44

277.67

ug/g

11.86

996

3393

1544

5903

2.43

215.09

1.5

1.4

242.40

272.98

ug/g

5.53

865

3437

Oral corticosteroids

2588

7711

2.03

213.41

1.4

279.37

273.66

ug/g

0.61

1488

4414

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2699

7425

2.01

212.87

1.4

277.25

276.25

ug/g

0.08

1576

4278

Bacterial infection, other or unspecified

1510

5503

2.46

212.53

1.5

1.4

232.21

277.08

ug/g

13.11

930

3212

1598

6065

2.38

212.28

1.5

1.4

242.75

274.12

ug/g

6.03

897

3535

Codeine or tramadol medication

2767

7753

1.99

211.69

1.4

282.29

272.77

ug/g

1.17

1654

4358

Diseases of liver

1086

3963

2.86

211.53

1.5

1.4

262.01

272.05

ug/g

0.72

647

2330

Any mental disorder

2661

6672

2.03

211.31

1.4

280.77

271.09

ug/g

1.10

1489

3919

Ductal carcinoma of pancreas

133

57.31

210.68

1.6

1.3

103.20

296.63

ug/g

6.72

Depression medications

612

632

4.98

210.62

1.4

1.2

301.90

346.96

ug/g

3.41

310

315

Unspecified jaundice

261

303

9.67

210.54

1.4

1.3

148.35

275.60

ug/g

12.22

135

182

General examination and investigation of persons without complaint and reported diagnosis

1487

3034

2.61

210.24

1.4

289.74

268.22

ug/g

2.82

848

1748

Type 2 diabetes, wide definition

1953

5711

2.24

209.92

1.5

1.4

251.33

287.20

ug/g

11.06

1215

3297

Autoimmune diseases

2628

6692

2.03

209.52

1.5

1.4

267.93

280.26

ug/g

1.89

1524

3767

Type 1 diabetes, wide definition, subgroup 1

638

1699

3.93

208.44

1.7

1.3

225.08

305.82

ug/g

18.86

448

922

ILD medications

2728

7588

1.98

206.98

1.4

277.51

277.07

ug/g

0.03

1552

4320

Symptoms and signs involving the circulatory and respiratory systems

2336

5626

2.12

206.22

1.4

291.70

270.96

ug/g

3.98

1297

3212

Complications of surgical and medical care, not elsewhere classified

2480

8613

2.01

206.20

1.5

1.4

261.17

278.36

ug/g

3.48

1516

4880

Pain, not elsewhere classified

796

2469

3.35

205.70

1.5

1.4

279.56

283.72

ug/g

0.19

456

1396

Lower back pain or/and sciatica

2590

8756

1.97

200.75

1.5

1.4

280.02

274.14

ug/g

0.65

1459

5051

Parasetamol

1656

3528

2.42

199.83

1.4

276.93

281.36

ug/g

0.31

922

1997

Other diseases of anus and rectum

766

2361

3.35

198.92

1.4

278.06

271.66

ug/g

0.32

410

1393

Other special examinations and investigations of persons without complaint or reported diagnosis

1495

3040

2.54

198.42

1.5

1.4

275.84

267.99

ug/g

0.62

869

1750

Other dorsopathies, not elsewhere classified

2374

6148

2.06

196.94

1.5

1.4

282.66

272.48

ug/g

1.06

1324

3524

Substance abuse, excluding more controls

1374

4887

2.46

194.59

1.5

1.4

258.53

265.98

ug/g

0.56

768

2874

Selective serotonin reuptake inhibitors

2311

5940

2.07

194.12

1.4

286.19

271.79

ug/g

1.74

1282

3494

Other or unspecified ileus, impaction or obstruction

540

1369

4.13

189.35

1.5

1.4

226.64

269.57

ug/g

4.59

338

825

Anxiety disorders

2203

7728

2.03

187.70

1.4

294.01

275.39

ug/g

2.61

1187

4481

Anxiety (asthma-related co-morbidities)

1444

4797

2.38

187.46

1.4

300.96

285.94

ug/g

1.13

751

2699

Implicit bacterial Sepsis

1250

4417

2.52

186.26

1.5

1.4

245.40

269.42

ug/g

3.67

767

2638

Neurotic, stress-related and somatoform disorders

2183

7689

2.03

186.14

1.4

294.87

275.63

ug/g

2.71

1174

4456

Used for control exclusion in common control thyroid runs

2417

6189

2.01

186.03

1.5

1.4

269.39

279.42

ug/g

1.28

1392

3478

Dyspnoea

2236

8446

2.00

184.92

1.4

290.64

269.97

ug/g

4.41

1261

4906

Other diseases of intestine

453

1036

4.63

182.80

1.5

1.4

253.73

270.81

ug/g

0.89

308

630

Hypothyroidism (congenital or acquired)

519

622

4.82

182.48

1.5

1.2

290.05

344.18

ug/g

4.83

277

312

Other gastritis (incl. Duodenitis)

689

2115

3.41

181.95

1.5

1.4

278.82

274.84

ug/g

0.18

428

1265

Other bacterial intestinal infections

721

2281

3.31

181.23

1.5

1.4

267.77

273.57

ug/g

0.29

421

1320

Use of hypnotics and sedatives

2552

7765

1.92

179.08

1.4

276.17

274.80

ug/g

0.09

1474

4468

Nerve, nerve root and plexus disorders

2560

8371

1.91

178.52

1.5

1.4

272.54

274.14

ug/g

0.12

1485

4816

Type 1 diabetes, wide definition

649

1947

3.47

177.01

1.7

1.3

225.64

297.18

ug/g

15.94

455

1088

Hypothyroidism, levothyroxine purchases

510

620

4.76

176.82

1.5

1.2

294.45

343.66

ug/g

4.00

270

310

Hypothyroidism and >3 levothyroxin purchases

510

620

4.76

176.82

1.5

1.2

294.45

343.66

ug/g

4.00

270

310

Implicit bacterial Sepsis

1140

4092

2.55

174.70

1.5

1.4

242.50

269.85

ug/g

4.25

700

2432

Other specific joint derangements/joint disorders

1750

5336

2.16

173.89

1.4

290.81

273.25

ug/g

2.49

973

2986

Complications of procedures, not elsewhere classified

1994

8385

2.01

171.67

1.5

1.4

257.92

277.44

ug/g

3.72

1220

4758

Benign neoplasm of other and ill-defined parts of digestive system

653

2024

3.43

171.17

1.5

1.4

245.82

277.64

ug/g

3.30

426

1182

Renal failure

1259

4763

2.41

170.99

1.5

1.4

240.73

267.02

ug/g

4.55

811

2841

Asthma, unspecified (mode), excluding more controls

1269

4005

2.43

170.30

1.5

1.4

278.70

278.13

ug/g

0.03

782

2251

Sub-endpoint used in defining T1D endpoints

837

2936

2.90

169.01

1.7

1.4

215.90

279.69

ug/g

16.28

558

1685

Bacterial Sepsis

1250

4563

2.41

168.93

1.5

1.4

241.73

269.84

ug/g

4.76

759

2713

Symptoms and signs involving cognition, perception, emotional state and behaviour

2317

8399

1.92

167.54

1.4

281.63

272.85

ug/g

0.91

1296

4864

Other diseases of the digestive system

909

3409

2.77

167.51

1.5

1.4

246.53

274.67

ug/g

3.29

542

2023

Diaphragmatic hernia

1058

4299

2.55

165.70

1.5

1.4

288.02

264.78

ug/g

3.18

652

2558

Explicit Sepsis

1169

4602

2.44

165.65

1.5

1.4

233.15

273.48

ug/g

7.56

670

2695

Psychiatric diseases

2278

5898

1.97

165.61

1.4

281.98

268.05

ug/g

1.67

1284

3475

Any reimbursement code in KELA

1175

2289

2.62

165.57

1.5

1.2

279.89

341.13

ug/g

14.55

668

1135

Asthma, unspecified (mode)

1302

4244

2.36

165.19

1.5

1.4

278.10

276.85

ug/g

0.07

801

2403

Certain infectious and parasitic diseases

1642

3756

2.23

164.38

1.4

272.12

287.97

ug/g

1.92

942

2092

Other anxiety disorders

1121

4004

2.49

163.79

1.4

305.79

285.47

ug/g

1.38

579

2231

All anxiety disorders

1470

5342

2.22

163.27

1.4

301.73

283.01

ug/g

1.62

758

3013

Shoulder lesions

1837

5465

2.08

162.25

1.5

1.4

275.16

266.52

ug/g

0.73

1095

3200

Faecal incontinence

338

675

5.38

161.45

1.6

1.3

291.17

290.85

ug/g

0.01

196

399

Soft tissue disorders

2301

6217

1.94

161.33

1.4

286.72

272.69

ug/g

2.13

1284

3543

Other septicaemia

1042

4072

2.54

161.32

1.5

1.4

231.33

278.19

ug/g

9.04

606

2398

Asthma, excluding more controls

1712

4206

2.16

161.16

1.5

1.4

284.86

279.18

ug/g

0.47

1003

2367

Hypertensive diseases (excluding secondary)

1215

2901

2.49

161.15

1.5

1.4

274.89

297.89

ug/g

2.79

722

1560

Septicaemia

1131

4454

2.45

160.96

1.5

1.4

232.62

277.86

ug/g

9.17

653

2633

Other intervertebral disc disorders

1916

5796

2.03

158.54

1.5

1.4

276.29

269.65

ug/g

0.66

1136

3369

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

614

1919

3.38

158.32

1.5

1.4

209.64

287.48

ug/g

14.38

377

1132

Asthma

1771

4468

2.12

158.28

1.5

1.4

283.64

278.05

ug/g

0.47

1036

2530

Spondylopathies

1840

5472

2.05

156.04

1.5

1.4

276.10

267.01

ug/g

1.00

1082

3212

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2062

6499

1.95

154.50

1.4

258.74

280.58

ug/g

4.35

1221

3714

2062

6499

1.95

154.50

1.4

258.74

280.58

ug/g

4.35

1221

3714

Complications of medical and surgical care

1811

8558

1.99

154.04

1.5

1.4

259.05

276.61

ug/g

2.90

1097

4897

Autoimmune diseases related-to ILD

2014

9133

1.92

153.82

1.4

279.85

275.10

ug/g

0.45

1133

5238

Chronic gastritis

757

2709

2.90

152.76

1.5

1.4

265.42

271.42

ug/g

0.32

464

1627

Nutritional anaemias

1306

5784

2.24

152.10

1.5

1.4

255.24

272.06

ug/g

2.18

796

3367

Implicit viral Sepsis

830

3124

2.76

151.94

1.5

1.4

271.96

278.38

ug/g

0.37

506

1823

Asthma (mode)

1731

4508

2.09

151.45

1.5

1.4

282.03

277.58

ug/g

0.35

1010

2545

Hypertension, essential

1785

5013

2.05

150.65

1.5

1.4

266.86

284.65

ug/g

2.70

1068

2824

Other disorders of urethra and urinary system

1643

5833

2.07

150.52

1.4

280.02

275.07

ug/g

0.39

924

3365

Non-selective monoamine reuptake inhibitors

978

3840

2.53

150.43

1.5

1.4

279.82

272.87

ug/g

0.31

549

2304

Aplastic and other anaemias

1224

5138

2.29

149.01

1.5

1.4

239.33

269.16

ug/g

5.35

764

3025

Cardiac arrhythmias

1282

3686

2.30

148.87

1.4

1.3

290.71

302.10

ug/g

1.04

715

1978

Other bacterial intestinal infections

568

1754

3.40

148.86

1.5

1.4

259.05

271.20

ug/g

0.68

341

1028

Spondylosis

1324

4964

2.23

148.47

1.5

1.4

279.37

264.68

ug/g

1.71

780

2923

Intestinal stricture

900

3573

2.62

148.17

1.5

1.4

234.98

271.88

ug/g

5.95

579

2105

All chronic kidney diseases

1363

5198

2.20

147.82

1.5

1.4

241.65

272.48

ug/g

6.46

879

3010

Dorsopathies

2257

6165

1.89

146.93

1.5

1.4

287.83

272.64

ug/g

1.87

1248

3536

Influenza and pneumonia

2408

8567

1.82

145.87

1.4

262.59

283.40

ug/g

4.62

1405

4848

Other (not insulin) diabetes medications

2193

7046

1.88

145.30

1.5

1.4

256.54

290.28

ug/g

10.08

1300

4015

Abnormalities of heart beat

892

3477

2.59

144.76

1.5

1.4

292.46

265.50

ug/g

3.12

495

2010

GI-bleeding

868

3425

2.62

144.25

1.5

1.4

248.18

274.57

ug/g

2.87

524

2042

Follow-up examination after treatment for conditions other than malignant neoplasms

976

2571

2.57

143.38

1.4

280.65

266.50

ug/g

0.76

561

1488

Type 2 diabetes, definitions combined

2101

6622

1.89

142.60

1.5

1.4

262.62

291.39

ug/g

5.44

1229

3759

Bleeding

2007

7687

1.89

141.33

1.5

1.4

255.02

272.88

ug/g

3.21

1208

4464

Asthma (only as main-diagnosis), excluding more controls

1531

4206

2.12

140.72

1.5

1.4

285.52

279.18

ug/g

0.51

878

2367

Pneumonias (Asthma/COPD co-morbidities)

2301

8658

1.81

140.35

1.4

258.66

283.73

ug/g

6.45

1363

4897

All pneumoniae

2312

8685

1.81

139.53

1.4

259.04

283.54

ug/g

6.19

1368

4918

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1408

5453

2.12

138.80

1.5

1.4

248.95

271.75

ug/g

3.67

827

3231

Oedema, not elsewhere classified

789

2985

2.69

138.26

1.5

1.4

269.83

271.95

ug/g

0.09

450

1737

Pneumonia, organism unspecified

2117

8170

1.85

138.25

1.4

256.71

281.80

ug/g

6.08

1251

4666

Symptoms and signs involving the urinary system

1853

7508

1.92

137.52

1.5

1.4

274.76

269.71

ug/g

0.34

1023

4425

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2215

8034

1.82

136.96

1.5

1.4

267.20

281.19

ug/g

2.26

1336

4509

Mental and behavioural disorders due to psychoactive substance use

1411

6421

2.08

136.66

1.5

1.4

258.86

273.11

ug/g

1.49

788

3726

Benign neoplasms

2118

6338

1.87

136.54

1.5

1.4

280.96

276.56

ug/g

0.32

1246

3550

Dental caries

659

2233

2.93

135.26

1.5

1.4

251.93

270.02

ug/g

1.32

398

1302

Persons encountering health services in other circumstances

975

4149

2.40

135.23

1.5

1.4

274.28

279.00

ug/g

0.25

518

2381

Intracranial trauma

1266

4114

2.20

135.09

1.4

277.62

275.16

ug/g

0.14

713

2359

Asthma (only as main-diagnosis)

1566

4468

2.06

135.06

1.5

1.4

284.92

278.05

ug/g

0.59

903

2530

Type 2 diabetes, strict (exclude DM1)

2106

6764

1.86

134.90

1.5

1.4

262.56

288.35

ug/g

4.51

1232

3846

Substance abuse

1374

6316

2.09

134.89

1.5

1.4

258.53

272.26

ug/g

1.38

768

3672

Personality disorders, excluding more controls

598

2007

3.07

134.89

1.4

299.31

287.67

ug/g

0.34

323

1107

Implicit viral Sepsis

593

1994

3.10

134.38

1.5

1.4

272.72

278.86

ug/g

0.29

357

1168

Viral Sepsis

593

1995

3.10

134.25

1.5

1.4

272.72

278.89

ug/g

0.30

357

1169

Care involving dialysis

302

644

5.06

133.95

1.6

1.4

232.94

286.14

ug/g

4.11

207

384

Hypertension

1764

5132

1.97

133.82

1.5

1.4

268.78

286.16

ug/g

2.57

1050

2879

Neoplasms

1529

3933

2.09

133.79

1.5

1.3

269.59

302.59

ug/g

6.48

902

2060

Other anaemias

1122

4853

2.26

133.77

1.5

1.4

241.44

268.75

ug/g

4.26

700

2859

Hypertensive diseases

1764

5137

1.97

133.53

1.5

1.4

268.78

286.24

ug/g

2.59

1050

2880

Chronic kidney disease

823

3224

2.59

133.00

1.5

1.4

241.22

265.57

ug/g

2.80

526

1946

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2246

8676

1.79

132.71

1.4

257.29

282.74

ug/g

6.53

1335

4913

Other and unspecified anaemias

1111

4818

2.26

132.51

1.5

1.4

241.21

268.87

ug/g

4.32

692

2838

Persons encountering health services for examination and investigation

1325

3040

2.22

132.10

1.4

276.28

267.99

ug/g

0.63

762

1750

Diseases of the skin and subcutaneous tissue

2208

6125

1.83

131.13

1.5

1.4

275.00

275.73

ug/g

0.05

1286

3492

Type 2 diabetes, definitions combined, including avohilmo

2083

6674

1.85

130.72

1.5

1.4

259.35

289.18

ug/g

7.61

1210

3791

Caries of dentine

587

1936

3.05

129.71

1.5

1.4

249.77

269.37

ug/g

1.36

356

1131

Gastroduodenal ulcer

670

2444

2.83

129.44

1.5

1.4

242.40

267.27

ug/g

2.12

415

1476

Heart failure, not strict

1812

6604

1.90

128.02

1.5

1.4

252.83

272.34

ug/g

2.71

1149

3815

Other pulmonary diagnosis

1744

4506

1.97

127.76

1.5

1.4

273.58

277.78

ug/g

0.31

992

2553

Cardiovascular diseases

1195

2891

2.26

126.47

1.4

1.3

291.23

307.80

ug/g

1.54

642

1513

Dizziness and giddiness

1751

7465

1.89

126.39

1.4

287.56

270.57

ug/g

1.96

988

4353

Cardiovascular diseases (excluding rheumatic etc)

1300

3517

2.16

126.15

1.5

1.3

282.82

307.51

ug/g

3.32

744

1834

Sleep disorders (combined)

2495

7629

1.74

126.02

1.4

291.80

269.56

ug/g

4.16

1367

4470

Other disorders of skin and subcutaneous tissue

1657

7859

1.91

125.24

1.5

1.4

267.68

272.50

ug/g

0.43

975

4571

Other headache syndromes

1032

4675

2.26

124.87

1.4

301.85

276.50

ug/g

3.16

552

2678

Other diseases of urinary system

2197

6988

1.79

124.71

1.4

277.83

274.80

ug/g

0.25

1230

4034

Excluding asthma or asthma-COPD overlap

1733

4506

1.96

124.70

1.5

1.4

273.13

277.78

ug/g

0.35

985

2553

Sciatica+with lumbago

1181

5172

2.15

124.23

1.4

283.77

270.38

ug/g

1.29

659

3012

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

139

143

11.62

124.22

1.6

1.3

131.57

301.56

ug/g

12.45

Disorders of lipoprotein metabolism and other lipidaemias

1865

6270

1.87

124.17

1.5

1.4

262.83

275.86

ug/g

1.86

1142

3646

Inflammatory bowel disease

833

3461

2.48

124.01

1.5

1.4

277.15

277.45

ug/g

0.01

474

1971

Concussion

1091

4067

2.23

123.98

1.4

281.41

274.44

ug/g

0.46

614

2337

Acute renal failure

632

2305

2.86

123.60

1.5

1.4

237.60

269.64

ug/g

3.27

413

1399

Other heart diseases

1026

2922

2.34

123.52

1.4

270.72

299.45

ug/g

3.76

587

1581

Benign neoplasm: Pancreas

185

274

8.11

123.40

1.6

1.5

216.70

280.86

ug/g

3.13

137

164

Disorders of eyelid, lacrimal system and orbit

1966

8372

1.81

122.99

1.4

282.54

271.96

ug/g

1.41

1146

4828

Hernia

2127

8135

1.78

122.24

1.5

1.4

281.41

273.92

ug/g

0.69

1269

4674

Hypokalaemia

412

1180

3.70

122.17

1.5

1.4

234.23

280.71

ug/g

4.70

275

690

Dialysis, with operation codes

423

1234

3.63

122.04

1.6

1.4

232.38

274.61

ug/g

3.99

298

738

Bacterial intestinal infections, IBD co-morbidities

566

1961

3.02

121.90

1.5

1.4

258.85

272.61

ug/g

0.82

340

1161

Other/unspecified dorsalgia

897

3842

2.37

121.58

1.4

278.35

272.21

ug/g

0.36

517

2206

Rotator cuff syndrome

1416

5128

2.02

120.96

1.5

1.4

270.20

265.18

ug/g

0.39

845

3022

Neurological diseases

1813

4855

1.90

120.71

1.5

1.4

284.23

273.72

ug/g

1.13

1006

2781

Osteopathies and chondropathies

1380

6576

2.00

119.70

1.5

1.4

273.31

273.47

ug/g

0.01

834

3767

COPD/asthma related infections

2264

6501

1.77

119.43

1.4

275.47

280.58

ug/g

0.47

1281

3715

COPD/asthma/ILD related infections

2264

6501

1.77

119.43

1.4

275.47

280.58

ug/g

0.47

1281

3715

COPD differential diagnosis

1713

4509

1.93

118.98

1.5

1.4

274.48

277.58

ug/g

0.21

974

2545

ILD differential diagnosis

1712

4508

1.93

118.78

1.5

1.4

274.10

277.58

ug/g

0.24

973

2545

Cystitis

1869

6104

1.85

118.59

1.4

280.07

276.03

ug/g

0.32

1053

3521

Haemorrhoids and perianal venous thrombosis

674

2586

2.67

117.53

1.5

1.4

275.81

266.09

ug/g

0.53

377

1528

Polyarthropathies

1480

4990

1.97

115.95

1.5

1.4

271.22

268.63

ug/g

0.17

881

2828

Neurological diseases, wide definition

579

922

3.21

115.90

1.4

1.3

305.69

295.83

ug/g

0.38

300

507

Other diseases of liver

545

1903

3.00

115.83

1.4

283.78

277.49

ug/g

0.27

328

1104

Syncope and collapse

977

3775

2.26

115.76

1.5

1.4

265.29

270.08

ug/g

0.28

560

2190

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1059

5011

2.15

113.67

1.5

1.4

251.20

267.59

ug/g

1.43

583

2965

Hypothyroidism, drug reimbursement

286

420

4.94

113.41

1.5

1.2

290.04

337.45

ug/g

2.57

169

208

Insulin, fast-acting (human)

407

1209

3.51

113.37

1.7

1.3

225.87

302.84

ug/g

12.38

289

648

Fentanyl

314

784

4.20

112.67

1.5

1.4

208.52

283.41

ug/g

7.69

187

459

Mental and behavioural disorders due to alcohol

1178

5621

2.06

111.69

1.5

1.4

254.04

270.01

ug/g

1.50

653

3277

Non-invasive ventilation

495

1462

3.10

111.41

1.6

1.3

252.73

289.44

ug/g

3.29

306

806

Episodal and paroxysmal disorders

2350

7077

1.71

111.38

1.4

289.40

272.67

ug/g

2.40

1291

4088

Nephropathy related operations

402

1206

3.53

111.12

1.5

1.4

236.01

271.57

ug/g

2.84

278

722

Myalgia

599

2249

2.75

110.15

1.5

1.4

303.17

273.77

ug/g

2.59

342

1303

Continuous positive airway pressure

440

1141

3.35

110.13

1.5

1.3

262.57

280.32

ug/g

0.88

264

659

Rheumatism, unspecified

434

1373

3.32

109.69

1.5

1.4

288.19

276.50

ug/g

0.50

236

802

Ascites

244

514

5.06

109.48

1.5

1.3

230.89

279.13

ug/g

2.74

160

306

Injuries to the head

2417

9006

1.67

109.47

1.4

271.92

278.39

ug/g

0.72

1374

5151

2468

7702

1.68

108.90

1.4

279.93

274.83

ug/g

0.52

1387

4453

Other joint disorders

1855

5461

1.82

108.41

1.5

1.4

294.07

273.05

ug/g

2.57

1021

3057

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1428

7560

1.90

108.35

1.5

1.4

259.02

275.40

ug/g

2.19

871

4363

Neuroendocrine tumor and carcinoma of pancreas

29.59

107.66

1.9

1.3

205.98

320.51

ug/g

2.34

Somatoform disorder

469

1570

3.12

107.28

1.4

316.96

277.49

ug/g

3.35

248

908

Alcohol use disorder, ICD-based

985

4672

2.16

106.61

1.5

1.4

249.11

267.54

ug/g

1.60

541

2760

Pure hypercholesterolaemia

1646

5914

1.85

106.27

1.5

1.4

256.55

273.87

ug/g

2.76

1009

3454

Fall on same level

2449

8147

1.66

105.86

1.4

267.36

281.91

ug/g

2.46

1409

4642

ILD medications: immunosuppressive drugs

1394

6920

1.90

105.63

1.5

1.4

277.93

277.60

ug/g

0.02

827

3954

Hypo-osmolality and hyponatraemia

514

1819

2.93

105.26

1.5

1.4

245.48

274.39

ug/g

2.28

307

1089

Lumbar disc prolapse

1371

5536

1.93

104.98

1.5

1.4

273.91

269.02

ug/g

0.37

829

3218

Other disorders of lacrimal gland

896

4130

2.23

104.74

1.5

1.4

290.56

272.72

ug/g

1.67

511

2385

Iron deficiency anaemia

1040

4993

2.10

104.60

1.5

1.4

257.78

274.79

ug/g

1.81

617

2881

Other heart diseases, wide

1975

7020

1.75

104.36

1.4

275.72

282.96

ug/g

0.76

1115

3949

Vocal cord dysfunction

315

734

3.97

103.34

1.3

300.07

278.27

ug/g

0.95

180

402

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

236

511

4.97

102.81

1.5

176.50

283.85

ug/g

10.08

144

311

Asthma-related infections

1336

6981

1.91

102.72

1.4

282.32

276.06

ug/g

0.51

804

3970

Asthma, hospital admission 2, infections

1336

6981

1.91

102.72

1.4

282.32

276.06

ug/g

0.51

804

3970

Fibromyalgia

293

753

4.11

101.61

1.5

1.4

323.17

293.18

ug/g

1.32

154

416

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

577

2201

2.67

101.41

1.4

277.80

288.28

ug/g

0.51

325

1225

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

934

2688

2.24

100.73

1.4

268.62

297.62

ug/g

3.47

535

1452

Other reaction to severe stress, and adjustment disorders

801

3577

2.29

100.60

1.5

1.4

291.65

284.83

ug/g

0.37

444

1994

Disorders of lacrimal system

1049

5200

2.06

100.29

1.5

1.4

288.79

272.49

ug/g

1.71

598

3026

Cough

912

4054

2.17

99.90

1.4

298.79

266.49

ug/g

4.47

548

2377

Viral and other specified intestinal infections

604

2293

2.60

99.80

1.5

1.4

281.40

293.62

ug/g

0.70

364

1230

Biguanides

2072

7546

1.70

99.12

1.5

1.4

254.46

280.94

ug/g

6.39

1228

4357

Heartburn

281

714

4.11

98.51

1.4

1.3

276.43

288.66

ug/g

0.39

146

408

Enterocolitis due to Clostridium difficile

356

1067

3.53

98.48

1.6

1.4

252.23

277.62

ug/g

1.41

217

630

Other nutritional deficiencies

1450

7601

1.83

96.68

1.4

285.75

278.52

ug/g

0.62

800

4327

Care involving use of rehabilitation procedures

1366

6857

1.86

96.66

1.5

1.4

270.65

284.33

ug/g

1.68

877

3860

Antihypertensive medication - note that there are other indications

1155

3028

2.05

96.45

1.4

1.3

293.38

302.44

ug/g

0.64

620

1606

Diseases of arteries, arterioles and capillaries (FINNGEN)

596

1581

2.69

96.37

1.5

1.4

246.78

279.04

ug/g

3.18

380

907

Other disorders of glucose regulation and pancreatic internal secretion

293

785

3.97

96.13

1.7

1.4

206.16

288.47

ug/g

7.87

181

452

Asthma (diagnoses ohter than nonallergic)

1885

9334

1.70

95.95

1.5

1.4

285.18

275.04

ug/g

1.27

1126

5288

Exposure to unspecified factor

2132

9415

1.65

95.05

1.4

275.06

277.46

ug/g

0.20

1238

5373

Gastric ulcer

454

1595

2.95

95.02

1.5

1.4

250.01

268.56

ug/g

1.07

284

957

Other and unspecified iron deficiency

829

3868

2.20

93.73

1.5

1.4

261.23

276.33

ug/g

1.25

488

2237

Other diseases of stomach and duodenum

226

510

4.75

93.50

1.6

1.4

233.30

278.11

ug/g

2.42

131

302

Factors influencing health status and contact with health services

568

1021

2.84

93.31

1.4

283.93

282.17

ug/g

0.06

335

586

Genitourinary diseases

1154

2882

2.04

93.19

1.4

278.32

271.52

ug/g

0.41

661

1673

Benign neoplasm: Colon, unspecified

677

2944

2.38

91.57

1.4

267.92

266.98

ug/g

0.04

411

1765

Transplanted organ and tissue status

311

896

3.67

91.52

1.5

1.4

263.18

273.45

ug/g

0.36

205

520

Malignant neoplasm of other and unspecified parts of biliary tract

12.15

91.02

1.6

1.3

116.93

316.09

ug/g

12.20

Nonorganic sleeping disorders, excluding more controls

435

1535

2.92

90.00

1.4

318.76

282.41

ug/g

1.16

240

873

Disorders of other endocrine glands

1021

5134

2.00

89.72

1.5

1.4

275.67

280.18

ug/g

0.28

605

2917

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1484

7605

1.78

89.35

1.5

1.4

275.62

267.79

ug/g

0.55

885

4451

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

428

1517

2.96

88.77

1.5

1.4

248.93

262.53

ug/g

0.57

251

913

Alcoholic liver disease

314

931

3.57

88.45

1.5

250.49

264.17

ug/g

0.42

175

560

Chronic lower respiratory diseases

2516

8582

1.58

88.31

1.4

281.80

276.51

ug/g

0.57

1460

4877

Behavioural syndromes associated with physiological disturbances and physical factors

1947

8435

1.66

88.21

1.4

298.87

274.19

ug/g

3.81

1065

4856

Hypothyroidism, strict autoimmune

1478

5486

1.80

87.91

1.4

283.61

277.16

ug/g

0.51

819

3106

Fissure and fistula of anal and rectal regions

487

1846

2.71

87.69

1.4

289.57

277.83

ug/g

0.49

263

1086

Extracorporeal dialysis

229

551

4.50

87.67

1.6

1.4

232.29

281.39

ug/g

2.75

150

334

Spinal stenosis

1116

4431

1.95

87.43

1.5

1.4

271.08

260.23

ug/g

0.99

678

2652

Intestinal adhesions without obstruction

237

583

4.28

87.20

1.6

1.4

232.16

283.97

ug/g

2.99

154

342

Crohn disease

350

1122

3.25

86.32

1.5

1.4

281.03

287.33

ug/g

0.20

189

625

Disorders of thyroid, IBD co-morbidities

330

672

3.53

85.56

1.4

1.3

278.08

282.34

ug/g

0.11

198

371

Falls/tendency to fall

2232

6990

1.62

85.36

1.4

277.63

281.81

ug/g

0.31

1263

3968

KRA_PSY_EATING, excluding more controls

199

430

4.78

85.30

1.3

317.01

320.42

ug/g

0.06

204

Bronchitis

2248

8981

1.60

85.29

1.4

279.83

275.73

ug/g

0.38

1265

5165

Acute tubulo-interstitial nephritis

1353

6584

1.80

85.22

1.5

1.4

252.48

278.20

ug/g

4.49

793

3729

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1297

7277

1.81

85.02

1.5

1.4

257.60

273.89

ug/g

2.05

793

4208

Pain and other conditions associated with female genital organs and menstrual cycle

438

1455

2.84

84.94

1.3

334.05

284.89

ug/g

4.26

214

730

Ulcerative colitis

580

2432

2.45

84.75

1.5

1.4

272.90

275.03

ug/g

0.09

353

1384

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

254

436

4.27

84.63

1.5

1.4

288.72

262.57

ug/g

0.41

152

262

Finngen Rheumatological endpoints

1980

6904

1.65

84.52

1.4

291.18

272.67

ug/g

3.16

1140

3880

Malignant neoplasm

1783

6316

1.69

84.22

1.5

1.4

241.88

293.06

ug/g

18.64

1073

3565

Migraine

1029

4314

1.97

84.16

1.4

315.08

283.67

ug/g

4.57

517

2420

Mycoses

1792

9553

1.65

83.07

1.4

276.76

276.41

ug/g

0.02

1040

5460

983

5056

1.97

82.87

1.4

289.37

279.18

ug/g

0.80

578

2869

Infections of the skin and subcutaneous tissue

1252

6938

1.82

82.87

1.5

1.4

261.38

278.07

ug/g

2.00

756

3947

Other retinal disorders

1436

6447

1.77

82.69

1.5

1.4

252.04

267.78

ug/g

2.24

905

3770

Convulsions, not elsewhere classified

490

1892

2.62

82.57

1.4

250.45

285.49

ug/g

2.66

287

1081

Diseases of the eye and adnexa

1576

4542

1.76

82.25

1.4

282.73

280.97

ug/g

0.11

921

2488

Polyneuropathies and other disorders of the peripheral nervous system

566

2403

2.44

80.91

1.6

1.4

244.00

269.44

ug/g

2.12

358

1442

Dermatitis and eczema

2291

9180

1.56

79.89

1.4

281.90

274.92

ug/g

0.78

1279

5293

Codes for special purposes

1155

6378

1.84

79.69

1.4

276.45

276.31

ug/g

0.01

663

3632

Alcohol dependence

626

2788

2.31

79.64

1.5

253.32

269.37

ug/g

0.87

332

1659

Malignant neoplasm of small intestine, including Hilmo

140

241

6.49

79.60

1.5

205.84

299.44

ug/g

5.86

103

138

Malignant neoplasm, wide definition for exclusion

1807

6460

1.66

79.53

1.5

1.4

243.66

293.80

ug/g

18.32

1088

3638

Secondary hypertension

236

611

4.01

79.31

1.6

1.4

249.84

290.85

ug/g

2.02

155

352

Provisional assignment of new diseases of uncertain etiology

1152

6374

1.84

78.97

1.4

276.78

276.36

ug/g

0.02

660

3630

Acute sinusitis

1081

5414

1.88

78.96

1.4

297.28

281.86

ug/g

1.47

606

3084

Haemorrhage from respiratory passages

749

3213

2.15

78.93

1.4

267.45

257.01

ug/g

0.66

445

1916

Cholecystitis

329

1072

3.18

78.73

1.5

1.3

252.74

304.67

ug/g

1.60

207

623

Disorders of adult personality and behaviour

631

2831

2.28

78.68

1.4

302.01

287.71

ug/g

0.47

344

1529

Volume depletion

281

835

3.53

78.65

1.5

1.4

238.82

275.60

ug/g

2.05

173

493

Glomerular disorders in diseases classified elsewhere

334

1104

3.17

78.55

1.6

1.4

210.65

280.22

ug/g

8.50

241

647

Other arrhythmias

1379

6000

1.76

78.54

1.5

1.4

285.01

277.34

ug/g

0.70

784

3424

Abnormal findings on examination of blood, without diagnosis

1039

5110

1.91

78.54

1.5

1.4

262.85

264.16

ug/g

0.07

607

3056

Other and unspecified polyneuropathies, also in other diseases

503

2056

2.54

78.29

1.6

1.4

242.70

266.49

ug/g

1.87

318

1239

Generalized anxiety disorder

359

1234

3.00

78.04

1.4

1.3

295.26

301.45

ug/g

0.19

165

661

Cervical disc disorders

791

3887

2.08

78.01

1.4

276.92

265.48

ug/g

0.80

449

2289

Diseases of the musculoskeletal system and connective tissue

1011

2571

2.00

77.78

1.4

299.58

276.97

ug/g

2.16

540

1424

Alcohol abuse, main dg, excluding more controls

343

1153

3.07

77.70

1.5

1.4

254.19

273.37

ug/g

0.74

194

651

Nonalcoholic fatty liver disease

302

950

3.35

77.40

1.4

290.30

291.08

ug/g

0.02

177

542

Persistent mood disorders

475

1900

2.58

77.06

1.5

1.4

280.77

273.90

ug/g

0.15

263

1074

Candidiasis

687

3221

2.19

77.03

1.5

1.4

289.13

281.16

ug/g

0.43

395

1827

Sleep apnoea, including avohilmo

2077

8209

1.59

76.78

1.5

1.4

287.12

271.25

ug/g

2.68

1164

4796

Acute upper respiratory infections

2152

8529

1.57

76.58

1.4

284.23

274.06

ug/g

1.32

1204

4943

Special screening examination for infectious and parasitic diseases

436

1187

2.75

76.38

1.4

1.3

289.45

281.70

ug/g

0.24

212

650

Kidney transplant status

193

453

4.60

76.30

1.5

253.00

289.63

ug/g

1.43

125

265

Symptoms and signs involving the skin and subcutaneous tissue

1499

8838

1.68

75.91

1.4

288.78

274.20

ug/g

1.86

841

5103

Other diseases of upper respiratory tract

2271

7670

1.56

75.53

1.4

285.99

269.88

ug/g

2.84

1296

4423

Pain in thoracic spine

376

1358

2.86

74.84

1.4

1.3

284.57

276.66

ug/g

0.28

202

777

Obesity related asthma

804

4051

2.03

74.21

1.5

1.4

290.96

274.11

ug/g

1.39

458

2321

Other general symptoms and signs

168

356

4.96

73.84

1.3

1.4

317.84

318.09

ug/g

0.00

188

Sleep apnoea

1960

8085

1.59

73.64

1.5

1.4

286.50

269.51

ug/g

2.92

1091

4757

Diabetic maculopathy, excluding more controls

291

920

3.30

73.60

1.6

1.3

223.72

297.11

ug/g

7.77

200

541

Sleep disorders

1811

8226

1.61

73.47

1.4

302.94

274.54

ug/g

4.50

990

4743

Personality disorders

598

2701

2.27

73.44

1.4

299.31

285.35

ug/g

0.43

323

1481

L04AD Calcineurin inhibitors

317

1058

3.15

73.40

1.4

264.29

288.65

ug/g

1.24

210

622

Ischemic heart diseases

1780

6647

1.63

73.09

1.5

1.4

272.32

271.62

ug/g

0.05

1045

3865

Osteoporosis

673

2987

2.17

72.43

1.5

1.4

260.76

270.57

ug/g

0.64

406

1765

Ulcerative colitis, NAS

348

1233

2.93

71.92

1.6

1.4

282.72

286.47

ug/g

0.12

217

698

5-aminosalicylic acid

494

2076

2.44

71.89

1.5

1.4

283.73

275.17

ug/g

0.38

291

1172

Asthma, including avohilmo

2393

8946

1.52

71.54

1.4

288.69

273.69

ug/g

2.69

1404

5080

Obesity and other hyperalimentation

1307

7432

1.72

71.45

1.4

283.95

279.07

ug/g

0.35

727

4225

Diseases of the respiratory system

1291

3665

1.79

71.20

1.4

282.68

274.26

ug/g

0.65

731

2072

Solid cancers, helper endpoint

1709

6243

1.64

71.17

1.5

1.4

240.98

292.45

ug/g

18.28

1035

3528

Vitamin B12 deficiency anaemia

310

1039

3.12

71.16

1.6

1.4

243.56

275.20

ug/g

2.02

208

612

Obesity

1299

7398

1.72

71.00

1.4

284.56

279.28

ug/g

0.39

721

4204

Acute upper respiratory infections of multiple and unspecified sites

1523

6866

1.66

70.88

1.4

286.76

276.80

ug/g

0.98

848

3952

Hard cardiovascular diseases

1765

6582

1.62

70.67

1.5

1.4

272.54

274.38

ug/g

0.13

1028

3806

Disorders of choroid and retina

1721

7674

1.62

70.39

1.5

1.4

253.94

270.77

ug/g

2.87

1065

4479

Glomerular diseases

460

1895

2.51

70.36

1.6

1.4

220.48

274.13

ug/g

7.42

330

1116

Polyuria

540

2388

2.33

70.15

1.4

285.07

264.22

ug/g

1.37

309

1449

Any death

1395

5965

1.71

69.87

1.4

212.27

275.93

ug/g

25.27

870

3546

Arthropathies

1746

5476

1.63

69.86

1.4

288.84

273.58

ug/g

1.96

959

3067

Symptoms and signs involving the nervous and musculoskeletal systems

1243

7297

1.73

69.74

1.5

1.4

290.36

271.74

ug/g

2.38

749

4193

Other external causes of accidental injury

1644

5023

1.66

69.57

1.4

275.65

282.19

ug/g

0.55

933

2861

Cervicalgia

481

2032

2.43

69.27

1.4

300.39

271.84

ug/g

2.30

278

1185

Percutaneous Coronary Intervention

1683

6440

1.62

68.37

1.5

1.4

273.37

271.12

ug/g

0.16

1007

3753

Substance use, excluding alcohol

450

1864

2.48

67.70

1.5

1.4

268.06

279.51

ug/g

0.51

256

1058

Other CVD (FINNGEN)

308

790

3.14

67.58

1.5

1.4

273.08

280.15

ug/g

0.23

200

468

IBD patients in KELA-register

497

2156

2.36

67.27

1.5

1.4

287.49

278.32

ug/g

0.42

279

1214

Vascular disorders of the intestines

179

434

4.33

67.17

1.6

1.3

239.41

284.55

ug/g

2.02

113

268

Coronary revascularization (ANGIO or CABG)

1678

6441

1.62

66.97

1.5

1.4

273.16

271.11

ug/g

0.14

1006

3754

Poisoning by drugs, medicaments and biological substances

530

2370

2.29

66.80

1.5

1.4

288.64

287.58

ug/g

0.02

314

1290

Covid-19 confirmed case

815

4290

1.94

66.14

1.4

269.53

271.09

ug/g

0.07

471

2503

Emergency coronary revascularization (for ACS)

1807

7028

1.58

66.08

1.5

1.4

272.79

269.75

ug/g

0.24

1087

4105

Hypoglycaemia, other or unspecified

216

608

3.76

66.01

1.7

1.5

215.46

292.39

ug/g

5.23

139

347

Cerebrovascular diseases (FINNGEN)

634

2106

2.17

65.74

1.5

1.4

267.09

285.91

ug/g

1.34

367

1176

Diseases of arteries, arterioles and capillaries

1422

6410

1.66

65.68

1.5

1.4

244.50

267.87

ug/g

4.27

893

3767

Missing teeth due to accident, extraction or parodontitis

1287

7295

1.69

65.52

1.5

1.4

265.85

268.29

ug/g

0.16

746

4290

Crohn's disease of small intestine

201

541

3.91

65.47

1.4

285.67

299.58

ug/g

0.35

299

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1964

8234

1.55

65.33

1.4

267.50

274.54

ug/g

0.60

1151

4754

Chronic apical periodontitis

2252

8603

1.51

65.19

1.4

272.64

276.98

ug/g

0.40

1268

4961

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

158

358

4.71

65.13

1.5

1.4

171.86

288.09

ug/g

8.11

218

Obesity due to excess calories

982

5516

1.81

64.56

1.4

283.29

281.22

ug/g

0.11

539

3099

Any event in cancer register

1824

6918

1.57

64.17

1.4

249.82

291.51

ug/g

12.92

1096

3867

Deforming dorsopathies

596

2845

2.14

63.69

1.5

1.4

294.16

272.60

ug/g

1.75

347

1641

Specific personality disorders

510

2290

2.28

63.65

1.4

312.85

288.52

ug/g

0.77

274

1246

Asthma, hospital admissions , main diagnosis only

1658

9389

1.58

63.62

1.4

286.82

276.43

ug/g

1.20

960

5349

Accidents

1614

5023

1.63

63.58

1.4

273.67

282.19

ug/g

0.79

912

2861

Other diseases of oesophagus

246

769

3.33

63.44

1.5

1.4

258.97

275.60

ug/g

0.58

152

448

Viral and other specified intestinal infections

416

1665

2.49

63.41

1.5

1.4

280.96

297.31

ug/g

0.84

253

860

Other arthrosis

1081

4266

1.78

63.35

1.4

291.53

261.78

ug/g

2.87

639

2473

Menorrhagia

700

1880

2.11

63.32

1.4

1.3

302.68

274.72

ug/g

2.69

371

1035

L04AA Selective immunosuppressants

537

2473

2.23

63.26

1.4

276.20

277.28

ug/g

0.04

338

1413

Other diseases of hard tissues of teeth

1161

3435

1.77

62.71

1.4

275.85

269.20

ug/g

0.48

702

2031

Erysipelas

1444

6849

1.63

62.27

1.5

1.4

250.25

280.76

ug/g

6.67

858

3970

Excessive, frequent and irregular menstruation

747

2040

2.04

62.20

1.4

1.3

305.00

278.60

ug/g

2.50

399

1092

Ventral hernia

563

2660

2.17

62.09

1.6

1.4

248.97

267.63

ug/g

1.34

336

1568

Asthma-related pneumonia

792

4209

1.92

61.99

1.5

1.4

270.45

271.12

ug/g

0.03

490

2447

Insomnia

1728

8151

1.56

61.91

1.4

303.79

275.14

ug/g

4.36

939

4669

Asthma, hospital admissions 3, pneumonia

792

4217

1.91

61.62

1.5

1.4

270.45

271.08

ug/g

0.03

490

2452

Asthma-related pneumonia or sepsis

792

4217

1.91

61.62

1.5

1.4

270.45

271.08

ug/g

0.03

490

2452

Bipolar affective disorders

394

1603

2.52

61.57

1.5

1.4

287.55

289.25

ug/g

0.05

216

877

STROKE

1124

4436

1.75

61.50

1.4

269.35

277.11

ug/g

0.40

654

2543

Elevated blood glucose level

249

803

3.26

61.32

1.6

1.4

226.72

283.61

ug/g

3.52

138

468

Dermatitis

1268

7717

1.66

61.22

1.4

279.66

274.10

ug/g

0.41

724

4471

Heart failure and antihypertensive medication

532

1556

2.29

61.15

1.5

1.4

241.78

267.10

ug/g

2.01

344

909

Hypothyroidism, other/unspecified

1775

7600

1.55

60.91

1.4

283.28

273.61

ug/g

1.07

985

4340

Cutaneous abscess, furuncle and carbuncle

573

2745

2.14

60.80

1.5

1.4

265.09

276.89

ug/g

0.68

350

1554

Inflammatory diseases of female pelvic organs

1227

5417

1.69

60.22

1.4

1.3

300.65

289.36

ug/g

1.01

659

2988

Type 1 diabetes, definitions combined

229

705

3.35

60.06

1.7

1.3

235.27

334.17

ug/g

9.99

154

353

External causes of morbidity and mortality

1271

3779

1.70

59.73

1.4

276.73

285.63

ug/g

0.69

707

2130

Temporomandibular joint disorders, including avohilmo

878

4809

1.83

59.71

1.4

298.84

288.98

ug/g

0.66

457

2631

Atrial fibrillation and flutter

627

1962

2.11

59.46

1.4

279.20

282.12

ug/g

0.12

383

1113

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

540

2520

2.17

59.44

1.4

207.16

286.29

ug/g

15.41

355

1478

Problems related to lifestyle

250

823

3.15

58.98

1.6

1.4

266.89

287.29

ug/g

0.62

118

461

Malignant neoplasm of small intestine

101

171

6.62

58.56

1.4

196.79

309.21

ug/g

6.34

Other symptoms and signs involving cognitive functions and awareness

962

5013

1.78

58.51

1.5

1.4

267.30

263.20

ug/g

0.25

538

2974

Major coronary heart disease event

1745

6872

1.55

58.49

1.5

1.4

270.85

270.60

ug/g

0.02

1044

4009

Early onset COPD, excluding more controls

436

1899

2.35

58.48

1.5

1.4

268.79

262.99

ug/g

0.23

262

1122

Injuries to the shoulder and upper arm

1698

8974

1.54

58.39

1.4

277.69

272.38

ug/g

0.37

1023

5177

Coeliac disease

310

1156

2.78

58.36

1.5

1.4

262.82

299.24

ug/g

2.23

199

634

Ovarian cyst

688

1977

2.04

58.21

1.4

1.3

297.73

277.34

ug/g

1.52

381

1071

Carpal tunnel syndrome

1251

6771

1.65

58.11

1.5

1.4

276.50

274.39

ug/g

0.10

726

3908

Chronic sinusitis

868

4848

1.82

58.00

1.4

307.31

271.71

ug/g

5.33

502

2774

Disorders of lens

1387

5380

1.63

57.74

1.5

1.4

253.39

269.96

ug/g

2.16

839

3175

Diseases of pulp and periapical tissues, including avohilmo

2075

7241

1.50

57.69

1.4

275.17

276.52

ug/g

0.10

1172

4149

Disorders of the thyroid gland

1855

8031

1.52

57.64

1.4

282.39

272.38

ug/g

1.18

1040

4589

Type 1 diabetes, strict (exclude DM2)

228

720

3.27

57.40

1.7

1.3

235.27

326.40

ug/g

8.62

154

363

Implicit fungal Sepsis

208

627

3.51

57.34

1.6

1.4

254.66

282.75

ug/g

1.12

120

363

Intracranial injury

1164

6686

1.67

57.00

1.4

275.07

273.82

ug/g

0.07

660

3872

Disorders of mineral metabolism

244

813

3.15

56.81

1.4

244.52

284.12

ug/g

2.03

153

467

Persons encountering health services for specific procedures, not carried out

220

689

3.33

56.65

1.4

258.70

302.58

ug/g

2.06

134

364

Disease of hard tissues of teeth, NOS

1090

3304

1.75

56.59

1.4

278.20

268.53

ug/g

0.76

633

1952

Hypothyreosis and Thyroxine purchase for inclusion criteria

1820

7942

1.52

56.55

1.4

283.52

274.28

ug/g

1.03

1017

4544

Systemic connective tissue disorders

779

4261

1.87

56.24

1.4

296.87

272.68

ug/g

2.68

431

2469

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1035

5968

1.71

55.65

1.4

290.81

268.66

ug/g

2.88

624

3446

Visual disturbances and blindness

1084

6523

1.69

55.62

1.4

291.71

272.38

ug/g

1.44

612

3784

Other systemic involvement of connective tissue (FG)

579

2843

2.06

55.40

1.4

297.15

265.95

ug/g

3.15

324

1622

Poisoning by medicine

461

2104

2.24

55.39

1.5

1.4

290.68

287.88

ug/g

0.06

273

1142

ILD medications: azathioprine

341

1367

2.57

55.24

1.5

1.4

278.02

282.89

ug/g

0.15

192

798

Emotionally unstable personality disorder

276

996

2.86

55.13

1.4

309.82

312.48

ug/g

0.06

139

498

Coxibs

533

1278

2.23

55.10

1.5

1.4

288.29

258.03

ug/g

2.12

299

760

Malignant neoplasm of stomach, including Hilmo

170

461

3.88

54.84

1.6

1.5

233.93

289.98

ug/g

3.47

134

280

Injuries to the thorax

938

5454

1.75

54.68

1.5

1.4

254.88

267.78

ug/g

1.10

547

3196

Mycoses

593

3000

2.02

54.34

1.5

1.4

270.20

272.40

ug/g

0.09

368

1736

Viral infections characterized by skin and mucous membrane lesions

1692

9654

1.51

54.09

1.4

277.40

276.47

ug/g

0.06

983

5510

Polycystic ovarian syndrome, consortium definition

1397

5220

1.61

54.08

1.4

1.3

300.44

289.57

ug/g

1.05

768

2864

Malignant neoplasm of stomach

153

390

4.14

53.94

1.7

1.5

226.25

291.34

ug/g

3.98

123

236

Panic disorder

301

1151

2.68

53.58

1.4

1.3

301.27

296.50

ug/g

0.12

148

617

Diseases of oral cavity, salivary glands and jaws

1134

3466

1.70

53.51

1.4

270.74

268.81

ug/g

0.11

671

2047

Hyperkalaemia

168

461

3.84

53.37

1.6

1.4

203.28

269.62

ug/g

3.67

111

276

Ulcer of lower limb, not elsewhere classified

354

1472

2.49

53.25

1.6

1.4

230.79

265.66

ug/g

2.64

224

889

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

577

2916

2.02

52.79

1.4

277.80

288.17

ug/g

0.52

325

1575

Presence of other functional implants

1218

5234

1.64

52.52

1.5

1.4

265.24

267.40

ug/g

0.13

745

3083

Exposure to other specified factors

1469

8816

1.55

52.39

1.4

277.21

278.97

ug/g

0.11

841

5049

Arthrosis

1364

4710

1.61

52.34

1.4

294.26

264.54

ug/g

5.46

796

2714

Endometriosis

653

1952

1.99

52.16

1.4

1.3

309.88

276.37

ug/g

3.47

342

1058

Migraine with aura

478

2264

2.15

52.14

1.3

1.4

319.02

289.97

ug/g

2.03

238

1235

Chronic rhinitis, nasopharyngitis and pharyngitis

655

3474

1.92

51.98

1.4

306.35

272.04

ug/g

3.90

373

1977

Visual disturbances

1002

6018

1.69

51.97

1.4

293.81

272.87

ug/g

1.51

573

3490

Azathioprine

341

1409

2.49

51.81

1.5

1.4

278.02

283.46

ug/g

0.18

192

820

Inflammatory bowel disease, strict (require KELA)

497

2399

2.12

51.78

1.5

1.4

287.49

279.69

ug/g

0.34

279

1356

Hyperkinetic disorders, excluding more controls

193

558

3.38

51.63

1.3

316.49

333.68

ug/g

0.43

273

Oter anti-inflammatory and antirheumatic agents, non-steroids

445

1073

2.33

51.49

1.5

1.4

272.13

246.91

ug/g

1.65

277

651

Other diseases of lip and oral mucosa

854

4927

1.77

51.48

1.4

274.35

275.63

ug/g

0.06

478

2836

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

360

1528

2.42

51.48

1.4

276.55

290.46

ug/g

0.54

202

833

303

1188

2.63

51.45

1.3

1.4

279.33

296.16

ug/g

0.63

176

645

Hernia of abdominal wall

946

5627

1.71

50.95

1.5

1.4

271.95

266.82

ug/g

0.21

560

3298

Nonorganic sleeping disorders

435

2011

2.22

50.73

1.4

318.76

286.02

ug/g

1.00

240

1130

Disturbances of skin sensation

580

2982

1.99

50.65

1.4

316.57

277.95

ug/g

4.33

311

1663

All influenza

533

2660

2.05

50.63

1.5

1.4

278.35

276.30

ug/g

0.07

294

1563

Neuroendocrine tumor and carcinoma of small intestine

8.56

50.56

1.4

1.3

209.33

309.08

ug/g

3.89

Other acute lower respiratory infections

1050

6111

1.66

50.46

1.5

1.4

278.06

274.34

ug/g

0.22

596

3510

Suicide or other Intentional self-harm

507

2489

2.08

50.44

1.4

273.89

280.00

ug/g

0.25

292

1363

Erysipelas

1091

5939

1.65

50.36

1.5

1.4

241.47

276.25

ug/g

6.80

653

3473

Benign neoplasm: Caecum

294

1154

2.66

50.36

1.5

1.4

262.50

267.27

ug/g

0.15

179

687

Eating disorder

199

628

3.27

50.31

1.3

317.01

327.42

ug/g

0.22

284

Other cataract

915

4049

1.74

50.11

1.5

1.4

249.91

268.16

ug/g

1.84

543

2401

Acute gastritis

192

600

3.34

49.71

1.5

1.4

262.22

281.46

ug/g

0.59

112

355

Charcot foot

130

6.94

49.46

1.9

1.4

198.05

287.67

ug/g

3.41

Caries of dentine, including avohilmo

1535

5122

1.55

49.38

1.4

276.33

272.75

ug/g

0.25

888

2976

Viral hepatitis, IBD co-morbidity

108

224

4.98

49.10

1.4

1.3

253.57

286.66

ug/g

0.85

140

Other enthesopathies

586

3054

1.95

49.07

1.4

281.36

272.05

ug/g

0.50

331

1779

Other and unspecified dermatitis

1033

6348

1.65

48.91

1.5

1.4

282.01

274.32

ug/g

0.54

587

3683

Polyarthrosis

464

2063

2.14

48.88

1.5

1.4

276.00

258.04

ug/g

1.15

253

1238

Asthma/COPD (KELA code 203)

1820

8570

1.47

48.67

1.4

277.27

276.52

ug/g

0.05

1074

4869

Dental caries, including avohilmo

1446

4790

1.56

48.36

1.4

277.09

271.66

ug/g

0.42

859

2783

Candidiasis

330

1389

2.46

48.35

1.5

1.4

282.10

286.35

ug/g

0.13

199

772

Disorders of vitreous body

1048

6259

1.64

48.34

1.5

1.4

288.21

265.56

ug/g

2.01

656

3673

Benign neoplasm: Rectum, anus and anal canal

471

2298

2.11

48.01

1.5

1.4

270.42

265.89

ug/g

0.18

288

1390

Eating disorders

229

805

2.93

47.96

1.3

1.4

300.18

314.85

ug/g

0.38

107

389

Urticaria and erythema

738

4169

1.80

47.80

1.4

313.06

280.89

ug/g

3.75

388

2357

Soft tissue disorders related to use, overuse and pressure

552

2848

1.98

47.73

1.4

302.85

263.59

ug/g

4.45

321

1688

Acute bronchitis

826

4720

1.74

47.72

1.5

1.4

276.06

272.40

ug/g

0.19

460

2725

Arthropathies in other diseases classified elsewhere

122

289

4.52

47.71

1.7

1.4

224.82

265.49

ug/g

1.31

169

Hypothyroidism, strict autoimmune, 3 medication purchases required

1621

7377

1.50

47.69

1.4

283.88

276.21

ug/g

0.72

903

4209

Hyperlipidaemia, other/unspecified

783

4131

1.78

47.66

1.5

1.4

265.28

267.86

ug/g

0.13

468

2439

Diseases of peritoneum

265

1017

2.71

47.37

1.6

1.4

240.00

280.15

ug/g

2.63

173

583

Disorders of synovium and tendon

977

5197

1.67

47.37

1.4

297.76

269.75

ug/g

2.25

579

3000

Gout

552

2497

1.98

47.18

1.5

1.4

256.90

247.05

ug/g

0.54

359

1505

Disorders of vitreous body and globe

1067

6403

1.63

47.12

1.4

288.51

265.69

ug/g

2.07

666

3765

Injury, poisoning and certain other consequences of external causes

1006

2998

1.70

47.12

1.4

282.16

288.17

ug/g

0.36

558

1691

Other dialysis

116

270

4.68

46.69

1.6

1.5

240.04

282.92

ug/g

1.35

162

Acute alcohol intoxication, ICD10

426

2019

2.16

46.69

1.5

1.4

254.29

274.91

ug/g

1.00

237

1157

Dental operations

1180

3774

1.62

46.64

1.4

273.64

267.34

ug/g

0.45

703

2236

Undetermined asthma, excluding more controls

282

1120

2.59

46.57

1.4

310.54

279.32

ug/g

1.58

169

651

Benign neoplasm: Sigmoid colon

450

2185

2.12

46.54

1.5

1.4

259.58

266.62

ug/g

0.32

281

1318

Obesity, other/unspecified

673

3729

1.84

46.53

1.4

285.12

284.23

ug/g

0.04

378

2088

Other sleep disorders

260

999

2.69

46.16

1.5

1.4

310.98

272.55

ug/g

2.06

159

596

Injuries to the abdomen, lower back, lumbar spine and pelvis

805

4657

1.74

46.08

1.5

1.4

259.62

273.17

ug/g

1.02

457

2709

Benign neoplasm: Ascending colon

347

1528

2.35

46.03

1.5

1.4

264.86

268.49

ug/g

0.11

208

921

Fracture of rib(s), sternum and thoracic spine

633

3463

1.87

45.79

1.5

1.4

249.96

268.59

ug/g

1.41

367

2066

Diseases of the ear and mastoid process

2201

7864

1.42

45.66

1.4

285.81

275.32

ug/g

1.40

1225

4507

Alcohol abuse, main dg

343

1508

2.34

45.37

1.5

1.4

254.19

272.37

ug/g

0.71

194

873

Urticaria

606

3280

1.88

45.27

1.3

1.4

321.24

284.60

ug/g

3.90

318

1837

Phobic anxiety disorders

253

965

2.68

45.18

1.5

1.4

286.95

301.87

ug/g

0.48

139

506

Other symptoms and signs involving the nervous and musculoskeletal systems

847

5054

1.70

45.09

1.5

1.4

300.50

276.67

ug/g

2.42

490

2899

Cervicobrachial syndrome

442

2155

2.09

44.86

1.5

1.4

284.27

275.06

ug/g

0.43

267

1235

Acute alcohol intoxication

507

2597

1.99

44.79

1.5

1.4

253.98

272.45

ug/g

0.97

290

1525

Undetermined asthma

282

1142

2.54

44.72

1.4

310.54

279.17

ug/g

1.60

169

674

Glucagon-like peptide-1 (GLP-1) analogues

591

3189

1.89

44.70

1.4

288.32

279.17

ug/g

0.49

349

1816

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

591

3189

1.89

44.70

1.4

288.32

279.17

ug/g

0.49

349

1816

Dialysis

131

344

4.07

44.65

1.5

1.4

238.61

284.91

ug/g

1.77

209

Acetic acid derivatives and related substances

502

1261

2.10

44.62

1.4

274.81

256.30

ug/g

0.99

285

753

Preparatory care for dialysis

143

402

3.81

44.22

1.5

1.4

228.31

281.25

ug/g

2.39

103

239

Disorder of pancreatic internal secretion, other and/or unspecified

10.28

44.14

2.0

1.4

156.60

304.19

ug/g

4.31

Migraine without aura

370

1698

2.22

43.85

1.3

328.70

301.00

ug/g

1.60

187

904

Abnormal findings on diagnostic imaging of lung

971

5783

1.63

43.84

1.5

1.4

273.99

262.98

ug/g

0.58

580

3425

Diseases of pulp and periapical tissues and dental caries

1281

4230

1.57

43.81

1.4

280.45

270.71

ug/g

0.85

760

2460

Postprocedural disorders of digestive system, not elsewhere classified

117

288

4.37

43.65

1.6

1.4

245.79

303.06

ug/g

2.06

162

Other systemic involvement of connective tissue

599

3275

1.87

43.52

1.4

296.04

273.89

ug/g

1.89

340

1888

Gonarthrosis

1208

4412

1.58

43.34

1.4

285.26

262.51

ug/g

2.13

733

2547

Symptoms and signs involving speech and voice

698

3998

1.78

43.32

1.4

275.25

272.64

ug/g

0.12

416

2315

Benign neoplasm: Rectum

420

2045

2.11

43.17

1.4

264.45

264.16

ug/g

0.01

258

1240

Disorders resulting from impaired renal tubular function

125

326

4.12

43.13

1.7

1.4

252.30

282.05

ug/g

0.83

193

Pain associated with micturition

281

1160

2.50

43.06

1.4

310.73

284.14

ug/g

1.11

137

669

Carcinoid syndrome

8.71

43.03

1.5

234.81

272.69

ug/g

0.63

Venous thromboembolism

1085

6716

1.58

42.97

1.5

1.4

255.83

267.63

ug/g

1.07

646

3929

Disorders of calcium metabolism

182

604

3.16

42.86

1.4

237.71

287.11

ug/g

2.46

116

348

Disorders of conjunctiva

1575

8711

1.47

42.67

1.4

284.85

280.43

ug/g

0.35

917

4912

Ischaemic heart disease, wide definition

1540

6495

1.49

42.59

1.5

1.4

260.32

268.04

ug/g

0.75

920

3804

Colectomy operation

391

1865

2.16

42.43

1.5

1.4

242.63

269.24

ug/g

1.67

251

1128

Exclusions for E4_PCOS_CONSORTIUM

1371

5719

1.52

42.23

1.4

289.39

287.40

ug/g

0.12

760

3199

Lactose intolerance

107

252

4.54

42.21

1.4

307.20

308.61

ug/g

0.02

143

Sequelae of external causes of morbidity and mortality

546

2929

1.90

42.16

1.4

260.38

272.04

ug/g

0.63

328

1723

Subjective visual disturbances

538

2876

1.91

41.99

1.4

306.59

275.37

ug/g

1.30

309

1651

Other abnormal uterine and vaginal bleeding

457

1617

2.07

41.99

1.4

1.3

294.97

273.43

ug/g

1.34

247

902

Enthesopathies of lower limb, excluding foot

430

2133

2.06

41.66

1.5

1.4

277.32

271.85

ug/g

0.23

240

1223

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

118

302

4.14

41.58

1.9

1.4

218.01

321.88

ug/g

7.23

160

Paroxysmal tachycardia

421

1718

2.09

41.28

1.4

288.72

287.49

ug/g

0.04

243

936

Spondylolisthesis/Spondylolysis

379

1804

2.15

41.17

1.5

1.4

285.49

271.76

ug/g

0.65

218

1058

Meniscus derangement

1040

4427

1.60

41.15

1.4

290.08

263.39

ug/g

2.27

607

2557

Other and unspecified effects of external causes

546

2952

1.88

41.00

1.5

1.4

292.75

282.83

ug/g

0.48

286

1646

Exclusions for E4_PCOS_BROAD

373

1767

2.16

41.00

1.5

1.4

263.58

286.27

ug/g

1.32

218

1001

Dentofacial anomalies [including malocclusion]

1293

6938

1.51

40.96

1.4

301.43

284.58

ug/g

2.05

677

3930

Other endocrine disorders

151

438

3.47

40.94

1.4

301.82

309.49

ug/g

0.16

102

236

Unspecified haematuria

817

4079

1.69

40.83

1.5

1.4

259.11

262.08

ug/g

0.10

467

2463

Assault

274

1148

2.45

40.46

1.4

276.25

287.86

ug/g

0.33

144

624

Portal vein thrombosis

133

6.21

40.43

1.5

193.33

298.15

ug/g

4.06

Mixed and other personality disorders

192

677

2.94

40.37

1.4

266.49

300.43

ug/g

1.22

102

344

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

501

2614

1.93

40.32

1.4

287.27

306.91

ug/g

1.25

278

1384

Peripheral artery disease

869

4245

1.65

40.16

1.5

1.4

236.15

262.48

ug/g

3.61

564

2564

Oxicams

429

1169

2.12

40.11

1.4

278.15

250.56

ug/g

1.83

237

706

Unspecified fall

980

6148

1.59

40.05

1.5

1.4

274.61

272.66

ug/g

0.08

593

3529

Coxarthrosis

957

3938

1.62

40.03

1.4

270.31

258.29

ug/g

0.98

572

2308

Diabetic neuropathy

331

1513

2.27

40.00

1.8

1.5

209.62

244.19

ug/g

2.39

223

904

Retention of urine

652

3045

1.79

39.99

1.5

1.4

254.27

255.72

ug/g

0.06

385

1845

Pruritus

259

1066

2.51

39.97

1.4

271.69

287.40

ug/g

0.49

146

595

Benign neoplasm: Small intestine

133

382

3.73

39.91

1.5

223.41

277.12

ug/g

2.47

231

Immunodeficiencies

147

450

3.46

39.77

1.5

1.4

316.57

292.03

ug/g

0.68

257

Senile cataract

1216

4900

1.54

39.73

1.5

1.4

253.18

267.61

ug/g

1.58

724

2927

Other eating disorders

119

315

3.92

39.66

1.2

1.3

311.36

322.48

ug/g

0.19

150

Superficial injury of head

479

2510

1.95

39.64

1.4

282.30

274.54

ug/g

0.34

285

1472

Other protozoal intestinal diseases

160

5.48

39.61

1.5

1.4

307.30

291.97

ug/g

0.25

Atrial fibrillation and flutter with reimbursement

492

1606

1.98

39.58

1.4

275.03

277.54

ug/g

0.10

305

932

Gingivitis and periodontal diseases

1948

7196

1.41

39.46

1.5

1.4

276.30

273.43

ug/g

0.18

1123

4163

Coronary atherosclerosis

1276

5396

1.51

38.92

1.5

1.4

257.96

264.65

ug/g

0.53

764

3160

Benign neoplasm: Duodenum

103

253

4.46

38.84

1.6

1.5

206.97

279.34

ug/g

3.07

155

Abnormal findings on diagnostic imaging of other body structures

330

1528

2.23

38.75

1.6

1.4

263.92

281.74

ug/g

0.84

207

887

COPD (mode)

585

2551

1.83

38.72

1.4

261.65

262.38

ug/g

0.03

352

1525

Voice disturbances

556

3086

1.84

38.54

1.4

279.84

276.11

ug/g

0.16

327

1767

Any operation in hilmo

11.78

38.51

1.4

1.2

282.56

354.50

ug/g

0.67

Other inflammatory liver diseases

179

627

2.99

38.31

1.5

1.4

215.30

291.04

ug/g

4.55

117

367

Disorders of skin appendages

889

5603

1.61

37.86

1.4

288.28

280.31

ug/g

0.51

498

3140

Gonarthrosis [arthrosis of knee](FG)

1434

5720

1.47

37.66

1.4

280.01

265.35

ug/g

1.30

866

3311

Benign neoplasm: Stomach

252

1057

2.48

37.56

1.5

1.4

255.50

277.50

ug/g

1.00

146

615

Immunodeficiency with predominantly antibody defects

235

4.46

37.10

1.6

1.5

322.30

298.85

ug/g

0.49

140

Liquid cancers, helper endpoint

712

3710

1.70

37.07

1.4

263.34

285.77

ug/g

2.24

438

2167

Trochanteric bursitis

304

1386

2.25

36.97

1.4

305.08

272.56

ug/g

2.08

180

820

Internal derangement of knee

683

4040

1.71

36.90

1.5

1.4

271.78

265.98

ug/g

0.29

370

2321

Crohn disease (strict definition, require KELA, min 2 HDR)

163

554

3.07

36.77

1.4

299.34

295.42

ug/g

0.07

305

Other disorders of kidney and ureter

300

1366

2.27

36.76

1.5

1.4

247.03

270.93

ug/g

1.18

182

809

Adhesive capsulitis of shoulder

346

1664

2.13

36.67

1.5

1.4

273.18

267.76

ug/g

0.18

210

999

Other shoulder lesions

208

804

2.67

36.59

1.4

281.70

280.15

ug/g

0.03

121

474

Other CVD

413

2119

1.99

36.57

1.5

1.4

264.40

264.57

ug/g

0.01

262

1282

Fibroblastic disorders

443

2327

1.94

36.46

1.4

275.41

259.15

ug/g

0.91

261

1394

Cervicocranial syndrome

231

942

2.52

36.33

1.5

1.4

339.20

277.05

ug/g

1.32

143

550

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

171

603

2.95

36.08

1.5

1.4

297.55

295.25

ug/g

0.04

330

Crohn disease (strict definition, require KELA)

163

560

3.03

36.07

1.4

299.34

295.40

ug/g

0.07

308

Duodenal ulcer

220

880

2.57

36.01

1.5

1.4

222.78

270.39

ug/g

2.57

131

531

Hypotension

363

1792

2.08

35.90

1.5

1.4

264.89

262.92

ug/g

0.07

235

1095

Open wound of head

995

6274

1.55

35.90

1.5

1.4

260.46

268.67

ug/g

0.59

573

3685

Heart failure,strict

1032

4757

1.55

35.85

1.4

254.76

265.28

ug/g

0.64

668

2795

Osteomyelitis

166

579

2.99

35.81

1.5

1.4

244.57

269.68

ug/g

0.89

110

349

Other disorders of ear

1746

8241

1.40

35.69

1.5

1.4

275.81

273.26

ug/g

0.19

992

4787

Volvulus

155

5.20

35.65

1.5

1.3

269.52

297.92

ug/g

0.49

Migraine without aura and triptan purchases

301

1385

2.22

35.63

1.3

1.4

330.82

305.99

ug/g

1.12

149

738

Conjunctivitis

1387

8079

1.45

35.55

1.4

288.15

283.35

ug/g

0.36

806

4539

Other neurological diseases

1385

7582

1.45

35.51

1.4

277.97

267.52

ug/g

0.77

807

4427

Other extrapyramidal and movement disorders in other diseases

498

2745

1.85

35.41

1.4

283.53

270.13

ug/g

0.80

305

1608

Injuries to the ankle and foot

1268

7752

1.47

35.31

1.4

285.17

281.05

ug/g

0.28

712

4353

Statin medication

1232

4664

1.50

35.30

1.5

1.4

285.28

281.62

ug/g

0.24

727

2626

Post-traumatic stress disorder

156

527

3.04

35.28

1.4

1.3

304.96

308.14

ug/g

0.05

256

Adrenocortical insufficiency

118

341

3.69

35.07

1.6

1.5

247.00

287.08

ug/g

1.17

199

Abscess of anal and rectal regions

156

530

3.02

34.96

1.5

1.4

272.94

296.83

ug/g

0.68

310

Psychotic depression

129

392

3.40

34.95

1.5

1.4

267.24

273.22

ug/g

0.12

234

Sequelae with surgical and medical care as external cause

436

2317

1.93

34.87

1.5

1.4

253.92

275.26

ug/g

1.32

260

1371

Chronic laryngitis and laryngotracheitis

304

1421

2.20

34.80

1.6

1.4

302.02

265.48

ug/g

2.43

173

835

Mental and behavioural disorders due to sedatives or hypnotics

168

599

2.91

34.74

1.5

1.4

260.22

295.65

ug/g

1.15

324

Injuries to the knee and lower leg

2199

9122

1.35

34.64

1.4

268.61

278.92

ug/g

1.43

1273

5208

Cellulitis

437

2330

1.91

34.47

1.5

1.4

252.08

275.08

ug/g

1.56

274

1333

Acute peritonitis

165

586

2.94

34.46

1.6

1.4

230.51

274.89

ug/g

2.13

113

340

Chronic periodontitis, including avohilmo

1812

8866

1.38

34.45

1.5

1.4

263.97

275.00

ug/g

1.04

1055

5156

DVT of lower extremities and pulmonary embolism

816

5145

1.60

34.40

1.5

1.4

261.21

268.01

ug/g

0.41

483

3052

Disorders of oesophagus in diseases classified elsewhere

157

5.18

34.39

1.4

1.3

263.30

286.92

ug/g

0.39

Periodontitis

1816

8872

1.38

34.38

1.5

1.4

263.95

275.07

ug/g

1.06

1060

5154

Alcoholic gastritis

6.98

34.33

1.4

1.5

254.35

258.59

ug/g

0.04

Infections with a predominantly sexual mode of transmission

663

3708

1.69

34.14

1.4

296.34

293.40

ug/g

0.12

385

1952

Irregular menses

829

4130

1.60

34.11

1.4

1.3

316.53

295.70

ug/g

1.97

442

2203

Diabetic retinopathy, excluding more controls

654

2153

1.74

33.81

1.6

1.4

216.57

254.21

ug/g

4.50

426

1264

Alcohol withdrawal state with delirium

172

631

2.84

33.80

1.4

250.57

269.97

ug/g

0.46

382

Paracetamol or NSAID medication

259

532

2.48

33.78

1.5

1.4

298.77

284.21

ug/g

0.42

145

301

Other symptoms and signs involving the circulatory and respiratory systems

153

526

3.01

33.74

1.5

1.4

270.78

263.64

ug/g

0.15

309

Non-allergic asthma (mode), excluding more controls

349

1717

2.05

33.69

1.5

1.4

277.43

274.20

ug/g

0.11

212

987

Papulosquamous disorders

773

4859

1.62

33.69

1.4

274.56

272.71

ug/g

0.09

451

2797

Other and unspecified urticaria

398

2075

1.96

33.64

1.3

1.4

318.04

283.98

ug/g

2.34

200

1153

Enlarged lymph nodes

290

1351

2.19

33.31

1.5

1.4

320.78

279.68

ug/g

2.63

172

783

Crohn's disease NAS

152

525

3.01

33.30

1.5

1.4

309.43

300.05

ug/g

0.20

294

Viral infections characterized by skin and mucous membrane lesions

798

5062

1.60

33.27

1.5

1.4

272.73

277.72

ug/g

0.28

461

2909

Certain disorders involving the immune mechanism

396

2071

1.96

33.25

1.5

1.4

297.12

270.77

ug/g

1.70

241

1196

Crohn disease (strict definition, all UC cases excluded)

135

438

3.22

33.11

1.5

1.4

311.71

295.29

ug/g

0.31

249

Fungal Sepsis

116

344

3.56

33.03

1.7

1.4

233.37

295.66

ug/g

2.76

211

Dental pulpitis, including avohilmo

1647

7733

1.39

32.93

1.4

295.34

277.74

ug/g

2.51

913

4391

Thiazolidinediones

253

1126

2.32

32.82

1.4

261.87

273.40

ug/g

0.40

154

677

Migraine with aura and triptan purchases

292

1374

2.17

32.73

1.4

325.71

303.10

ug/g

0.86

140

742

Diseases of external ear

653

3967

1.67

32.71

1.4

285.43

275.20

ug/g

0.58

354

2315

Second line medication for Crohn's disease

1078

7326

1.49

32.60

1.5

1.4

279.63

278.02

ug/g

0.09

623

4203

Type 1 diabetes, strict definition, subgroup 1

142

475

3.06

32.59

1.7

1.2

252.87

361.54

ug/g

8.32

103

224

Non-allergic asthma (mode)

350

1746

2.02

32.52

1.5

1.4

277.43

275.68

ug/g

0.06

212

1012

Unspecified kidney failure

221

932

2.44

32.42

1.6

1.4

232.26

269.51

ug/g

2.13

156

563

Disorders of parathyroid gland

444

2401

1.87

32.29

1.5

1.4

263.40

275.81

ug/g

0.68

263

1420

Infections with a predominantly sexual mode of transmission

530

3048

1.76

32.27

1.5

1.4

291.09

293.62

ug/g

0.09

316

1624

Gout, idiopatic and unspecified

488

2756

1.81

32.04

1.5

258.81

258.18

ug/g

0.02

318

1673

Other protozoal intestinal diseases

103

6.17

31.96

1.6

1.3

302.24

311.46

ug/g

0.11

Gout, FINNGEN

552

3219

1.74

31.96

1.5

1.4

256.90

256.36

ug/g

0.02

359

1958

Other diseases of blood and blood-forming organs, wide

454

2514

1.84

31.86

1.4

270.84

274.48

ug/g

0.14

285

1470

Other disorders of eyelid

854

5288

1.56

31.83

1.4

283.86

264.11

ug/g

2.18

514

3113

Amenorrhoea

129

415

3.19

31.81

1.4

1.3

296.86

297.81

ug/g

0.01

197

Oesophageal varices

120

373

3.40

31.77

1.4

271.81

283.33

ug/g

0.21

222

Brachial plexus disorders

196

792

2.55

31.52

1.4

316.79

305.32

ug/g

0.27

110

421

Adverse effects, not elsewhere classified

389

2058

1.93

31.49

1.4

299.73

286.87

ug/g

0.53

194

1143

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

316

1558

2.07

31.35

1.4

1.3

302.92

297.41

ug/g

0.16

165

818

Benign neoplasm: Endocrine pancreas

9.20

31.31

1.8

1.4

218.60

296.55

ug/g

1.19

Paralytic ileus

219

4.15

31.28

1.4

295.50

276.76

ug/g

0.36

139

Other and unspecified mood [affective] disorders

139

472

3.03

31.26

1.4

276.15

294.60

ug/g

0.43

245

Other disorders of skin and subcutaneous tissue, not elsewhere classified

305

1489

2.10

31.21

1.5

1.4

258.27

277.90

ug/g

0.98

174

873

Misadventures to patients during surgical and medical care

301

1466

2.11

31.01

1.5

1.4

238.94

282.53

ug/g

3.10

178

843

Anaemia in chronic diseases classified elsewhere

210

4.31

30.87

1.7

1.5

211.80

277.60

ug/g

2.01

123

Transport accidents

783

4306

1.58

30.85

1.4

269.68

282.15

ug/g

0.85

434

2449

Superficial injury of abdomen, lower back and pelvis

299

1455

2.10

30.78

1.5

1.4

269.94

284.66

ug/g

0.54

172

806

Artrosis, including avohilmo

1507

5917

1.40

30.72

1.4

293.72

268.02

ug/g

4.70

861

3402

Hypocalcemia

216

4.27

30.63

1.4

241.15

306.82

ug/g

2.21

127

Lesion of ulnar nerve

285

1366

2.14

30.62

1.4

298.16

275.48

ug/g

0.36

155

785

Fenamates

276

857

2.23

30.58

1.4

270.64

257.79

ug/g

0.44

157

511

Noninflammatory disorders of female genital tract

681

2062

1.68

30.56

1.4

1.3

311.33

279.11

ug/g

3.08

346

1102

Extrapyramidal and movement disorders

736

4686

1.59

30.46

1.4

284.86

266.64

ug/g

1.63

452

2765

Other diseases of gallbladder

106

312

3.55

30.42

1.4

1.3

298.19

311.60

ug/g

0.23

175

Implicit fungal Sepsis

107

318

3.55

30.42

1.7

1.4

237.40

288.62

ug/g

1.83

194

Other specified/unspecified arthritis

487

2788

1.77

30.38

1.4

282.89

263.90

ug/g

1.14

273

1612

Gout, unspecified

409

2230

1.87

30.24

1.4

1.5

256.92

260.30

ug/g

0.12

266

1352

Diabetic nephropathy, excluding more controls

378

1641

1.95

30.21

1.7

1.5

211.23

250.03

ug/g

3.36

273

968

Cluster headache, strict

271

3.76

30.18

1.5

1.3

305.32

301.90

ug/g

0.04

143

Use of disulfiram, acamprosate or naltrexone

197

816

2.49

30.16

1.5

1.4

250.16

275.72

ug/g

0.85

109

481

Cluster headache, wide

102

295

3.62

30.11

1.5

1.3

304.94

300.30

ug/g

0.06

158

Diseases of male genital organs

856

2771

1.57

30.03

1.5

273.63

258.61

ug/g

1.12

519

1668

Other disorders of bladder

245

1116

2.25

30.01

1.5

1.4

267.71

265.23

ug/g

0.07

160

669

Type 1 diabetes, strict definition

149

536

2.84

29.99

1.7

1.3

251.11

346.41

ug/g

7.27

109

261

Iron deficiency anaemia secondary to blood loss (chronic)

334

1709

2.00

29.97

1.6

1.4

247.48

274.98

ug/g

1.60

192

1015

Vasomotor and allergic rhinitis

641

3885

1.64

29.89

1.4

303.76

280.06

ug/g

2.05

339

2151

Otitis externa

428

2374

1.84

29.84

1.4

297.10

277.13

ug/g

1.10

231

1360

Angina pectoris

1087

4965

1.48

29.76

1.5

1.4

262.75

263.76

ug/g

0.06

669

2925

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

310

1365

2.05

29.67

1.3

315.48

323.35

ug/g

0.22

139

665

Adenocarcinoma and papillary adenocarcinoma of stomach

194

4.30

29.51

1.7

1.4

241.58

286.17

ug/g

1.34

114

Impingement syndrome of shoulder

454

2571

1.80

29.50

1.4

282.63

262.65

ug/g

0.59

274

1525

Nonhereditary hypogammaglobulinemia

6.23

29.37

1.5

1.4

337.07

288.43

ug/g

0.91

Benign neoplasm: Transverse colon

245

1131

2.24

29.21

1.4

261.71

269.25

ug/g

0.22

147

674

Other and unspecified disorders of vitreous body

822

5342

1.54

29.13

1.4

308.30

267.63

ug/g

3.91

504

3152

Other metabolic disorders

271

1301

2.13

29.01

1.4

286.71

296.49

ug/g

0.31

156

716

Other disorders of adrenal gland

125

420

3.12

29.00

1.6

1.5

250.63

294.77

ug/g

1.45

244

Other diseases of pleura

839

4851

1.54

29.00

1.5

1.4

251.18

264.16

ug/g

1.02

516

2902

Diabetic retinopathy, strict definition

440

2189

1.83

28.98

1.7

1.5

220.80

249.62

ug/g

2.37

305

1298

Stomatitis and related lesions

386

2094

1.88

28.97

1.4

285.21

280.22

ug/g

0.17

222

1188

Coxarthrosis [arthrosis of hip](FG)

1027

4935

1.48

28.87

1.4

269.64

261.49

ug/g

0.62

617

2903

Disorders of magnesium metabolism

9.04

28.87

1.7

1.4

192.56

246.60

ug/g

0.64

Disorders of tooth development and eruption

280

1088

2.12

28.61

1.5

1.4

289.65

291.36

ug/g

0.04

164

609

Obsessive-compulsive disorder

123

410

3.08

28.60

1.4

1.3

298.70

309.08

ug/g

0.20

216

Oesophagitis

125

423

3.07

28.50

1.5

1.4

286.54

290.70

ug/g

0.08

250

Vascular diseases of the intestine

110

347

3.33

28.40

1.6

1.5

238.33

281.92

ug/g

1.45

208

Lactose intolerance, other/unspecified

227

3.97

28.37

1.4

303.86

307.81

ug/g

0.06

128

Dermatophytosis

1092

7635

1.44

28.37

1.4

267.22

274.56

ug/g

0.56

634

4411

Colonic or urogenital fistula

517

3072

1.71

28.33

1.4

286.53

271.44

ug/g

0.83

283

1782

Migraine, single triptan purchase ok & required. ICD-code if available is included

1346

6558

1.40

28.15

1.4

303.35

280.43

ug/g

3.49

731

3693

Triptan medication for migraine, single purchase ok

1346

6558

1.40

28.15

1.4

303.35

280.43

ug/g

3.49

731

3693

Monoamine oxidase A inhibitors

230

1048

2.25

28.14

1.4

291.06

270.65

ug/g

0.26

129

620

Hypermobility syndrome

124

422

3.05

27.99

1.3

338.01

323.13

ug/g

0.28

200

Other noninflammatory disorders of vulva and perineum

186

776

2.46

27.94

1.4

1.3

304.01

284.17

ug/g

0.57

106

403

Radiculopathy

304

1545

2.01

27.78

1.4

282.59

270.21

ug/g

0.48

193

928

Other postsurgical states

156

604

2.68

27.62

1.5

248.77

278.92

ug/g

1.26

114

351

Unspecified/other endometriosis

163

644

2.59

27.44

1.4

1.3

341.75

297.70

ug/g

1.50

312

Mucosal proctocolitis

232

1073

2.21

27.31

1.5

1.4

276.37

287.39

ug/g

0.32

141

605

Allergic asthma (mode), excluding more controls

362

1912

1.88

27.30

1.4

295.89

290.68

ug/g

0.17

195

1053

Other ulcerative colitis

129

455

2.94

27.30

1.5

1.4

284.12

297.38

ug/g

0.29

250

ILD, hospital admission 2, with pulmonary infections

208

923

2.32

27.23

1.4

1.5

268.23

263.48

ug/g

0.12

123

582

Coagulation defects, purpura and other haemorrhagic conditions

377

2072

1.86

27.18

1.5

1.4

288.45

276.76

ug/g

0.48

212

1195

Malnutrition

181

4.34

27.15

1.4

1.5

256.99

292.15

ug/g

0.59

113

Asthma and allergy

210

921

2.29

27.05

1.4

305.33

297.39

ug/g

0.21

116

489

Convalescence

127

447

2.95

27.03

1.6

1.4

322.21

295.82

ug/g

0.18

245

Gastrojejunal ulcer

6.82

27.00

1.8

1.3

230.81

294.35

ug/g

1.09

L04AX Other immunosuppressants

1025

7158

1.45

26.99

1.4

281.17

277.45

ug/g

0.23

592

4117

Early onset COPD

436

2508

1.77

26.97

1.5

1.4

268.79

267.53

ug/g

0.04

262

1488

Hypertensive heart and/or renal disease

473

2048

1.75

26.90

1.4

240.95

268.80

ug/g

2.37

307

1228

Atherosclerosis, excluding cerebral and coronary sclerosis

758

3926

1.55

26.88

1.5

1.4

239.86

260.85

ug/g

2.23

484

2375

Amputation of toe

164

661

2.57

26.76

1.5

236.06

263.95

ug/g

1.08

105

403

Allergic asthma (mode)

362

1925

1.86

26.75

1.4

295.89

290.27

ug/g

0.19

195

1060

Atypical facial pain

129

462

2.91

26.65

1.5

1.4

314.35

307.26

ug/g

0.13

249

Injuries to the wrist and hand

1793

9430

1.33

26.56

1.4

279.58

276.29

ug/g

0.26

1032

5408

Special screening examination for other diseases and disorders

185

788

2.39

26.40

1.5

1.4

272.32

266.51

ug/g

0.13

124

435

Right hemicolectomy

144

549

2.73

26.40

1.5

235.64

278.28

ug/g

1.61

323

Gout, strict definition

354

1930

1.87

26.28

1.5

253.43

258.21

ug/g

0.16

236

1174

Asthma and allergy, excluding more controls

210

933

2.26

26.25

1.4

305.33

299.22

ug/g

0.15

116

497

Fracture of shoulder and upper arm

668

4303

1.57

26.16

1.4

266.00

273.03

ug/g

0.38

405

2501

Peripheral artery operations in Hilmo

254

1238

2.10

26.13

1.4

240.32

268.53

ug/g

1.55

164

759

Adjustment and management of implanted device

326

1734

1.91

26.05

1.5

1.4

252.78

270.37

ug/g

0.95

201

1036

Postmenopausal bleeding

498

1549

1.74

25.99

1.4

279.92

268.43

ug/g

0.55

281

899

Other Crohn's disease

143

546

2.70

25.97

1.5

1.4

270.61

301.36

ug/g

0.96

302

COPD

823

4520

1.51

25.88

1.5

1.4

257.90

264.07

ug/g

0.37

493

2707

Adenomyosis (Endometriosis of uterus)

251

1223

2.10

25.86

1.3

311.27

275.30

ug/g

1.77

135

684

Anorexia (incl.atypical)

119

413

2.96

25.83

1.4

278.68

302.90

ug/g

0.45

204

Other chronic obstructive pulmonary disease, including avohilmo

989

5695

1.45

25.78

1.5

1.4

259.77

263.91

ug/g

0.25

583

3430

Pulmonary embolism

558

3464

1.64

25.78

1.5

1.4

254.37

271.88

ug/g

1.21

337

2071

Amputation

209

951

2.26

25.75

1.5

1.4

236.05

271.04

ug/g

1.88

140

578

Acidosis

162

4.43

25.73

1.6

1.5

246.48

268.25

ug/g

0.29

Pulmonary heart disease

558

3469

1.63

25.63

1.5

1.4

254.37

271.89

ug/g

1.21

337

2075

Female genital prolapse

512

1713

1.71

25.58

1.4

304.78

272.72

ug/g

2.84

286

963

Pulmonary heart disease, diseases of pulmonary circulation

606

3845

1.60

25.54

1.5

1.4

256.36

270.38

ug/g

0.93

366

2298

Neuralgia and neuritis, unspecified

117

407

2.98

25.44

1.6

1.4

303.30

289.44

ug/g

0.22

233

Personal history of other diseases and conditions

209

950

2.24

25.43

1.4

1.3

303.52

309.84

ug/g

0.13

465

Assault by bodily force

157

634

2.55

25.39

1.5

1.4

283.11

305.87

ug/g

0.56

339

Disturbance of activity and attention

189

810

2.33

25.34

1.3

315.79

335.43

ug/g

0.54

394

Fibrosis and cirrhosis of liver

177

758

2.42

25.33

1.4

1.5

279.61

278.77

ug/g

0.02

105

452

Heart failure, strict

1097

5493

1.42

25.19

1.4

254.27

261.59

ug/g

0.42

705

3270

All-cause Heart Failure

1083

5416

1.43

25.17

1.4

254.36

261.28

ug/g

0.38

694

3227

Vitreous haemorrhage

215

1002

2.21

25.04

1.7

1.4

218.23

273.41

ug/g

4.67

147

597

Hyperparathyroidism

376

2096

1.81

24.95

1.4

262.18

274.83

ug/g

0.61

224

1241

Hepatic failure, not elsewhere classified

103

340

3.19

24.75

1.5

214.63

292.23

ug/g

2.58

207

Propionic acid derivatives

459

1324

1.76

24.75

1.5

1.4

302.30

260.67

ug/g

3.62

267

784

Hyperplasia of prostate

605

2144

1.62

24.65

1.5

265.64

245.84

ug/g

1.38

389

1299

Peripheral arterial reconstruction

324

1755

1.88

24.56

1.5

236.49

260.04

ug/g

1.36

206

1084

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

949

6465

1.44

24.45

1.4

286.07

285.14

ug/g

0.05

549

3584

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

190

851

2.30

24.39

1.5

1.4

281.01

288.30

ug/g

0.18

113

465

Sensorineural hearing loss

1391

6999

1.36

24.34

1.5

1.4

274.19

267.45

ug/g

0.58

818

4119

Inflammatory diseases of prostate (prostatitis)

230

1111

2.12

24.30

1.5

295.03

246.51

ug/g

2.50

133

679

Diseases of salivary glands

600

3850

1.58

24.14

1.4

280.91

276.59

ug/g

0.20

337

2220

Abnormal results of function studies

187

836

2.30

24.14

1.5

1.4

292.87

284.88

ug/g

0.19

105

465

Bulimia nervosa (incl. atypical)

207

3.76

23.74

1.3

312.11

344.63

ug/g

0.52

Restless leg syndrome

278

1452

1.96

23.69

1.4

292.33

282.80

ug/g

0.34

173

832

Other chronic obstructive pulmonary disease

784

4380

1.49

23.67

1.5

1.4

259.64

263.13

ug/g

0.18

466

2628

Allergic conjunctivitis

990

6854

1.42

23.65

1.4

286.07

286.25

ug/g

0.01

572

3818

Otalgia

174

762

2.35

23.62

1.4

278.15

285.12

ug/g

0.15

407

Other specified/unspecified bacterial intestinal infections

153

634

2.50

23.59

1.5

1.4

285.20

285.68

ug/g

0.01

367

Vitamin deficiency, wide

119

438

2.83

23.40

1.5

265.90

288.78

ug/g

0.45

258

Vitamin deficiency

119

438

2.83

23.40

1.5

265.90

288.78

ug/g

0.45

258

Chronic periodontitis, complicated

1002

7094

1.41

23.36

1.5

1.4

258.18

270.06

ug/g

1.03

593

4180

Deviated nasal septum

576

3684

1.58

23.36

1.4

272.71

260.68

ug/g

0.68

334

2147

Congenital malformations, deformations and chromosomal abnormalities

1085

7225

1.39

23.25

1.4

300.29

282.84

ug/g

1.87

598

4045

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

626

4092

1.55

23.20

1.4

286.53

281.25

ug/g

0.27

372

2342

Combinations of oral blood glucose lowering drugs

510

3183

1.63

23.16

1.4

265.81

274.12

ug/g

0.40

313

1901

Other arthritis (FG)

552

3509

1.59

23.11

1.4

280.10

266.42

ug/g

0.79

315

2009

Ulcerative colitis (strict definition, require KELA)

305

1652

1.88

23.11

1.6

1.4

284.33

286.39

ug/g

0.06

182

937

Other diseases of arteries and capillaries

190

871

2.24

23.10

1.5

1.4

247.77

281.17

ug/g

1.29

113

503

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

296

1590

1.90

23.03

1.6

1.4

281.71

286.81

ug/g

0.16

178

896

Fall on same level involving ice and snow

1025

7371

1.40

22.99

1.4

276.44

273.36

ug/g

0.19

591

4261

Hyperkinetic disorders

196

889

2.20

22.90

1.3

320.89

334.38

ug/g

0.34

427

Rheumatoid arthritis

560

3199

1.59

22.86

1.4

279.85

263.28

ug/g

1.15

324

1868

Fracture of skull and facial bones

379

2196

1.75

22.85

1.4

272.72

271.10

ug/g

0.05

203

1269

Seborrhoeic keratosis

433

2605

1.69

22.83

1.4

282.77

270.39

ug/g

0.70

255

1553

Atopic dermatitis

950

5502

1.43

22.82

1.4

303.49

286.27

ug/g

1.52

493

3073

Other problems related to primary support group, including family circumstances

210

975

2.14

22.81

1.4

272.21

317.96

ug/g

2.36

127

489

Recurrent aphthous stomatitis , including avohilmo

279

1481

1.92

22.60

1.4

282.43

281.92

ug/g

0.01

156

844

Neuromuscular dysfunction of bladder

181

821

2.26

22.56

1.5

1.4

272.40

271.61

ug/g

0.02

101

470

Covid-19 suspected case

382

2227

1.74

22.53

1.5

1.4

297.34

287.41

ug/g

0.43

219

1216

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

326

1819

1.82

22.44

1.6

1.4

281.79

283.71

ug/g

0.06

197

1033

Other viral diseases

491

3048

1.63

22.41

1.4

309.66

283.99

ug/g

1.94

289

1659

Injuries to the hip and thigh

853

5392

1.45

22.39

1.4

262.25

268.38

ug/g

0.39

511

3163

Ocular pain

177

800

2.28

22.30

1.4

314.14

297.02

ug/g

0.48

428

Lateral epicondylitis

242

1230

2.01

22.25

1.4

292.86

268.18

ug/g

1.06

143

716

Cluster headache, strict, including avohilmo

115

428

2.79

22.13

1.4

297.77

300.14

ug/g

0.04

224

Gonarthrosis,primary

1625

7679

1.31

22.10

1.4

282.77

265.82

ug/g

1.88

972

4512

Other disorders of eye and adnexa

272

1443

1.92

22.07

1.4

295.15

291.64

ug/g

0.10

156

794

Other disorders of bone

356

2049

1.77

22.04

1.4

314.09

274.34

ug/g

1.07

200

1129

Trigger finger

262

1373

1.94

22.03

1.5

1.4

283.73

271.80

ug/g

0.17

159

808

Necrosis of pulp, including avohilmo

982

7042

1.40

22.01

1.4

269.84

278.45

ug/g

0.64

569

3990

Barrett oesophagus

106

379

2.90

22.01

1.8

1.4

298.75

275.80

ug/g

0.54

226

Valvular heart disease excluding rheumatic fever

834

4174

1.46

21.98

1.4

259.02

269.99

ug/g

0.86

501

2454

Sequelae of injuries, of poisoning and of other consequences of external causes

427

2585

1.68

21.93

1.6

1.4

241.58

273.83

ug/g

2.39

242

1483

Other blood glucose lowering drugs, excl. Insulins

311

1725

1.84

21.93

1.5

1.4

245.63

271.94

ug/g

1.71

202

1033

Other/unspecified enthesopathies of lower limb, excluding foot

138

564

2.51

21.83

1.4

284.85

288.41

ug/g

0.06

316

Conductive and sensorineural hearing loss

1430

7300

1.33

21.82

1.5

1.4

277.10

268.77

ug/g

0.79

839

4280

Fracture of foot, except ankle

432

2626

1.67

21.81

1.4

263.25

273.89

ug/g

0.50

256

1471

Non-rheumatic valve diseases

828

4143

1.46

21.77

1.4

259.24

269.31

ug/g

0.76

496

2437

Congenital malformations, deformations and chromosomal abnormalities

975

6677

1.40

21.67

1.4

297.80

283.71

ug/g

1.23

542

3712

Diabetic nephropathy

381

2224

1.74

21.67

1.7

1.5

210.67

244.18

ug/g

2.96

275

1326

Flatulence and related conditions

7.24

21.57

1.8

1.2

273.73

339.78

ug/g

0.73

Total colectomy

102

362

2.94

21.54

1.6

1.5

256.95

287.90

ug/g

0.64

208

Total colectomy operation

102

362

2.94

21.54

1.6

1.5

256.95

287.90

ug/g

0.64

208

Presence of cardiac and vascular implants and grafts

779

3982

1.47

21.52

1.5

1.4

255.87

262.40

ug/g

0.41

479

2395

Mental and behavioural disorders due to tobacco

181

838

2.22

21.52

1.4

272.52

278.69

ug/g

0.15

102

488

Other disorders of penis

173

786

2.25

21.44

1.6

1.5

277.99

248.07

ug/g

1.03

100

479

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

105

379

2.88

21.44

1.4

262.05

292.14

ug/g

0.75

235

Postmenopausal atrophic vaginitis

467

1562

1.67

21.40

1.4

303.89

268.20

ug/g

3.00

271

897

Artificial opening status

124

488

2.64

21.39

1.6

1.5

232.20

274.16

ug/g

1.35

292

Cluster headache, wide,, including avohilmo

120

465

2.67

21.33

1.4

297.78

302.42

ug/g

0.07

245

Unspecified privation

212

1046

2.08

21.29

1.5

1.4

243.69

286.27

ug/g

2.12

127

596

Other complications of surgical and medical care, not elsewhere classified

194

926

2.15

21.28

1.5

1.4

270.31

290.32

ug/g

0.64

118

505

Purpura and other haemorrhagic conditions

260

1377

1.93

21.26

1.5

1.4

279.93

279.59

ug/g

0.01

145

792

Other/unspecified synovitis and tenosynovitis

210

1032

2.08

21.25

1.5

1.4

303.98

275.51

ug/g

0.40

129

609

Postprocedural endocrine and metabolic disorders, not elsewhere classified

236

1210

1.99

21.22

1.5

1.4

287.69

296.68

ug/g

0.26

138

664

Erosion of teeth , including avohilmo

419

2546

1.67

21.19

1.4

275.90

285.30

ug/g

0.40

236

1401

Chronic diseases of tonsils and adenoids

1326

6288

1.34

21.16

1.4

298.18

275.33

ug/g

3.33

723

3592

Phlebitis and thrombophlebitis (not including DVT)

414

2515

1.67

21.02

1.4

261.41

274.36

ug/g

0.61

242

1474

Smoking dependency

181

846

2.20

21.02

1.4

272.52

281.21

ug/g

0.22

102

492

Lichen ruber planus, wide definition including periferal and oral lichen planus

427

2617

1.66

21.01

1.4

278.13

275.94

ug/g

0.08

248

1532

Reimbursement for rheumatic diseases

1020

7418

1.38

20.86

1.4

276.45

277.29

ug/g

0.04

597

4278

Diseases of the myoneural junction and muscle

239

1240

1.97

20.82

1.4

255.49

274.96

ug/g

0.76

131

737

Kela reimbursement Agammaglobulinemia (D80-84)

6.32

20.76

1.4

1.5

383.68

271.25

ug/g

2.76

Other disorders of veins

728

4994

1.47

20.70

1.4

271.54

276.09

ug/g

0.26

440

2891

Lichen planus, including avohilmo

374

2225

1.71

20.68

1.4

277.16

276.41

ug/g

0.02

216

1292

Disorders of ocular muscles, binocular movement, accommodation and refraction

791

5495

1.44

20.59

1.4

278.47

283.17

ug/g

0.25

433

3091

Other disorders of patella

290

1604

1.84

20.56

1.4

303.19

271.89

ug/g

1.54

154

914

Osteoporosis with pathological fracture (FG)

168

771

2.25

20.53

1.6

1.4

259.60

270.27

ug/g

0.28

104

452

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

200

980

2.09

20.53

1.4

255.77

281.52

ug/g

0.95

123

564

Diseases of tongue

129

527

2.52

20.50

1.5

1.4

296.91

281.95

ug/g

0.34

304

Fracture of lumbar spine and pelvis

405

2459

1.67

20.49

1.5

1.4

243.82

271.96

ug/g

1.98

230

1458

Degeneration of macula and posterior pole

861

4856

1.43

20.49

1.5

1.4

267.07

264.09

ug/g

0.16

508

2913

Hallux valgus (acquired)

588

2771

1.54

20.48

1.4

289.05

266.68

ug/g

0.91

346

1618

Invasive ventilation

156

695

2.31

20.44

1.7

1.4

248.79

279.99

ug/g

0.96

411

Striking against or struck by other objects

547

3566

1.55

20.44

1.5

1.4

269.58

279.94

ug/g

0.54

311

2022

Unspecified urinary incontinence

192

929

2.12

20.42

1.4

296.32

286.09

ug/g

0.24

537

Triptan medication for migraine, min. 3 purchases

913

4981

1.41

20.42

1.3

1.4

317.68

288.60

ug/g

3.53

479

2709

Other and unspecified nerve root and plexus disorders, also in other diseases

353

2073

1.73

20.39

1.5

1.4

273.58

276.04

ug/g

0.08

200

1171

Endometriosis of pelvic peritoneum

248

1244

1.93

20.37

1.4

1.3

331.47

282.07

ug/g

2.91

122

649

Palmar fascial fibromatosis [Dupuytren]

268

1452

1.88

20.37

1.4

262.55

252.76

ug/g

0.33

164

898

Excessive attrition of teeth

947

6865

1.39

20.30

1.4

285.91

278.44

ug/g

0.53

558

3870

DVT of lower extremities

352

2070

1.73

20.26

1.4

274.77

273.59

ug/g

0.03

200

1244

Other and unspecified visual disturbances

207

1032

2.06

20.26

1.4

281.37

278.35

ug/g

0.07

116

575

COPD related to multimorbidity

698

4037

1.48

20.19

1.5

1.4

256.08

258.29

ug/g

0.10

415

2438

Drug-induced adrenocortical insufficiency

175

3.87

20.13

1.7

1.4

270.69

309.96

ug/g

0.66

102

Anogenital herpesviral [herpes simplex] infection

181

859

2.15

20.10

1.4

305.30

307.25

ug/g

0.04

411

Glomerulonephritis

196

963

2.09

19.97

1.5

1.4

239.31

285.09

ug/g

2.59

134

567

Ptosis of eyelid

223

1148

1.99

19.94

1.4

280.31

272.17

ug/g

0.26

145

699

Mental and behavioural disorders due to opioids

274

3.14

19.89

1.6

1.4

250.28

312.02

ug/g

1.57

148

Abnormal serum enzyme levels

517

3268

1.56

19.87

1.4

1.5

260.55

257.38

ug/g

0.13

319

1991

Benign neoplasm: Descending colon

157

713

2.28

19.72

1.5

1.4

246.04

269.57

ug/g

0.84

108

431

Hyperhidrosis

190

3.60

19.69

1.3

334.22

305.59

ug/g

0.42

100

Injuries to the neck

387

2351

1.67

19.65

1.4

276.35

276.91

ug/g

0.02

206

1321

Superficial injury of lower leg

435

2721

1.62

19.62

1.5

1.4

265.35

280.19

ug/g

0.79

241

1538

Sulfonylureas

594

3147

1.52

19.62

1.5

1.4

240.36

268.83

ug/g

2.71

366

1893

Zoster [herpes zoster]

889

6315

1.40

19.61

1.4

276.59

269.19

ug/g

0.49

531

3669

Psoriasis

505

3277

1.56

19.46

1.4

276.23

273.77

ug/g

0.10

296

1882

Other and unspecified local infections of skin and subcutaneous tissue

186

905

2.10

19.45

1.4

241.59

282.94

ug/g

1.88

109

513

Other and unspecified tonsillitis

489

2631

1.58

19.37

1.4

305.08

286.02

ug/g

0.93

226

1465

Other viral diseases

601

4015

1.50

19.33

1.4

312.79

285.83

ug/g

2.42

341

2211

Social phobias

133

565

2.40

19.28

1.4

295.53

302.83

ug/g

0.14

289

Localized swelling, mass and lump of skin and subcutaneous tissue

560

3723

1.52

19.27

1.4

283.01

274.01

ug/g

0.45

328

2155

Complications of internal orthopaedic prosthetic devices, implants and grafts

412

2559

1.64

19.22

1.5

1.4

266.67

271.05

ug/g

0.17

255

1516

Anti-inflammatory and antirheumatic products, non-steroids

433

1324

1.66

19.06

1.5

1.4

296.25

260.67

ug/g

2.67

254

784

Explicit bacterial Sepsis

190

938

2.07

19.05

1.4

248.04

279.45

ug/g

1.11

104

563

Hypertensive Heart Disease

401

1923

1.65

19.01

1.4

234.57

266.95

ug/g

2.71

254

1151

Ulcerative colitis (strict definition, all Crohn cases excluded)

253

1377

1.87

19.00

1.6

1.4

286.74

289.60

ug/g

0.07

147

776

All influenza (not pneumonia)

257

1405

1.86

18.99

1.5

1.4

284.41

277.10

ug/g

0.21

139

826

Other specified and unspecified personality disorders

163

761

2.19

18.96

1.4

336.55

293.24

ug/g

0.44

399

Diabetic retinopathy

767

3352

1.45

18.93

1.6

1.5

214.50

250.56

ug/g

5.49

490

1989

Dislocation, sprain and strain of joints and ligaments at neck level

256

1401

1.86

18.87

1.3

1.4

295.01

291.36

ug/g

0.09

134

749

Other local infections of skin and subcutaneous tissue

194

970

2.05

18.84

1.4

248.04

281.85

ug/g

1.34

112

556

Use of pramipexole

417

2613

1.62

18.80

1.4

277.94

271.03

ug/g

0.28

250

1557

Abnormal involuntary movements

257

1412

1.86

18.80

1.5

1.4

273.73

273.91

ug/g

0.00

161

816

Bacterial pneumoniae

691

4228

1.45

18.73

1.5

1.4

252.81

272.27

ug/g

1.72

435

2485

Fitting and adjustment of other devices

593

3610

1.50

18.72

1.5

1.4

275.34

270.48

ug/g

0.23

364

2116

Umbilical hernia

451

2879

1.59

18.69

1.5

1.4

298.99

263.40

ug/g

1.24

257

1690

Other and unspecified drugs and medicaments

175

846

2.12

18.69

1.5

1.4

276.99

287.91

ug/g

0.28

105

467

Cirrhosis of liver, NAS

120

497

2.50

18.67

1.4

1.5

261.26

281.53

ug/g

0.41

308

Inflammatory disease of uterus

238

1278

1.89

18.65

1.4

1.3

327.78

299.84

ug/g

1.11

114

676

Supplementary factors related to causes of morbidity and mortality classified elsewhere

535

3551

1.52

18.56

1.5

1.4

280.01

273.77

ug/g

0.27

300

2036

Major coronary heart disease event excluding revascularizations

1069

5294

1.36

18.53

1.4

253.97

263.43

ug/g

0.80

656

3111

Lichen planus

262

1457

1.84

18.49

1.4

272.05

278.43

ug/g

0.20

153

863

Disorder of lipoprotein metabolism, unspecified

248

1356

1.87

18.42

1.5

1.4

252.99

268.80

ug/g

0.59

146

812

Conduction disorders

517

2748

1.54

18.42

1.5

1.4

249.94

264.55

ug/g

0.99

305

1636

Blepharochalasis

542

3618

1.52

18.39

1.4

281.86

268.92

ug/g

0.81

314

2171

Herpesviral [herpes simplex] infections

419

2640

1.61

18.38

1.4

269.43

286.64

ug/g

0.90

232

1471

Agoraphobia

204

3.40

18.35

1.6

1.4

282.43

306.37

ug/g

0.32

110

Dermatophytosis

243

1323

1.87

18.32

1.6

1.4

254.86

272.25

ug/g

0.67

152

773

Transient ischemic attack

933

5535

1.38

18.27

1.4

268.53

264.51

ug/g

0.17

572

3290

Other predominantly sexually transmitted diseases, not elsewhere classified

309

1804

1.73

18.22

1.4

327.18

303.60

ug/g

1.18

185

928

Follow-up examination after treatment for malignant neoplasms

171

826

2.11

18.19

1.5

1.4

272.14

261.08

ug/g

0.27

106

496

Conjunctivitis (acute, non atopic)

472

3058

1.56

18.02

1.4

293.36

279.17

ug/g

0.82

281

1705

Heart failure and coronary heart disease

744

3716

1.43

17.98

1.5

1.4

253.46

261.14

ug/g

0.49

493

2241

Disorders of sclera, cornea, iris and ciliary body

937

6919

1.37

17.98

1.5

1.4

272.96

274.40

ug/g

0.05

566

3989

Delirium, not induced by alcohol and other psychoactive substances

223

1186

1.92

17.97

1.5

1.4

240.20

267.60

ug/g

1.10

131

728

Other female pelvic inflammatory diseases

300

1748

1.75

17.96

1.4

300.71

284.91

ug/g

0.61

156

974

Cerebrovascular diseases

1313

7105

1.31

17.90

1.5

1.4

257.98

266.91

ug/g

0.85

795

4156

735

4780

1.43

17.88

1.4

277.81

261.39

ug/g

1.46

442

2883

Other enthesopathy of foot (+metatarsalgia)

180

893

2.06

17.85

1.4

264.90

280.37

ug/g

0.43

521

Late syphilis

142

4.00

17.84

1.7

1.4

208.26

286.91

ug/g

2.21

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

164

788

2.14

17.84

1.4

1.5

273.37

272.87

ug/g

0.01

462

Urolithiasis

553

3730

1.50

17.79

1.5

1.4

265.53

263.84

ug/g

0.06

308

2215

Other viral diseases, not elsewhere classified

313

1847

1.71

17.63

1.4

312.59

287.73

ug/g

1.29

190

1018

Unspecified mental disorder

664

4647

1.44

17.53

1.4

290.02

278.01

ug/g

0.82

387

2625

Disorders of breast

842

5563

1.39

17.51

1.4

295.42

288.68

ug/g

0.44

483

3069

Other symptoms and signs involving the urinary system

190

970

2.00

17.43

1.4

259.30

272.75

ug/g

0.35

108

584

ILD, hospital admissions 3, with pneumonia sepsis

168

822

2.10

17.40

1.4

1.5

271.02

270.65

ug/g

0.01

504

Secondary malignant neoplasm of respiratory and digestive organs

113

4.32

17.36

1.6

1.4

237.74

296.66

ug/g

0.91

Other disorders of nervous system

140

640

2.25

17.32

1.7

1.4

262.73

282.15

ug/g

0.49

377

COPD, early/later onset

789

4794

1.40

17.24

1.5

1.4

260.37

260.09

ug/g

0.01

470

2886

Other/unspecified cytomegaloviral diseases

174

3.61

17.23

1.5

1.4

287.79

310.99

ug/g

0.38

107

Other specified/unspecified soft tissue disorders

104

418

2.57

17.22

1.6

1.4

271.35

290.00

ug/g

0.37

235

Other respiratory diseases principally affecting the interstitium

324

1951

1.69

17.18

1.4

282.14

263.21

ug/g

0.39

201

1186

Rash and other nonspecific skin eruption

187

956

2.00

17.12

1.3

1.4

268.93

287.81

ug/g

0.60

111

538

Disorders of vestibular function (Vertigo)

835

6008

1.38

17.05

1.4

278.61

269.68

ug/g

0.59

459

3517

Other disorders of the musculoskeletal system and connective tissue

279

1619

1.76

17.01

1.5

1.4

251.83

274.64

ug/g

1.26

179

950

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

580

3963

1.47

16.99

1.4

301.97

285.04

ug/g

1.12

312

2158

Metatarsalgia

169

835

2.07

16.99

1.4

270.70

281.53

ug/g

0.26

487

Kela-code for severe mental illness

600

4148

1.46

16.98

1.4

292.49

277.01

ug/g

1.09

349

2348

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

136

621

2.27

16.98

1.4

258.89

287.77

ug/g

0.93

347

Plantar fascial fibromatosis

174

869

2.04

16.98

1.5

1.4

292.21

280.03

ug/g

0.33

517

Fracture of femur

473

2824

1.54

16.89

1.5

1.4

248.45

264.37

ug/g

0.97

285

1709

Unknown and unspecified causes of morbidity

120

518

2.37

16.89

1.5

1.4

284.07

286.18

ug/g

0.03

281

Actinic keratosis

672

4392

1.43

16.87

1.4

276.86

259.73

ug/g

1.47

401

2670

Skin changes due to chronic exposure to nonionizing radiation

692

4534

1.42

16.75

1.4

276.24

260.43

ug/g

1.34

416

2752

Hypopituitarism

135

616

2.25

16.72

1.5

1.4

302.35

289.03

ug/g

0.30

362

Other noninflammatory disorders of uterus, except cervix

368

1526

1.65

16.72

1.4

281.73

267.95

ug/g

0.68

219

875

Decubitus ulcer and pressure area

123

543

2.33

16.55

1.5

267.51

271.26

ug/g

0.08

331

Calculus of kidney and ureter

508

3421

1.50

16.53

1.5

1.4

261.32

265.24

ug/g

0.15

286

2025

Cachexia

7.90

16.49

1.7

1.2

278.87

320.42

ug/g

0.31

Diseases of inner ear

954

6923

1.34

16.46

1.4

283.37

269.05

ug/g

1.28

527

4053

Gluteal tendinitis

311

2.80

16.45

1.5

1.3

296.16

304.85

ug/g

0.17

179

Other embolism and thrombosis

235

1311

1.83

16.40

1.4

278.63

279.39

ug/g

0.01

137

778

Chronic ulcer of skin, not elsewhere classified

139

648

2.20

16.38

1.7

1.5

224.42

271.13

ug/g

2.31

378

Cerebral palsy and other paralytic syndromes

203

1083

1.91

16.35

1.5

1.4

273.72

286.96

ug/g

0.44

132

610

Persons with potential health hazards related to communicable diseases

568

3879

1.46

16.32

1.4

284.08

291.69

ug/g

0.36

345

2061

Abnormalities of gait and mobility

226

1249

1.85

16.32

1.5

1.4

285.63

270.58

ug/g

0.58

155

755

Cytomegalovirus infection, IBD co-morbidity

201

3.31

16.22

1.5

1.4

281.02

300.27

ug/g

0.31

118

Need for other prophylactic measures

124

555

2.30

16.19

1.6

1.5

229.41

288.26

ug/g

2.37

324

Viral pneumonia

228

1265

1.83

16.19

1.4

271.46

277.12

ug/g

0.15

125

732

Ulcer of oesophagus

120

529

2.32

16.16

1.4

272.43

275.32

ug/g

0.05

317

Other infectious diseases

174

886

2.01

16.15

1.4

266.33

281.42

ug/g

0.43

107

513

Streptococcal septicaemia

159

784

2.07

16.12

1.4

1.5

246.14

283.85

ug/g

1.24

466

COPD, hospital admissions

774

4759

1.39

16.09

1.5

1.4

261.10

259.99

ug/g

0.05

461

2863

Other and unspecified disorders of skin and subcutaneous tissue

132

608

2.23

16.06

1.4

282.56

287.26

ug/g

0.10

348

Other inflammation of eyelid

242

1372

1.80

16.01

1.5

1.4

276.75

280.10

ug/g

0.09

145

815

Cholangitis (primary sclerosing, PSC), with reimbursement 202

158

3.62

15.95

1.6

1.5

218.12

314.35

ug/g

2.10

Cytomegaloviral disease

214

3.20

15.88

1.5

1.4

288.64

299.13

ug/g

0.15

123

Mouth breathing

674

4814

1.41

15.88

1.4

293.98

269.62

ug/g

2.04

381

2796

Type of accident

484

3259

1.50

15.76

1.5

1.4

279.45

273.85

ug/g

0.23

278

1878

Crohn's disease of large intestine

100

412

2.50

15.73

1.5

1.4

274.09

302.32

ug/g

0.63

231

Oesophageal obstruction

257

2.94

15.72

1.5

1.4

260.87

280.76

ug/g

0.41

150

Other predominantly sexually transmitted diseases, not elsewhere classified

265

1549

1.73

15.67

1.4

322.96

307.64

ug/g

0.60

165

808

Cystic fibrosis

23.66

15.64

1.3

1.2

228.47

339.66

ug/g

—

Open wound of lower leg

264

1545

1.74

15.61

1.4

247.38

274.57

ug/g

1.42

164

887

Fracture at wrist and hand level

556

3846

1.46

15.56

1.4

265.50

273.67

ug/g

0.43

339

2217

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

459

3065

1.51

15.56

1.4

277.12

278.01

ug/g

0.03

274

1721

Acute suppurative otitis media

373

2215

1.59

15.54

1.3

1.4

307.71

301.42

ug/g

0.20

201

1138

Diplopia

235

1334

1.79

15.51

1.5

1.4

280.05

273.67

ug/g

0.19

138

763

Traumatic subdural haemorrhage

213

1124

1.85

15.45

1.4

255.00

255.66

ug/g

0.01

129

688

Iron deficiency

201

3.21

15.44

1.2

1.4

369.49

322.41

ug/g

0.83

101

ILD, hospital admissions

274

1628

1.71

15.38

1.4

288.31

264.76

ug/g

0.44

173

980

Benign neoplasm of other and unspecified endocrine glands

249

1442

1.76

15.36

1.5

1.4

242.28

276.57

ug/g

1.98

138

842

SLE (Finngen)

283

2.82

15.34

1.4

332.74

313.22

ug/g

0.33

157

Superficial injury of ankle and foot

196

1056

1.89

15.30

1.5

1.4

292.04

292.73

ug/g

0.01

105

569

Other pleural conditions

188

1001

1.92

15.30

1.4

248.19

271.76

ug/g

0.80

113

596

Late syphilis

111

4.15

15.28

1.8

1.5

211.41

273.21

ug/g

1.22

Type1 diabetes, definitions combined, early onset

113

495

2.32

15.28

1.7

1.4

258.32

332.54

ug/g

3.95

253

Zoster [herpes zoster]

331

2067

1.63

15.25

1.5

1.4

267.36

272.02

ug/g

0.16

190

1230

Disorders of continuity of bone

183

967

1.93

15.25

1.3

1.4

273.62

288.15

ug/g

0.40

111

528

Thyroiditis, ILD-related definition

207

1139

1.85

15.16

1.4

300.73

287.48

ug/g

0.40

124

633

Injuries to the elbow and forearm

1192

8186

1.29

15.09

1.4

262.46

279.98

ug/g

2.16

668

4695

Familial hypercholesterolemia

267

1583

1.71

15.08

1.4

245.42

268.34

ug/g

1.07

153

958

Artificial joint operation, meniscal resection

1592

8319

1.25

14.99

1.4

280.74

267.21

ug/g

1.31

970

4850

Disorders of muscles

169

874

1.97

14.97

1.5

1.4

295.74

275.21

ug/g

0.58

520

Speech and linguistic disorders, excluding more controls

111

457

2.32

14.96

1.4

328.05

321.61

ug/g

0.12

248

Other follicular disorders

132

625

2.16

14.95

1.5

1.4

291.59

295.58

ug/g

0.07

341

Other diseases of peritoneum

103

443

2.41

14.85

1.5

1.4

262.97

294.99

ug/g

0.88

252

Psoriatic and enteropathic arthropathies

204

1125

1.85

14.83

1.5

1.4

278.71

269.84

ug/g

0.27

126

654

Injury of muscle and tendon at shoulder and upper arm level

601

4277

1.42

14.65

1.5

1.4

281.47

263.02

ug/g

0.79

383

2537

Atopic dermatitis, strict definition with reimbursement

437

2822

1.51

14.61

1.4

307.87

296.38

ug/g

0.50

233

1517

Other otitis externa (chronic)

129

612

2.16

14.60

1.6

1.4

300.17

289.58

ug/g

0.20

341

Superficial injury of thorax

254

1500

1.72

14.56

1.4

271.06

275.23

ug/g

0.11

148

879

Primary biliary cholangitis (PBC)

178

3.30

14.50

1.3

1.5

302.24

309.71

ug/g

0.09

103

Sicca syndrome [Sjögren]

178

950

1.92

14.48

1.4

306.72

292.88

ug/g

0.39

539

Other interstitial pulmonary diseases

274

1655

1.68

14.48

1.4

288.31

264.91

ug/g

0.44

173

1002

Appendectomy

1061

7863

1.30

14.46

1.4

285.58

279.26

ug/g

0.43

596

4458

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

119

548

2.22

14.45

1.6

1.4

245.32

299.69

ug/g

1.66

293

Bacterial pneumonia, not elsewhere classified

633

3997

1.41

14.44

1.5

1.4

249.22

272.42

ug/g

2.17

406

2359

Interstitial lung disease

274

1657

1.68

14.42

1.4

288.31

265.36

ug/g

0.42

173

1003

Interstitial lung disease endpoints

274

1657

1.68

14.42

1.4

288.31

265.36

ug/g

0.42

173

1003

Pollen allergy

279

1669

1.67

14.41

1.4

317.43

312.07

ug/g

0.14

128

866

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

473

3232

1.48

14.36

1.4

283.66

273.33

ug/g

0.46

270

1855

Malignant neoplasm of skin

811

4130

1.36

14.30

1.4

269.66

284.40

ug/g

1.34

505

2401

Fracture of lower leg, including ankle

930

7028

1.32

14.30

1.5

1.4

260.69

276.34

ug/g

1.58

528

4073

Sacrococcygeal disorders, not elsewhere classified

232

2.95

14.29

1.3

340.88

297.09

ug/g

0.87

131

Unspecified misadventure during surgical and medical care

114

520

2.26

14.29

1.4

212.81

282.79

ug/g

3.38

306

Allergic rhinitis

474

3204

1.48

14.28

1.4

310.02

290.10

ug/g

1.19

242

1752

Acute pharyngitis

217

1221

1.78

14.26

1.3

1.4

272.20

286.02

ug/g

0.39

118

687

Other and unspecified myopathies

162

842

1.97

14.24

1.4

255.52

272.52

ug/g

0.48

506

Schizophrenia or delusion, excluding more controls

407

2674

1.52

14.18

1.4

283.80

278.11

ug/g

0.21

238

1556

Drug-induced cataract

218

3.04

14.15

1.4

275.45

294.16

ug/g

0.28

126

Cystic kidney disease

296

2.71

14.14

1.3

1.4

295.04

299.97

ug/g

0.07

179

Disorder of the sleep-wake schedule

136

3.63

14.11

1.4

293.39

277.19

ug/g

0.17

Other and unspecified immunodeficiencies with predominantly antibody defects

118

3.92

14.09

1.6

1.4

365.76

311.25

ug/g

0.89

Ehlers-Danlos syndrome

104

4.11

14.08

1.6

1.4

329.95

324.18

ug/g

0.05

Superficial injury of wrist and hand

320

2020

1.60

14.07

1.4

294.24

280.68

ug/g

0.47

170

1128

Polyp of the female genital tract

463

1784

1.50

14.06

1.4

1.3

272.82

273.41

ug/g

0.02

256

989

Benign neoplasm: Ill-defined sites within the digestive system

5.37

14.02

1.3

1.4

289.57

284.56

ug/g

0.04

Corns and callosities

132

643

2.11

13.96

1.5

1.4

253.57

285.91

ug/g

1.18

373

Diabetic maculopathy

279

1613

1.67

13.89

1.6

1.5

223.09

255.55

ug/g

1.96

194

965

Algoneurodystrophy

287

2.71

13.87

1.5

302.28

305.59

ug/g

0.04

160

Amputation of foot

215

3.02

13.85

1.5

223.42

254.98

ug/g

0.60

126

Diagnoses used for exclusion with ILD

426

2874

1.50

13.84

1.4

255.84

268.25

ug/g

0.63

253

1708

Cramp and spasm

426

2.37

13.78

1.6

1.5

267.22

283.89

ug/g

0.34

242

Polycystic kidney disease

249

2.86

13.76

1.3

1.5

297.32

295.58

ug/g

0.02

148

Vulvovaginal ulceration/inflammation in other diseases

100

438

2.33

13.73

1.5

1.3

327.40

318.78

ug/g

0.15

220

Bacterial pneumonia (organism specified)

734

4934

1.36

13.72

1.5

1.4

252.78

268.20

ug/g

1.27

459

2864

Corticotropin deficiency

4.75

13.71

1.6

1.3

261.05

306.03

ug/g

0.62

Open wound of ankle and foot

175

944

1.89

13.70

1.4

266.24

277.55

ug/g

0.28

107

542

Diseases of middle ear and mastoid

882

5483

1.32

13.66

1.4

293.26

284.31

ug/g

0.59

482

3062

Vitamin D deficiency

144

3.50

13.65

1.6

1.4

239.12

305.71

ug/g

1.12

Viral warts

344

2225

1.56

13.64

1.5

1.4

264.97

283.15

ug/g

0.94

205

1233

Anogenital herpesviral [herpes simplex] infection

108

491

2.25

13.58

1.5

1.4

283.18

309.50

ug/g

0.56

246

Enteropathic arthropathies

170

3.25

13.50

1.6

1.4

280.46

294.89

ug/g

0.20

Benign neoplasm: Adrenal gland

155

810

1.96

13.49

1.5

1.4

231.58

282.16

ug/g

2.37

481

Other viral diseases, not elsewhere classified

409

2735

1.50

13.47

1.4

314.98

287.63

ug/g

1.77

236

1501

Other menopausal disorders

425

1592

1.52

13.45

1.4

1.3

298.48

272.47

ug/g

1.72

238

886

Other degenerative diseases of the nervous system

416

2078

1.51

13.45

1.4

262.03

258.19

ug/g

0.13

216

1248

Ethmoidectomy

223

1301

1.74

13.44

1.4

302.34

280.04

ug/g

0.78

118

742

Selective deficiency of immunoglobulin G [IgG] subclasses

5.23

13.43

1.8

1.5

297.59

274.13

ug/g

0.24

Psoriasis vulgaris

315

2007

1.59

13.39

1.4

276.73

277.11

ug/g

0.01

182

1175

Atrophic disorders of skin

266

1629

1.66

13.36

1.4

292.19

287.53

ug/g

0.14

155

923

Hydronephrosis

195

1098

1.81

13.30

1.5

1.4

241.30

276.43

ug/g

1.33

121

636

Emotional disorders starting during childhood or adolecense, excluding more controls

186

3.04

13.28

1.4

264.20

348.61

ug/g

1.57

Chronic hepatitis, not elsewhere classified

300

2.63

13.23

1.4

278.39

307.39

ug/g

0.56

175

Varicose veins

1044

6149

1.29

13.22

1.4

270.66

271.13

ug/g

0.03

653

3603

Cystic kidney disease

324

2.56

13.22

1.4

1.5

299.02

299.56

ug/g

0.01

196

Leisure time condition

301

1904

1.60

13.20

1.5

1.4

292.41

278.05

ug/g

0.54

179

1082

Intussusception

132

3.55

13.20

1.6

1.3

261.02

308.55

ug/g

0.74

Eosinophilic disease (BM)

4.09

13.17

1.6

1.3

274.30

304.72

ug/g

0.32

Malignant neoplasm of colon, including Hilmo

301

1903

1.60

13.17

1.4

241.25

283.77

ug/g

3.06

197

1136

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

782

3972

1.35

13.14

1.4

270.16

284.19

ug/g

1.20

487

2316

Other infectious diseases

144

740

1.99

13.13

1.3

1.4

267.62

284.68

ug/g

0.45

436

Nonsuppurative otitis media

326

1809

1.57

13.10

1.4

325.92

298.69

ug/g

1.46

176

936

Congenital malformations of the musculoskeletal system, not elsewhere classified

143

3.45

13.10

1.5

1.4

336.77

324.87

ug/g

0.13

Secondary uncertain malignant neoplasm

209

1206

1.76

13.09

1.5

1.4

254.81

292.95

ug/g

1.78

130

715

Disorders of refraction and accommodation

420

2847

1.48

13.06

1.4

287.29

284.44

ug/g

0.10

227

1578

Nephrotic syndrome

279

2.68

13.03

1.5

254.22

290.84

ug/g

0.95

170

Fall on and from stairs and steps

435

2988

1.47

12.95

1.5

1.4

264.03

271.83

ug/g

0.34

255

1728

Complications following infusion, transfusion and therapeutic injection

115

3.76

12.94

1.5

1.3

229.58

305.24

ug/g

1.28

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

147

767

1.96

12.84

1.5

1.4

248.01

289.93

ug/g

1.75

437

Systemic sclerosis (FG)

219

2.91

12.83

1.5

1.4

297.68

290.39

ug/g

0.10

128

6-mercaptopurine

252

2.74

12.79

1.7

1.4

257.16

304.49

ug/g

0.88

141

Protein-energy malnutrition of moderate and mild degree

4.56

12.76

1.4

1.5

263.41

281.68

ug/g

0.16

Hypercalcemia

429

2.32

12.74

1.5

1.4

229.75

279.78

ug/g

1.38

247

Injury of eye and orbit

222

1312

1.72

12.74

1.5

1.4

262.66

271.02

ug/g

0.24

130

735

Pure hyperglyceridaemia

171

3.17

12.73

1.6

1.5

266.80

268.48

ug/g

0.02

100

Non-ischemic cardiomyopathy

531

3042

1.42

12.64

1.4

247.43

263.51

ug/g

1.13

328

1834

Hypertrophic disorders of skin

105

487

2.21

12.63

1.5

1.4

294.09

306.84

ug/g

0.24

252

Folate deficiency anaemia

4.40

12.61

1.4

1.6

187.95

271.41

ug/g

1.41

Bronchiectasis

154

822

1.92

12.59

1.3

1.4

293.32

272.96

ug/g

0.64

482

Endometriosis of ovary

243

1438

1.67

12.57

1.5

1.3

296.55

274.98

ug/g

0.78

118

783

Degenerative macular diseases

215

1269

1.72

12.49

1.4

263.63

272.00

ug/g

0.24

131

765

Diseases of spleen

148

3.34

12.43

1.4

281.84

284.77

ug/g

0.03

Other and unspecified injuries of head

130

658

2.02

12.40

1.4

256.90

285.63

ug/g

0.74

358

Deficiency of other B group vitamins

174

3.12

12.39

1.4

1.5

304.65

278.44

ug/g

0.33

102

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

243

1485

1.66

12.33

1.4

257.43

293.95

ug/g

1.97

150

875

ILD, hospital admissions 1, main diag only

239

1456

1.67

12.32

1.4

1.5

293.85

265.21

ug/g

0.47

147

874

Colorectal cancer

360

2351

1.51

12.32

1.3

1.4

244.97

282.08

ug/g

2.76

226

1403

Sequelae of injuries of lower limb

162

884

1.87

12.31

1.5

1.4

237.53

288.26

ug/g

2.36

496

Congenital malformations and deformations of the musculoskeletal system

177

986

1.81

12.29

1.4

328.73

309.92

ug/g

0.56

518

Haemorrhage, not elsewhere classified

275

2.62

12.26

1.7

1.4

234.56

282.07

ug/g

1.13

156

Common variable immunodeficiency

5.49

12.25

1.3

399.45

325.23

ug/g

1.15

Unspecified protein-energy malnutrition

6.19

12.23

1.4

1.5

210.46

284.32

ug/g

0.84

CR(E)ST syndrome

150

3.33

12.22

1.5

1.3

284.90

316.52

ug/g

0.44

FESS (DNB20)

212

1254

1.72

12.20

1.4

304.47

280.61

ug/g

0.82

112

713

Childhood asthma (age<16)

145

593

1.94

12.18

1.3

350.70

321.92

ug/g

0.74

291

COPD, hospital admission 2, with asthma infections

523

3209

1.41

12.17

1.4

266.21

259.49

ug/g

0.31

312

1956

Early lumbar disc prolapse, operated

137

710

1.96

12.12

1.4

285.78

290.90

ug/g

0.09

395

Other maltreatment syndromes

231

2.77

12.09

1.4

298.44

315.23

ug/g

0.18

130

Later onset COPD, excluding more controls

330

1666

1.55

12.09

1.4

253.09

255.95

ug/g

0.09

195

1008

Childhood asthma (age<16), excluding more controls

144

589

1.94

12.07

1.3

350.70

321.96

ug/g

0.74

288

Ischaemic Stroke, excluding all haemorrhages

950

5516

1.29

12.06

1.4

250.83

263.16

ug/g

1.12

573

3273

Primary gonarthrosis, bilateral

883

5861

1.30

12.06

1.5

1.4

275.29

262.90

ug/g

1.10

548

3491

Speech therapy

448

3139

1.44

12.05

1.4

275.53

274.83

ug/g

0.03

299

1816

Seborrhoeic dermatitis

161

883

1.86

12.04

1.6

1.4

256.14

276.61

ug/g

0.60

102

507

Hepatocellular carcinoma, including Hilmo

193

2.95

12.00

1.2

1.4

307.79

289.66

ug/g

0.23

116

Benign paroxysmal vertigo

500

3575

1.41

12.00

1.4

284.05

272.74

ug/g

0.60

269

2121

COPD-related respiratory insufficiency

196

1142

1.75

11.94

1.5

1.4

285.21

261.20

ug/g

0.92

127

688

Systemic sclerosis, icd10

228

2.80

11.93

1.5

1.4

297.68

301.90

ug/g

0.05

126

Epilepsy

465

3274

1.43

11.89

1.4

254.27

271.45

ug/g

1.05

281

1905

Chondrocostal junction syndrome [Tietze]

347

2.41

11.86

1.6

1.4

297.82

298.62

ug/g

0.01

199

Drug-induced hypoglycaemia without coma

117

3.59

11.86

1.9

1.3

197.44

312.04

ug/g

2.05

Short stature, not elsewhere classified

144

3.20

11.84

1.4

1.3

380.47

386.94

ug/g

0.07

Heart failure and bmi 25plus

568

2781

1.39

11.82

1.4

262.78

259.21

ug/g

0.10

365

1626

Cerebral cysts

101

474

2.18

11.82

1.4

317.09

299.80

ug/g

0.32

256

Other respiratory disorders and diseases

331

2196

1.53

11.77

1.5

1.4

268.93

266.04

ug/g

0.09

206

1317

Other diseases of the respiratory system

331

2196

1.53

11.77

1.5

1.4

268.93

266.04

ug/g

0.09

206

1317

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

163

904

1.83

11.76

1.3

1.4

250.21

287.47

ug/g

1.52

545

Basal cell carcinoma, including avohilmo

729

3790

1.34

11.73

1.4

266.86

284.71

ug/g

1.69

458

2208

Thrombocytopenia, unspecified

132

686

1.97

11.72

1.4

263.71

283.23

ug/g

0.46

409

355

2245

1.50

11.72

1.4

262.40

265.37

ug/g

0.10

216

1355

Other disorders of white blood cells

106

510

2.13

11.68

1.5

281.52

280.57

ug/g

0.01

304

Trigeminal neuralgia

111

543

2.09

11.68

1.4

282.72

295.13

ug/g

0.22

299

Hallux rigidus

234

1438

1.65

11.65

1.4

291.68

254.07

ug/g

2.12

131

863

Systemic sclerosis

231

2.76

11.64

1.5

1.4

297.68

306.90

ug/g

0.13

128

Maltreatment syndromes

393

2.29

11.62

1.6

1.4

260.56

310.13

ug/g

1.05

204

Degeneration of the brain due to alcohol

192

2.94

11.60

1.7

1.6

266.85

253.82

ug/g

0.14

114

Caries of enamel

1460

8656

1.22

11.59

1.4

293.63

278.33

ug/g

1.36

831

4944

Dermatographic urticaria

117

585

2.04

11.58

1.3

1.4

341.28

299.13

ug/g

1.22

311

Other hammer toe(s) (acquired)

295

1765

1.56

11.54

1.5

1.4

283.97

259.39

ug/g

1.28

178

1061

Colitis, primary sclerosing

105

3.71

11.50

1.5

1.4

199.98

312.71

ug/g

2.33

Scoliosis

131

682

1.95

11.50

1.5

1.3

288.62

285.89

ug/g

0.05

374

Other benign neoplasms of skin

622

4638

1.35

11.48

1.5

1.4

263.24

273.23

ug/g

0.61

355

2715

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

119

601

2.02

11.45

1.5

1.4

339.92

300.46

ug/g

0.34

315

Visual impairment including blindness (binocular or monocular)

124

636

1.99

11.43

1.5

1.4

280.04

280.79

ug/g

0.01

366

Presence of other devices

384

2631

1.47

11.40

1.5

1.4

273.64

267.59

ug/g

0.23

239

1568

Glaucoma

949

6434

1.28

11.38

1.5

1.4

260.30

266.00

ug/g

0.39

582

3792

Oligomenorrhoea

221

2.74

11.37

1.5

1.3

332.61

294.48

ug/g

0.70

101

Small fibre neuropathy

257

2.63

11.36

1.6

1.5

278.32

287.41

ug/g

0.12

159

Malignant neoplasm of kidney, except renal pelvis

144

778

1.89

11.33

1.4

1.5

249.85

283.52

ug/g

1.21

475

Congenital malformations and deformations of the musculoskeletal system

143

766

1.89

11.33

1.4

322.73

313.44

ug/g

0.18

405

Mixed connective tissue disease

123

632

1.99

11.32

1.4

311.28

294.70

ug/g

0.40

349

Suppurative and unspecified otitis media

506

3232

1.40

11.32

1.4

296.72

288.51

ug/g

0.35

274

1755

Other bursitis of hip

173

3.02

11.27

1.4

305.35

296.03

ug/g

0.12

Congenital malformations of the urinary system

107

524

2.09

11.25

1.4

291.56

302.02

ug/g

0.19

296

Reactive arthropathies

140

751

1.90

11.25

1.4

256.68

255.55

ug/g

0.02

456

Other necrotizing vasculopathies (FG)

112

558

2.06

11.24

1.5

277.11

259.14

ug/g

0.40

329

Other malignant neoplasms of skin (=non-melanoma skin cancer)

722

3754

1.33

11.24

1.4

264.23

284.32

ug/g

2.00

447

2199

Other skin changes

310

2051

1.53

11.23

1.5

1.4

265.75

269.94

ug/g

0.13

170

1228

Systemic lupus erythematosus

331

2.40

11.22

1.4

332.74

301.44

ug/g

0.62

192

Tinnitus

393

2726

1.46

11.21

1.5

1.4

283.05

270.18

ug/g

0.58

215

1602

Other disorders starting during childhood or adolecense, excluding more controls

223

2.66

11.16

1.2

1.4

364.35

363.74

ug/g

0.01

112

Other disorders of conjunctiva

243

1525

1.62

11.15

1.5

265.66

271.76

ug/g

0.17

141

908

Degeneration of nervous system due to alcohol

197

2.87

11.08

1.7

1.6

266.85

258.26

ug/g

0.09

115

Other disorders involving the immune mechanism, not elsewhere classified

278

2.53

11.07

1.5

269.79

288.51

ug/g

0.33

159

Extreme obesity with alveolar hypoventilation

390

2.28

11.06

1.6

1.5

280.76

286.29

ug/g

0.08

238

Flat foot [pes planus] (acquired)

161

907

1.81

11.06

1.4

290.85

269.63

ug/g

0.62

527

Other necrotizing vasculopathies

135

722

1.91

11.04

1.5

1.4

279.24

274.16

ug/g

0.10

421

Impotence

422

2.21

11.02

1.6

254.33

239.30

ug/g

0.30

268

Viral warts

163

923

1.80

11.01

1.5

1.4

276.34

292.12

ug/g

0.49

101

491

Dysplasia of cervi uteri

315

1504

1.53

10.93

1.3

334.74

281.28

ug/g

4.02

174

785

Malignant neoplasm of colon

229

1423

1.63

10.91

1.4

239.71

287.54

ug/g

2.71

148

847

Congenital malformations of the urinary system

112

565

2.03

10.86

1.4

296.72

302.78

ug/g

0.10

321

Panniculitis affecting regions of neck and back

280

2.49

10.85

1.5

1.4

235.72

287.80

ug/g

1.19

160

Orchitis and epididymitis

134

717

1.90

10.85

1.5

1.6

240.48

243.22

ug/g

0.05

438

Hypertensive Renal Disease

268

2.53

10.84

1.4

265.03

285.46

ug/g

0.40

159

Lichen simplex chronicus and prurigo

116

593

2.00

10.84

1.4

272.74

289.70

ug/g

0.40

341

Thyrotoxicosis, other and/or unspecified

324

2179

1.50

10.84

1.4

282.28

282.81

ug/g

0.02

199

1225

Agranulocytosis

199

1198

1.69

10.82

1.3

1.4

255.34

280.56

ug/g

1.02

131

690

Stroke, excluding SAH

1004

5837

1.26

10.79

1.4

250.62

264.02

ug/g

1.30

599

3459

Chronic viral hepatitis

432

2.18

10.79

1.4

252.78

309.34

ug/g

1.89

231

Disorders of plasma-protein metabolism, not elsewhere classified

5.37

10.72

1.1

1.4

293.50

292.89

ug/g

—

Basal cell carcinoma

691

3630

1.33

10.72

1.4

265.82

284.73

ug/g

1.79

433

2133

Superficial injury of hip and thigh

239

1509

1.60

10.66

1.5

1.4

275.74

279.90

ug/g

0.11

140

873

Ehlers-Danlos syndrome

3.93

10.66

1.6

1.4

321.14

320.96

ug/g

0.00

Other viral hepatitis

105

521

2.06

10.64

1.4

248.83

303.12

ug/g

2.09

288

Other/unspecified enthesopathies, not elsewhere classified

137

745

1.87

10.58

1.4

301.32

272.34

ug/g

0.88

448

Otitis externa, unspecified

181

1068

1.72

10.58

1.4

310.54

290.46

ug/g

0.55

586

Stroke, including SAH

1054

6138

1.25

10.56

1.4

253.67

264.51

ug/g

0.99

632

3628

Spondyloarthritis

273

1780

1.55

10.56

1.4

252.43

275.71

ug/g

1.01

151

1041

Unspecified acute lower respiratory infection

234

1474

1.61

10.55

1.4

277.78

270.72

ug/g

0.21

135

841

Biological medication for rheuma

263

1704

1.56

10.49

1.5

1.4

288.28

288.22

ug/g

0.00

147

954

Bruxism

164

2.99

10.47

1.1

1.4

374.72

304.08

ug/g

1.20

Open wound of wrist and hand

671

5007

1.32

10.47

1.4

273.61

274.08

ug/g

0.02

375

2867

Follow-up care involving plastic surgery

329

2.34

10.43

1.4

301.68

315.69

ug/g

0.21

174

Myocardial infarction

804

4400

1.29

10.43

1.4

250.64

262.91

ug/g

0.96

506

2593

486

3077

1.39

10.42

1.5

1.4

258.28

263.86

ug/g

0.24

292

1875

Diseases of appendix

1188

8747

1.23

10.39

1.4

284.30

276.54

ug/g

0.64

688

4980

Atopic dermatitis, strict definition

417

2900

1.42

10.39

1.4

311.56

297.45

ug/g

0.65

221

1535

Redundant prepuce, phimosis and paraphimosis

276

1793

1.54

10.34

1.5

256.58

257.92

ug/g

0.04

162

1081

Other specified/unspecified systemic involvement of connective tissue

112

576

1.99

10.33

1.3

1.4

315.59

297.84

ug/g

0.40

311

Tongue abnormality

117

611

1.96

10.33

1.5

1.4

306.27

282.41

ug/g

0.62

354

Acne

131

707

1.87

10.27

1.4

1.3

270.15

323.02

ug/g

1.64

340

Postprocedural musculoskeletal disorders, not elsewhere classified

134

733

1.87

10.25

1.5

1.4

250.67

279.20

ug/g

1.02

426

Seronegative rheumatoid arthritis

202

1238

1.66

10.25

1.4

273.03

269.55

ug/g

0.09

112

723

Malignant neoplasm of urinary organs

151

855

1.80

10.24

1.4

248.30

287.78

ug/g

1.69

515

therapeutic use

289

2.44

10.22

1.5

271.93

287.41

ug/g

0.23

175

Congenital malformations of the musculoskeletal system, not elsewhere classified

124

3.30

10.20

1.5

1.4

331.53

319.06

ug/g

0.11

Failure and rejection of transplanted organs and tissues

114

3.43

10.20

1.8

1.3

288.12

324.62

ug/g

0.41

Appendicitis, broad definition

1177

8706

1.23

10.20

1.4

286.03

276.57

ug/g

0.84

682

4953

Sulfasalazine

436

3136

1.40

10.15

1.5

1.4

267.12

273.78

ug/g

0.28

256

1799

Colitis due to radiation

4.27

10.14

1.6

1.3

297.15

295.19

ug/g

0.02

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

164

956

1.75

10.10

1.4

265.92

276.31

ug/g

0.28

558

Allergic urticaria

137

757

1.84

10.09

1.3

1.4

320.90

294.99

ug/g

0.76

404

Chondropathies

242

1554

1.58

10.09

1.4

339.49

282.12

ug/g

1.13

135

861

Superficial injury of shoulder and upper arm

180

1077

1.70

10.01

1.4

272.65

286.29

ug/g

0.42

109

601

SLE, ICD10

323

2.33

10.01

1.4

339.18

296.56

ug/g

0.99

186

SLE, strict definition

323

2.33

10.01

1.4

339.18

296.56

ug/g

0.99

186

Female infertility

380

1600

1.45

10.00

1.4

1.3

311.43

281.31

ug/g

1.67

190

825

Other infective otitis externa

107

548

2.00

9.98

1.5

1.4

287.55

286.26

ug/g

0.02

317

Other noninflammatory disorders of vagina

123

659

1.90

9.98

1.3

320.24

280.73

ug/g

1.24

347

Unstable angina pectoris

604

3598

1.33

9.98

1.4

260.35

258.91

ug/g

0.06

361

2147

Strabismus

410

2921

1.41

9.96

1.5

1.4

278.83

282.51

ug/g

0.13

226

1653

Nail disorders

142

797

1.81

9.95

1.6

1.4

260.32

296.70

ug/g

1.49

447

Medical abortion

1021

4438

1.25

9.94

1.4

1.3

294.53

287.65

ug/g

0.45

561

2464

Anosmia

3.57

9.94

1.5

1.3

293.62

302.79

ug/g

0.08

Pacemaker

526

3748

1.36

9.93

1.5

1.4

258.13

261.30

ug/g

0.14

320

2296

Hepatomegaly and splenomegaly, not elsewhere classified

4.91

9.90

1.5

1.3

327.94

284.89

ug/g

0.34

Keratitis

564

4244

1.34

9.86

1.5

1.4

280.91

277.08

ug/g

0.10

326

2434

Acute appendicitis, no complications

854

6748

1.27

9.86

1.4

286.93

277.99

ug/g

0.63

495

3803

Malignant neoplasm of liver and intrahepatic bile ducts

186

2.77

9.84

1.2

1.5

253.81

283.99

ug/g

0.40

112

Lesion of radial nerve

325

2.31

9.84

1.7

1.5

252.78

286.67

ug/g

0.63

179

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

254

1605

1.55

9.83

1.4

288.03

291.52

ug/g

0.09

147

898

Hypertrophic scar

450

2.09

9.75

1.4

304.17

304.33

ug/g

0.00

235

Other strabismus

333

2293

1.46

9.73

1.5

1.4

282.92

286.55

ug/g

0.11

177

1283

Postmenopausal osteoporosis with pathological fracture

130

718

1.86

9.71

1.5

1.4

253.93

279.72

ug/g

0.67

416

Acute bronchiolitis

361

2.16

9.68

1.5

1.3

339.94

337.05

ug/g

0.04

169

Disorders of psychological development

157

844

1.74

9.66

1.4

333.36

319.85

ug/g

0.36

430

Lack of expected normal physiological development

3.56

9.64

1.3

339.32

393.83

ug/g

0.62

Postprocedural disorders of nervous system

111

582

1.94

9.64

1.5

1.3

333.96

308.55

ug/g

0.51

287

Osteonecrosis

116

619

1.92

9.62

1.6

1.4

255.27

278.61

ug/g

0.65

357

Periapical abscess

717

5593

1.29

9.62

1.5

1.4

269.57

274.36

ug/g

0.25

412

3226

Alcohol induced polyneuropathy

3.72

9.57

1.6

297.79

268.92

ug/g

0.31

Anankastic personality disorder

316

2.30

9.57

1.3

1.4

306.30

302.35

ug/g

0.06

167

Salpingitis and oophoritis

292

1977

1.50

9.55

1.4

290.46

285.41

ug/g

0.15

170

1098

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

261

2.46

9.54

1.5

263.22

286.75

ug/g

0.43

153

Syphilis

231

2.56

9.52

1.8

1.5

207.52

284.27

ug/g

2.14

131

Syphilis

231

2.56

9.52

1.8

1.5

207.52

284.27

ug/g

2.14

131

Myocardial infarction, without ST-elevation

639

4477

1.31

9.48

1.4

251.04

258.45

ug/g

0.41

393

2726

Methotrexate

229

1475

1.57

9.45

1.4

289.80

276.29

ug/g

0.42

126

847

Lung diseases due to external agents

216

1373

1.59

9.44

1.4

231.42

269.56

ug/g

2.25

132

830

Memory loss

158

930

1.73

9.43

1.4

266.33

270.47

ug/g

0.08

557

Spinal instabilities

214

2.60

9.41

1.5

1.4

234.39

274.12

ug/g

0.87

119

Tonsillectomy and adenotomy

798

4373

1.28

9.41

1.4

315.22

293.32

ug/g

1.72

385

2418

Ganglion

293

1990

1.49

9.37

1.4

305.44

274.47

ug/g

1.41

165

1149

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

268

1735

1.52

9.36

1.4

293.74

287.60

ug/g

0.18

157

970

Special screening examination for neoplasms

403

2.12

9.35

1.3

1.4

284.58

253.77

ug/g

0.61

242

Ulcerative enterocolitis

257

2.44

9.34

1.5

1.4

237.19

317.41

ug/g

2.52

149

Other specified/unspecified inflammatory spondylopathies

338

2.23

9.34

1.5

1.4

277.81

294.99

ug/g

0.27

189

Other and unspecified rosacea

151

880

1.75

9.34

1.4

317.65

292.38

ug/g

0.71

489

Other coagulation defects

125

689

1.85

9.33

1.5

1.4

311.27

294.74

ug/g

0.34

373

Car occupant injured in other and unspecified transport accidents

279

1881

1.50

9.29

1.5

1.4

291.29

285.27

ug/g

0.17

152

1037

AV-block

275

1614

1.51

9.28

1.5

1.4

237.28

262.28

ug/g

1.43

161

975

Effects of foreign body entering through natural orifice

367

2607

1.42

9.26

1.5

1.4

270.23

275.84

ug/g

0.20

208

1494

Other peripheral vascular diseases

140

801

1.78

9.24

1.5

1.4

281.64

285.41

ug/g

0.08

448

Hemiplegia

453

2.05

9.23

1.5

280.83

289.86

ug/g

0.16

264

Idiopathic gout

154

906

1.73

9.21

1.5

251.41

260.45

ug/g

0.24

551

Morphin

121

3.16

9.20

1.3

254.00

326.37

ug/g

1.40

Acute appendicitis

1095

8408

1.22

9.17

1.4

287.68

276.84

ug/g

0.98

637

4779

Problems related to social environment

223

2.54

9.14

1.5

1.4

267.85

293.50

ug/g

0.41

121

Arterial embolism and thrombosis

509

1.98

9.14

1.5

239.05

271.74

ug/g

0.87

313

Assault by unspecified means

143

2.96

9.13

1.4

1.6

257.30

296.11

ug/g

0.41

Encephalopathy

3.66

9.13

1.4

307.82

292.68

ug/g

0.14

Emphysema

118

644

1.87

9.10

1.6

1.4

222.73

265.08

ug/g

1.36

387

Herpesviral [herpes simplex] infections

189

1176

1.63

9.08

1.5

1.4

258.03

287.42

ug/g

1.16

111

649

Viral hepatitis

118

645

1.86

9.06

1.4

251.68

297.29

ug/g

1.82

360

Suppurative and necrotic conditions of lower respiratory tract

505

1.98

9.04

1.5

199.28

275.14

ug/g

3.28

309

Procreative management

490

3042

1.35

9.01

1.5

1.4

272.06

283.38

ug/g

0.55

275

1718

Inguinal hernia

879

4703

1.26

9.00

1.5

1.4

269.77

264.03

ug/g

0.23

525

2770

Disorders of phosphorus metabolism and phosphatases

7.30

8.98

1.6

1.3

242.99

304.07

ug/g

0.54

Somnolence, stupor and coma

364

2.16

8.97

1.5

223.74

274.44

ug/g

1.37

220

conjunctival haemorrhage

133

757

1.79

8.97

1.5

1.4

251.24

278.78

ug/g

0.92

447

Sequelae of injuries of neck and trunk

256

2.42

8.97

1.6

1.4

246.54

291.62

ug/g

0.87

150

Pediculosis, acariasis and other infestations

102

534

1.95

8.96

1.6

1.4

275.69

288.17

ug/g

0.23

304

Pneumonitis due to solids and liquids

129

727

1.80

8.95

1.5

229.18

274.36

ug/g

1.80

444

Other (seronegative) rheumatoid arthritis, wide

317

2210

1.45

8.94

1.4

284.80

276.29

ug/g

0.32

183

1288

Non-Hodgkin lymphoma, all, including Hilmo

201

1274

1.60

8.94

1.5

1.4

266.50

293.93

ug/g

1.14

126

752

Follicular cysts of skin and subcutaneous tissue

284

1939

1.48

8.92

1.4

293.71

276.43

ug/g

0.70

165

1127

Lesion of lateral popliteal nerve

439

2.05

8.90

1.6

1.5

225.17

285.86

ug/g

1.81

249

Scar conditions and fibrosis of skin

359

2.17

8.89

1.3

1.4

301.64

304.91

ug/g

0.05

193

Primary hyperparathyroidism

201

1278

1.60

8.88

1.4

262.38

275.41

ug/g

0.41

112

756

Injuries to unspecified part of trunk, limb or body region

168

1022

1.67

8.85

1.4

264.24

286.15

ug/g

0.65

102

580

Spondylopathies (FG)

204

1300

1.59

8.84

1.4

261.85

273.04

ug/g

0.31

114

750

Hypertrophy of breast in women and men

311

2164

1.45

8.84

1.4

287.20

287.78

ug/g

0.02

162

1173

Other congenital malformations of the digestive system

478

2.00

8.81

1.6

1.4

268.71

316.27

ug/g

1.42

264

Emotional disorders and disorders of social functioning with onset specific to childhood

289

2.28

8.81

1.4

299.33

349.00

ug/g

0.68

139

Hydrocele

163

984

1.68

8.80

1.7

1.5

226.90

248.85

ug/g

0.67

108

592

Heterophoria

128

724

1.80

8.79

1.4

288.52

297.02

ug/g

0.15

386

Parkinson's disease, strict definition, excluding more controls

174

1016

1.65

8.77

1.4

274.33

249.40

ug/g

0.86

111

628

Parkinson's disease, excluding more controls

185

1085

1.62

8.76

1.4

274.64

248.99

ug/g

0.96

119

664

Raynaud syndrome

143

837

1.74

8.73

1.4

314.27

291.67

ug/g

0.68

450

Rheumatoid arthritis, including avohilmo

624

4848

1.30

8.72

1.4

285.13

271.12

ug/g

1.00

364

2827

Drug-induced osteoporosis with pathological fracture

159

2.84

8.71

1.8

1.4

290.81

292.90

ug/g

0.03

Psoriatic arthropathies

155

927

1.70

8.71

1.5

1.4

277.38

260.79

ug/g

0.50

554

Dystonia

100

526

1.94

8.70

1.3

1.4

320.46

294.13

ug/g

0.64

293

Post-traumatic wound infection, not elsewhere classified

229

2.48

8.69

1.4

1.5

294.12

292.09

ug/g

0.03

135

Necrobiosis lipoidica, not elsewhere classified

4.51

8.68

1.9

1.4

259.53

313.11

ug/g

0.57

Systemic lupus erythematosus, unspecified

279

2.33

8.68

1.3

1.4

351.46

301.09

ug/g

1.15

159

Other disorders of electrolyte and fluid balance, not elsewhere classified

4.01

8.68

1.4

1.3

238.39

291.92

ug/g

0.75

Scabies

396

2.09

8.66

1.5

276.13

291.92

ug/g

0.27

230

Speech disturbances, not elsewhere classified

147

869

1.72

8.66

1.4

257.95

269.89

ug/g

0.29

512

Glucosamine medication

813

5193

1.26

8.64

1.5

1.4

269.83

265.45

ug/g

0.27

504

3075

Abrasion of teeth

545

4165

1.32

8.63

1.5

1.4

291.10

277.25

ug/g

0.88

334

2375

Coxarthrosis, primary

992

6875

1.23

8.59

1.4

270.74

264.06

ug/g

0.48

587

4094

Amputation of ankle bones

177

2.69

8.57

1.5

240.78

273.21

ug/g

0.54

101

Ulcerative proctitis

486

1.97

8.57

1.6

1.4

280.22

301.01

ug/g

0.38

275

Other disorders of breast

216

1407

1.56

8.56

1.4

297.36

288.12

ug/g

0.29

124

751

207

2.55

8.53

1.4

1.5

280.30

263.21

ug/g

0.24

119

Endometriosis of rectovaginal septum and vagina

119

665

1.82

8.52

1.3

1.4

300.56

276.97

ug/g

0.57

364

Respiratory insufficiency

121

678

1.81

8.49

1.4

286.86

277.19

ug/g

0.20

397

Granulomatous disorders of skin and subcutaneous tissue

220

2.49

8.44

1.5

1.4

288.58

312.84

ug/g

0.46

115

Benign lipomatous neoplasm

471

3539

1.34

8.43

1.4

295.92

271.23

ug/g

1.80

281

2063

Benign neoplasm of mouth and pharynx

180

1129

1.62

8.42

1.6

1.4

297.67

278.71

ug/g

0.21

114

645

Other bursopathies

199

1278

1.58

8.39

1.3

1.4

277.37

269.38

ug/g

0.21

101

773

Acute and subacute iridocyclitis

296

2063

1.45

8.37

1.5

1.4

258.85

275.84

ug/g

0.73

187

1215

Family history of malignant neoplasm

173

1077

1.63

8.33

1.5

1.4

265.54

292.01

ug/g

0.87

106

576

Medial epicondylitis

303

2.23

8.31

1.3

1.4

299.93

286.54

ug/g

0.16

175

Impacted cerumen

165

1018

1.65

8.27

1.5

1.4

254.66

275.29

ug/g

0.58

603

Reactive arthropathies, FINNGEN

113

628

1.83

8.26

1.4

264.03

276.76

ug/g

0.24

364

Cardiac murmurs and other cardiac sounds

128

728

1.76

8.26

1.5

1.4

270.48

283.77

ug/g

0.31

395

Primary_lymphoid and hematopoietic malignant neoplasms

383

2800

1.38

8.23

1.5

1.4

264.01

270.87

ug/g

0.29

240

1685

Idiopathic thrombocytopenic purpura

260

2.34

8.23

1.6

1.5

307.93

300.33

ug/g

0.10

162

Tobacco use

494

1.94

8.22

1.5

271.00

291.35

ug/g

0.37

283

Tumor necrosis factor alpha inhibitors

227

1509

1.52

8.17

1.4

294.55

291.88

ug/g

0.06

125

849

Other congenital malformations of the digestive system

389

2.06

8.15

1.6

1.4

264.66

320.10

ug/g

1.52

226

Campylobacter enteritis

230

2.42

8.14

1.5

1.4

245.65

285.00

ug/g

0.58

131

Clear cell adenocarcinoma of kidney

372

2.09

8.14

1.3

1.4

237.61

296.65

ug/g

1.80

224

Implicit parasitic Sepsis

4.60

8.14

1.9

1.3

314.14

314.59

ug/g

0.00

Dermatitis due to substances taken internally

475

1.95

8.11

1.3

1.4

279.92

292.98

ug/g

0.20

255

Wide developmental disorders, excluding more controls

144

2.78

8.11

1.5

1.4

353.41

339.36

ug/g

0.13

Other and unspecified aplastic anaemias

3.42

8.09

1.3

1.4

239.38

326.41

ug/g

1.13

Hypoparathyroidism

367

2.10

8.09

1.8

1.4

264.00

294.05

ug/g

0.75

208

Dislocation, sprain and strain of joints and ligaments of knee

909

6846

1.23

8.08

1.4

280.05

281.66

ug/g

0.08

521

3853

Iridocyclitis

352

2547

1.39

8.06

1.5

1.4

255.96

274.89

ug/g

0.99

222

1478

Other fall from one level to another

329

2353

1.41

8.04

1.5

1.4

276.28

278.65

ug/g

0.07

177

1339

Ingrowing nail

484

1.94

8.02

1.6

1.5

263.21

296.26

ug/g

0.97

280

Colorectal adenocarcinoma

280

1943

1.45

8.01

1.3

1.4

240.35

281.13

ug/g

2.62

172

1173

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

121

3.00

7.97

1.2

1.4

204.04

295.85

ug/g

2.13

Other specified/unspecified spondylopathies

190

2.55

7.93

1.4

243.31

301.82

ug/g

1.14

120

Chronic nephritic syndrome

356

2.10

7.92

1.6

1.5

240.90

284.76

ug/g

1.12

212

Infective dermatitis

175

1107

1.60

7.91

1.4

275.88

276.12

ug/g

0.00

104

627

Anorexia

133

2.90

7.90

1.3

1.4

272.89

320.91

ug/g

0.84

All dysplastic lesions of the vulva

418

2.01

7.89

1.4

344.29

307.40

ug/g

0.68

233

Superficial injury of forearm

145

876

1.68

7.89

1.4

263.54

290.03

ug/g

0.77

482

Sleep disorders, other/unspecified

271

2.27

7.87

1.3

1.4

315.18

304.10

ug/g

0.12

147

Giant cell arteritis

405

2.03

7.86

1.5

1.4

271.64

282.85

ug/g

0.17

243

Ulcerative rectosigmoiditis

119

682

1.77

7.85

1.6

1.4

303.37

297.46

ug/g

0.11

378

Mixed hyperlipidaemia

337

2.13

7.84

1.5

263.49

272.07

ug/g

0.13

197

Cyst of kidney

123

714

1.76

7.82

1.4

234.61

273.91

ug/g

1.33

420

Other epidermal thickening

393

2.03

7.74

1.4

1.5

233.25

285.21

ug/g

1.36

226

Pleural effusion

237

1610

1.49

7.72

1.4

233.82

265.35

ug/g

1.51

152

984

Open wound of forearm

143

866

1.67

7.72

1.5

1.4

255.17

280.76

ug/g

0.79

496

Other disorders of Eustachian tube

268

2.27

7.69

1.5

1.4

295.20

290.46

ug/g

0.06

150

Adalimumab

144

875

1.67

7.68

1.5

1.4

304.07

295.08

ug/g

0.20

471

Acne vulgaris

540

1.85

7.67

1.5

1.3

261.59

321.64

ug/g

1.43

256

Gonarthrosis, primary, with knee surgery

941

6175

1.22

7.63

1.4

280.37

260.68

ug/g

1.38

579

3673

Congenital lactase deficiency

10.72

7.59

1.7

1.5

388.25

386.88

ug/g

—

Other overlap syndromes

165

2.65

7.57

1.5

1.4

305.22

300.06

ug/g

0.05

Endocrine disorders, other/unspecified

171

2.61

7.55

1.3

1.4

276.12

302.74

ug/g

0.38

106

Tubulo-interstitial nephritis, not specified as acute or chronic

109

617

1.79

7.54

1.4

260.29

283.26

ug/g

0.48

361

Achalasia of cardia

125

2.90

7.53

1.5

1.4

262.12

296.83

ug/g

0.43

Arthropathy in Crohn disease

3.42

7.53

1.6

1.3

293.80

300.57

ug/g

0.06

Injury of intra-abdominal organs

195

2.48

7.52

1.3

1.5

312.57

292.54

ug/g

0.25

115

Sacroiliitis, not elsewhere classified

316

2.12

7.47

1.5

1.3

288.11

303.94

ug/g

0.21

166

Corneal ulcer

275

1936

1.43

7.42

1.5

1.4

266.59

278.53

ug/g

0.43

156

1116

Myocardial infarction, strict

728

4165

1.25

7.41

1.4

250.69

260.94

ug/g

0.71

466

2464

Simple and mucopurulent chronic bronchitis

358

2.05

7.41

1.6

1.4

295.45

271.08

ug/g

0.44

201

Other and unspecified abdominal hernia

359

2.05

7.38

1.6

1.5

270.56

273.16

ug/g

0.04

214

Varicose veins of other sites

103

578

1.81

7.35

1.5

1.4

278.76

289.45

ug/g

0.20

338

Other diseases of blood and blood-forming organs

114

660

1.76

7.33

1.5

1.4

295.18

282.94

ug/g

0.23

387

In situ neoplasms

601

4757

1.27

7.32

1.3

1.4

281.89

270.68

ug/g

0.66

341

2779

Organic, including symptomatic, mental disorders

823

4777

1.23

7.32

1.4

260.30

261.34

ug/g

0.05

465

2926

Toxic effects of substances chiefly nonmedicinal as to source

171

1097

1.58

7.31

1.4

266.93

288.36

ug/g

0.63

617

Cushing syndrome

3.20

7.31

1.6

1.3

220.18

305.57

ug/g

1.16

Injury of other and unspecified intrathoracic organs

102

572

1.81

7.31

1.6

1.4

232.04

276.26

ug/g

1.33

352

Acute generalized exanthematous pustulosis

416

1.97

7.28

1.3

1.4

248.59

291.71

ug/g

1.04

238

Other prurigo

3.26

7.28

1.3

280.11

326.47

ug/g

0.56

Congenital iodine-deficiency syndrome/hypothyroidism

249

2.27

7.24

1.4

261.31

306.95

ug/g

1.04

135

COPD, hospital admissions 3, with asthma pneumonia sepsis

407

2613

1.34

7.20

1.4

1.5

259.31

259.71

ug/g

0.01

238

1598

Female infertility, cervical, vaginal, other or unspecified origin

332

1560

1.39

7.20

1.4

1.3

310.30

280.58

ug/g

1.60

174

809

Shock, not elsewhere classified

3.92

7.18

1.6

1.4

256.47

259.01

ug/g

0.02

Other noninfective disorders of lymphatic vessels and lymph nodes

323

2.09

7.13

1.7

1.4

288.10

312.83

ug/g

0.46

197

Other and unspecified follicular disorders

350

2.05

7.13

1.6

1.5

296.50

295.65

ug/g

0.01

198

Acute nasopharyngitis (common cold)

168

1072

1.57

7.13

1.5

1.4

278.74

270.66

ug/g

0.21

653

Other abnormalities of plasma proteins

141

2.74

7.11

1.4

233.35

273.92

ug/g

0.51

Hidradenitis suppurativa

303

2.13

7.11

1.3

1.5

308.79

313.88

ug/g

0.06

167

Multiple myeloma, including Hilmo

357

2.03

7.11

1.4

1.5

217.09

292.85

ug/g

2.46

216

Excessive vomiting in pregnancy

116

680

1.73

7.11

1.2

1.4

331.44

309.39

ug/g

0.45

337

Eosinophilia

141

2.73

7.11

1.6

1.4

274.30

294.81

ug/g

0.21

Dissociative [conversion] disorders

270

2.19

7.09

1.3

361.54

293.55

ug/g

1.55

148

Other erythematous conditions

331

2.08

7.08

1.4

1.5

300.83

284.55

ug/g

0.25

195

Rosacea

181

1186

1.55

7.07

1.3

1.4

320.27

289.26

ug/g

1.16

102

667

Moderate visual impairment, binocular

252

2.24

7.03

1.4

1.5

277.70

278.43

ug/g

0.01

142

Postviral fatigue syndrome

3.87

7.03

1.3

1.4

391.40

343.19

ug/g

—

Other/unspecified soft tissue disorders related to use, overuse and pressure

220

2.33

7.03

1.5

1.4

316.33

302.44

ug/g

0.15

126

Pediculosis, acariasis and other infestations

223

1526

1.47

7.02

1.5

1.4

265.89

292.11

ug/g

1.00

124

824

L04AC Interleukin inhibitors

521

1.84

7.02

1.6

1.4

293.29

296.40

ug/g

0.05

283

Fracture of forearm

882

6685

1.21

7.01

1.4

261.91

279.58

ug/g

1.78

491

3859

Protozoal diseases

267

2.20

6.93

1.6

1.4

241.12

288.93

ug/g

1.00

156

Chronic tubulo-interstitial nephritis

361

2.01

6.91

1.5

1.4

288.32

294.71

ug/g

0.10

214

Allergic colitis

125

2.78

6.90

1.2

1.3

353.14

360.33

ug/g

0.06

Achilles tendinitis

145

908

1.62

6.90

1.6

1.4

253.51

275.82

ug/g

0.76

537

Other and unspecified erythematous conditions

294

2.13

6.89

1.4

297.23

289.09

ug/g

0.11

172

Benign neoplasm: Rectosigmoid junction

383

1.98

6.87

1.3

1.5

316.93

271.03

ug/g

1.06

236

Personal history of certain other diseases

126

2.77

6.84

1.6

1.3

300.06

309.40

ug/g

0.07

Contusion of other and unspecified parts of foot

425

1.92

6.83

1.4

303.77

307.94

ug/g

0.05

227

Pericarditis

288

2.13

6.82

1.4

232.58

277.58

ug/g

0.90

168

Foreign body in alimentary tract

497

1.85

6.82

1.5

1.4

271.08

286.87

ug/g

0.33

290

Hypertrophy of breast

267

1901

1.42

6.82

1.4

291.50

292.42

ug/g

0.02

139

1010

Complications of other internal prosthetic devices, implants and grafts

370

1.99

6.81

1.5

1.4

208.09

295.64

ug/g

2.86

212

Need for immunization against other single viral diseases

168

2.53

6.80

1.5

239.90

294.48

ug/g

0.99

Ulcerative ileocolitis

336

2.04

6.78

1.5

1.4

290.14

305.31

ug/g

0.21

191

Other and unspecified disorders of white blood cells

364

2.00

6.77

1.4

1.5

284.89

277.99

ug/g

0.10

216

Unspecified renal colic

4.26

6.76

1.2

1.4

274.00

269.29

ug/g

—

Spondylopathies in diseases classified elsewhere

3.17

6.74

1.6

1.4

234.31

285.03

ug/g

0.52

Dependent personality disorder

181

2.46

6.73

1.4

443.34

306.13

ug/g

0.49

102

Urethritis and urethral syndrome

187

2.42

6.73

1.3

1.5

403.39

283.68

ug/g

2.89

110

Anterior Iridocyclitis

305

2226

1.38

6.72

1.5

1.4

261.43

275.00

ug/g

0.56

195

1296

Erythema intertrigo

200

2.37

6.69

1.4

243.97

291.64

ug/g

0.92

119

Endocarditis

304

2.09

6.68

1.4

292.36

276.61

ug/g

0.24

181

Mantle cell lymphoma, including Hilmo

3.21

6.68

1.3

214.79

312.73

ug/g

1.55

Other salmonella infections

304

2.08

6.68

1.4

436.28

290.35

ug/g

0.52

175

Maternal care for other conditions predominantly related to pregnancy

262

1828

1.42

6.67

1.3

315.65

315.37

ug/g

0.01

130

915

Endometriosis ASRM stages 1,2

258

1834

1.42

6.65

1.4

332.17

295.68

ug/g

1.93

127

977

Female infertility, tubal origin

359

1.98

6.63

1.4

1.3

320.04

293.20

ug/g

0.32

185

Torticollis

117

2.82

6.63

1.7

1.4

387.92

290.05

ug/g

1.57

Sequelae of other external causes

517

1.81

6.60

1.4

1.5

270.08

286.95

ug/g

0.29

296

Benign neoplasm: Anus and anal canal

266

2.17

6.59

1.5

1.4

308.38

289.59

ug/g

0.30

163

Nasal polyp

276

1988

1.40

6.59

1.4

1.5

285.11

262.89

ug/g

1.01

152

1168

Alzheimer disease, excluding more controls

241

1104

1.45

6.59

1.3

1.4

251.26

246.22

ug/g

0.14

123

684

Carcinoma in situ of skin of other and unspecified parts of face

136

850

1.63

6.59

1.4

268.48

265.75

ug/g

0.05

528

Acute laryngitis and tracheitis

143

888

1.60

6.55

1.4

301.39

296.78

ug/g

0.09

475

Superficial injuries involving multiple body regions

221

2.28

6.54

1.5

1.4

302.43

300.37

ug/g

0.02

134

Rare circulating lymphoid malignancy, including Hilmo

208

2.31

6.54

1.2

1.4

281.45

302.31

ug/g

0.34

126

UC patients in KELA-register (code 208), prior to 1994

411

1.92

6.53

1.7

1.4

259.56

284.74

ug/g

0.65

240

Other specified disorders of muscle

234

2.23

6.52

1.4

296.00

291.83

ug/g

0.05

135

Nummular dermatitis

123

752

1.66

6.50

1.4

292.22

276.92

ug/g

0.38

438

Generalized skin eruption due to drugs and medicaments

356

1.98

6.48

1.3

1.5

257.37

291.96

ug/g

0.67

205

Radial styloid tenosynovitis [de Quervain]

447

1.86

6.48

1.2

1.3

422.39

306.63

ug/g

0.71

254

Isolated proteinuria

235

2.23

6.47

1.6

1.5

261.25

280.20

ug/g

0.28

136

Sequelae of injuries of upper limb

147

940

1.58

6.45

1.7

1.4

249.22

285.37

ug/g

1.22

535

Kyphosis

108

2.89

6.43

1.4

278.00

301.39

ug/g

0.22

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

106

624

1.72

6.43

1.3

1.4

312.16

283.12

ug/g

0.79

362

Foreign body entering into or through eye or natural orifice

120

731

1.66

6.43

1.4

1.5

301.03

287.23

ug/g

0.29

429

Attention to artificial openings

309

2.05

6.40

1.2

1.4

243.50

288.74

ug/g

0.79

194

Pneumonia due to Streptococcus pneumoniae

358

1.96

6.36

1.5

297.15

283.63

ug/g

0.19

212

Viral infections of the central nervous system

112

673

1.69

6.34

1.4

284.47

300.20

ug/g

0.36

371

D07AA Corticosteroids, weak (group I)

216

1500

1.45

6.30

1.4

299.37

299.68

ug/g

0.01

129

811

Other peripheral vertigo

150

970

1.57

6.30

1.5

1.4

268.10

277.22

ug/g

0.20

566

Thyrotoxicosis

393

3010

1.32

6.29

1.4

281.66

281.14

ug/g

0.02

239

1702

Other and unspecified glaucoma

118

721

1.66

6.28

1.4

1.5

250.41

273.42

ug/g

0.60

423

Arthropathic psoriasis

170

1130

1.52

6.27

1.5

1.4

281.23

289.54

ug/g

0.22

103

638

Viral pneumonia (unknown virus, not influenza)

105

622

1.71

6.27

1.5

1.4

272.75

284.14

ug/g

0.24

353

Residual foreign body in soft tissue

395

1.90

6.25

1.6

1.5

244.08

274.44

ug/g

0.57

230

Left ventricular outflow tract obstruction (LVOTO), broad definition

151

979

1.56

6.25

1.4

242.25

274.09

ug/g

1.21

581

Pregnancy with abortive outcome

1020

4481

1.19

6.24

1.4

1.3

298.86

287.41

ug/g

0.88

557

2476

Other hearing loss

422

3194

1.30

6.24

1.5

1.4

272.57

265.73

ug/g

0.27

240

1914

Peptic ulcer

3.65

6.24

1.5

1.4

260.62

273.10

ug/g

0.07

Benign neoplasm: Other and unspecified parts of small intestine

151

2.55

6.24

1.4

1.5

273.32

280.03

ug/g

0.09

Leiomyoma of uterus

992

4729

1.19

6.24

1.4

291.42

285.89

ug/g

0.35

545

2671

Event of undetermined intent

548

1.76

6.24

1.4

294.47

297.83

ug/g

0.05

299

Bursitis of shoulder

200

2.31

6.23

1.3

1.5

255.12

287.18

ug/g

0.48

119

Premenstrual syndrome

3.31

6.23

1.2

1.3

337.75

356.41

ug/g

0.13

Speech and linguistic disorders

115

669

1.67

6.22

1.3

1.4

329.42

318.27

ug/g

0.23

341

Other symptoms and signs involving general sensations and perceptions

340

1.98

6.22

1.3

1.4

285.75

290.74

ug/g

0.06

196

Haemorrhage in early pregnancy

388

2892

1.31

6.18

1.3

1.4

301.82

298.29

ug/g

0.12

207

1506

Temporal arteritis

356

1.96

6.16

1.4

279.31

280.10

ug/g

0.01

213

Giant cell arteritis with polymyalgia rheumatica

356

1.96

6.16

1.4

279.31

277.31

ug/g

0.03

211

Vasomotor rhinitis (mode)

115

702

1.66

6.15

1.7

1.4

289.85

287.13

ug/g

0.05

397

Other and unspecified intracranial injuries

240

2.17

6.15

1.3

1.5

270.08

285.62

ug/g

0.21

148

Aortic valve malfunction, age under 60 years

140

897

1.58

6.12

1.4

240.45

269.95

ug/g

1.03

531

Acute posthaemorrhagic anaemia

301

2.04

6.11

1.5

200.63

287.81

ug/g

2.89

180

Somnolence

100

2.91

6.10

1.5

1.4

252.67

297.33

ug/g

0.52

Recurrent dislocation and subluxation of joint

514

1.77

6.10

1.3

1.4

312.72

296.30

ug/g

0.31

297

Inflammatory diseases of the central nervous system

127

796

1.62

6.09

1.4

247.80

289.46

ug/g

1.47

455

Colitis, primary sclerosing, strict definition

3.36

6.09

1.3

1.4

246.75

292.66

ug/g

0.39

Lichen simplex chronicus

302

2.03

6.07

1.6

1.4

313.31

287.62

ug/g

0.38

169

Deep bite

154

881

1.55

6.07

1.3

1.4

307.24

309.15

ug/g

0.04

469

Astigmatism

552

1.75

6.06

1.4

304.16

300.82

ug/g

0.06

306

Other immunodeficiencies

2.97

6.06

1.5

1.4

323.08

311.87

ug/g

0.07

Allergic contact dermatitis

196

1350

1.47

6.06

1.3

1.4

305.66

293.87

ug/g

0.32

105

745

Viral infections of the central nervous system

117

720

1.65

6.05

1.4

287.93

298.69

ug/g

0.23

394

Nontoxic goitre/thyroid nodule

475

3749

1.28

6.05

1.4

302.88

274.13

ug/g

2.67

285

2177

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

164

1087

1.52

6.04

1.5

1.4

238.85

281.35

ug/g

2.00

102

670

Chronic hepatitis NAS

112

2.79

6.04

1.3

252.86

318.70

ug/g

0.81

Excessive earwax

858

7022

1.20

6.04

1.5

1.4

263.65

267.92

ug/g

0.26

507

4088

Left hemicolectomy

210

2.26

6.02

1.8

1.4

215.09

267.20

ug/g

1.09

122

Benign neoplasm: Skin of trunk

387

1.90

6.01

1.3

1.5

317.00

291.84

ug/g

0.48

221

Other neurotic disorders

437

1.84

6.01

1.5

1.4

252.32

271.94

ug/g

0.36

258

Unspecified chronic bronchitis

296

2.03

6.00

1.5

1.4

290.26

277.55

ug/g

0.14

173

Exposure to other and unspecified inanimate mechanical forces

110

668

1.67

6.00

1.5

288.23

292.96

ug/g

0.09

378

Other inflammation of vagina/vulva

269

2.08

5.99

1.6

1.3

282.32

318.63

ug/g

0.46

140

Malignant neoplasm of oesophagus, including Hilmo

276

2.07

5.99

1.4

1.5

257.55

288.97

ug/g

0.62

170

Abnormal findings on examination of urine, without diagnosis

402

1.88

5.98

1.6

1.4

267.87

290.29

ug/g

0.43

237

COPD, hospital admissions 1, only main diagnosis

517

3524

1.26

5.98

1.4

265.79

259.25

ug/g

0.31

307

2152

230

2.19

5.97

1.6

1.4

270.98

296.73

ug/g

0.32

132

Benign neoplasm: Skin of eyelid, including canthus

248

1788

1.40

5.97

1.5

1.4

247.33

274.34

ug/g

1.38

147

1062

Other and unspecified mononeuropathies, also in other diseases

270

2.09

5.97

1.4

1.5

273.03

279.50

ug/g

0.07

152

Hordeolum and other deep inflammation of eyelid

511

1.77

5.97

1.6

1.4

261.92

296.91

ug/g

0.85

288

Carcinoma in situ of skin

139

896

1.58

5.96

1.3

1.5

296.74

263.51

ug/g

1.15

537

Autoimmune thyroiditis

142

2.54

5.94

1.4

331.88

326.19

ug/g

0.05

Injuries involving multiple body regions

332

1.97

5.94

1.5

1.4

267.33

293.98

ug/g

0.43

191

Other and unspecified papulosquamous disorders

4.01

5.93

1.5

1.4

282.11

284.18

ug/g

—

Nontoxic single thyroid nodule

115

709

1.65

5.93

1.3

1.4

327.67

288.51

ug/g

1.43

394

Malignant neoplasm of rectum, including Hilmo

169

1136

1.50

5.92

1.3

1.4

254.24

289.70

ug/g

1.41

102

697

Toxic colitis

6.18

5.91

1.6

1.3

189.10

262.77

ug/g

—

Injury of unspecified body region

121

756

1.62

5.90

1.4

268.23

287.46

ug/g

0.42

429

Testicular hypofunction

244

2.14

5.90

1.3

1.5

347.85

259.85

ug/g

2.65

139

Spirochaetal infections, other/unspecified

137

882

1.58

5.90

1.4

304.26

285.50

ug/g

0.58

516

Arthropod-borne viral fevers and viral haemorrhagic fevers

270

1977

1.38

5.88

1.4

265.22

275.60

ug/g

0.35

159

1142

Stenosis and insufficiency of lacrimal passages

146

954

1.55

5.87

1.5

1.4

295.74

278.40

ug/g

0.54

561

Cardiomyopathy

246

1775

1.40

5.87

1.3

1.4

280.64

263.34

ug/g

0.28

164

1081

Ankylosing spondylitis

113

695

1.64

5.85

1.4

259.08

276.82

ug/g

0.37

414

Scabies

180

1228

1.48

5.84

1.5

1.4

270.63

299.05

ug/g

0.94

654

Other salmonella infections

369

1.90

5.84

1.4

428.00

291.73

ug/g

0.57

207

Disorders of myoneural junction and muscle in diseases classified elsewhere

3.14

5.84

1.7

1.4

313.06

315.89

ug/g

0.03

Labour and delivery complicated by fetal stress [distress]

145

1438

0.66

5.81

1.3

352.94

319.46

ug/g

0.88

717

Abnormal findings in nipple discharge synovial fluid wound secretions

132

2.59

5.81

1.5

1.3

257.75

282.77

ug/g

0.26

Nontoxic multinodular goitre

304

2274

1.35

5.80

1.5

1.4

300.51

277.67

ug/g

1.25

188

1325

Open wound of shoulder and upper arm

150

2.47

5.78

1.6

1.4

315.56

301.23

ug/g

0.13

Entropion and trichiasis of eyelid

126

799

1.60

5.78

1.4

296.09

262.96

ug/g

1.12

494

LSIL lesion of the vulva

274

2.06

5.76

1.5

1.4

323.40

311.71

ug/g

0.14

153

Unspecified severe protein-energy malnutrition

8.33

5.74

1.4

1.3

291.20

216.58

ug/g

—

Secondary and unspecified malignant neoplasm of lymph nodes

115

716

1.63

5.70

1.5

1.4

280.02

294.76

ug/g

0.36

430

Retinal haemorrhage

222

2.18

5.67

1.5

272.59

276.87

ug/g

0.05

130

Other specified/unspecified dorsopathies

262

2.06

5.64

1.5

1.4

305.20

289.13

ug/g

0.25

144

Bronchitis, not specified as acute or chronic

125

796

1.59

5.63

1.5

1.4

219.56

281.34

ug/g

3.41

444

Bicipital tendinitis

388

1.86

5.63

1.5

1.4

263.28

278.52

ug/g

0.22

232

Sequelae of intentional self-harm, assault and events of undetermined intent

4.00

5.63

1.3

1.4

366.22

338.68

ug/g

—

!Aliquae complicationes praecoces traumatis

403

1.85

5.62

1.3

1.5

292.53

289.85

ug/g

0.04

235

Early complications of trauma

403

1.85

5.62

1.3

1.5

292.53

289.85

ug/g

0.04

235

Benign neoplasm of urinary organs

432

1.82

5.62

1.5

238.86

279.13

ug/g

0.85

258

Single delivery by forceps and vacuum extractor

870

0.58

5.62

1.2

1.3

346.81

309.50

ug/g

0.73

431

Benign neoplasm: Liver/bile ducts

243

2.11

5.60

1.5

1.4

312.11

300.44

ug/g

0.13

137

Pyogenic arthritis

566

1.70

5.59

1.6

1.5

263.70

252.43

ug/g

0.22

346

Haemangioma, any site

130

838

1.57

5.58

1.5

1.4

299.47

290.63

ug/g

0.21

473

Haemorrhagic disorder due to circulating anticoagulants

2.86

5.55

1.5

298.21

266.97

ug/g

0.34

Xerosis cutis

129

2.57

5.55

1.3

1.4

236.47

278.59

ug/g

0.51

Other acquired deformities of musculoskeletal system and connective tissue

434

1.81

5.55

1.4

1.5

292.81

287.64

ug/g

0.09

252

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

191

2.25

5.54

1.4

239.48

298.24

ug/g

1.21

110

Multiple myeloma

191

2.25

5.54

1.4

239.48

298.24

ug/g

1.21

110

Malignant neoplasm, without specification of site, including Hilmo

347

1.90

5.53

1.3

1.5

222.81

289.40

ug/g

1.61

210

Biomechanical lesions, not elsewhere classified

472

1.77

5.51

1.5

1.4

245.65

281.89

ug/g

0.91

275

Primary coxarthrosis, bilateral

448

3555

1.27

5.50

1.4

267.68

264.28

ug/g

0.13

266

2153

Secondary thrombocytopenia

112

2.70

5.50

1.4

1.5

272.15

273.12

ug/g

0.01

Squamous cell neoplasms and carcinomas of the skin

110

683

1.63

5.50

1.4

251.22

281.48

ug/g

0.96

422

Emotional disorders starting during childhood or adolescence

296

1.97

5.48

1.4

1.3

271.95

354.54

ug/g

1.60

138

Pyothorax

385

1.85

5.47

1.4

1.5

215.60

274.24

ug/g

1.56

232

Other and unspecified injuries of lower leg

109

677

1.63

5.47

1.5

1.4

277.12

294.09

ug/g

0.35

370

Autoimmune hyperthyroidism

532

1.72

5.47

1.4

1.3

291.52

303.20

ug/g

0.22

284

Symptoms and signs involving emotional state

245

2.08

5.47

1.5

1.4

275.60

291.28

ug/g

0.19

132

Right bundle-branch block

314

1.95

5.46

1.6

1.4

241.77

283.15

ug/g

0.90

175

Habit and impulse disorders

118

2.62

5.45

1.6

1.5

256.56

293.85

ug/g

0.33

Cardiac arrest

452

1.72

5.44

1.5

1.4

247.04

280.03

ug/g

0.81

270

Polymyalgia rheumatica

205

1456

1.42

5.43

1.5

1.4

258.70

265.51

ug/g

0.23

122

872

Cardiomyopathy, other and unspecified

117

741

1.60

5.43

1.2

1.4

328.08

269.16

ug/g

0.53

419

Malignant neoplasm of bladder, including Hilmo

148

980

1.51

5.42

1.5

225.92

275.75

ug/g

2.06

600

Explicit fungal Sepsis

3.59

5.42

1.5

1.4

163.31

292.23

ug/g

2.44

Haemangioma and lymphangioma, any site

139

916

1.54

5.41

1.5

1.4

300.47

289.94

ug/g

0.27

515

Perineal laceration during delivery

1250

0.60

5.41

1.2

1.3

305.54

317.13

ug/g

0.17

613

Seropositive rheumatoid arthritis

373

2889

1.29

5.39

1.4

281.34

263.24

ug/g

1.02

219

1663

Other congenital malformations

119

757

1.59

5.39

1.4

302.84

315.52

ug/g

0.28

400

Benign neoplasm: Other and unspecified parts of mouth

309

1.95

5.38

1.6

1.5

265.95

276.26

ug/g

0.14

189

Other aneurysm

491

1.74

5.34

1.5

255.35

271.47

ug/g

0.30

306

severe traumatic brain injury, does not include concussion

315

2398

1.32

5.34

1.4

260.14

262.18

ug/g

0.05

182

1439

Other superficial mycoses

135

886

1.54

5.34

1.3

1.4

308.22

294.75

ug/g

0.36

474

Assault by blunt object

2.79

5.34

1.3

1.6

294.61

300.46

ug/g

0.04

Other congenital malformations

174

1202

1.46

5.34

1.4

316.66

303.94

ug/g

0.34

636

Factitial dermatitis

3.88

5.33

1.7

1.3

310.94

301.26

ug/g

0.05

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

317

1.93

5.32

1.4

307.08

304.15

ug/g

0.04

182

Secondary parkinsonism, excluding more controls

156

2.35

5.31

1.3

238.58

262.35

ug/g

0.28

Alcohol abuse counselling and surveillance

138

2.47

5.30

1.7

1.5

241.85

282.98

ug/g

0.43

Malignant neoplasm of oropharynx, including Hilmo

144

2.43

5.30

1.7

1.4

216.73

300.88

ug/g

1.42

Benign neoplasm: Liver

215

2.15

5.29

1.5

300.96

305.19

ug/g

0.04

126

Mixed disorders of conduct and emotions, excluding more controls

3.02

5.28

1.2

1.3

243.41

365.01

ug/g

—

Other/unspecified rheumatoid arthritis

195

1381

1.43

5.27

1.5

1.4

283.95

275.80

ug/g

0.23

116

825

Procedures for purposes other than remedying health state

202

2.18

5.27

1.3

322.91

316.26

ug/g

0.07

109

Fracture of neck

546

1.69

5.26

1.3

1.5

243.80

273.78

ug/g

0.75

324

Polyarthritis, unspecified

297

1.96

5.26

1.3

1.5

298.69

261.70

ug/g

0.78

178

Other/unspecified reactive arthropathies

100

615

1.65

5.26

1.4

276.88

286.62

ug/g

0.15

343

Drug-induced osteoporosis

127

2.55

5.25

1.5

1.4

208.59

288.82

ug/g

1.24

Glaucoma suspect

565

4625

1.23

5.24

1.5

1.4

259.67

271.05

ug/g

0.67

346

2744

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

189

2.21

5.24

1.5

1.3

326.54

299.36

ug/g

0.34

Seminoma of testis, including Hilmo

3.59

5.24

1.6

1.4

285.38

334.72

ug/g

—

Testicular dysfunction

284

1.97

5.22

1.3

1.5

343.66

253.31

ug/g

2.91

169

Malignant neoplasm of tonsil, including Hilmo

115

2.60

5.20

1.6

1.4

231.03

311.11

ug/g

1.06

IBD (strict) with PSC

3.12

5.19

1.5

1.3

222.93

324.63

ug/g

1.16

Unspecified nephritic syndrome

197

2.19

5.18

1.3

1.5

231.09

276.53

ug/g

0.84

115

Gout due to impairment of renal function

2.96

5.18

1.8

1.5

266.12

273.21

ug/g

0.07

Macular pucker

236

1732

1.38

5.17

1.5

1.4

282.38

267.62

ug/g

0.66

140

1057

Pleural plaque with presence of asbestos

102

634

1.63

5.14

1.4

1.5

258.82

247.39

ug/g

0.26

409

Benign intracranial hypertension

3.19

5.14

1.7

1.4

273.27

334.48

ug/g

0.50

Other and unspecified paralytic syndromes

122

2.54

5.13

1.4

251.05

301.43

ug/g

0.65

Other disorders of amino-acid metabolism

5.03

5.13

1.5

1.3

227.00

314.66

ug/g

—

Traumatic subarachnoid haemorrhage

258

2.01

5.12

1.4

213.37

255.29

ug/g

0.60

157

Primary adrenocortical insufficiency

2.80

5.10

1.6

1.3

274.69

320.97

ug/g

0.51

Alzheimer’s disease (Late onset), excluding more controls

198

916

1.43

5.09

1.3

1.4

268.04

249.43

ug/g

0.64

100

564

Amoebiasis

3.10

5.09

1.7

1.3

266.86

325.81

ug/g

0.77

IgA nephropathy (IgA glomerulonephritis)

212

2.13

5.08

1.5

271.14

286.30

ug/g

0.20

124

Familial hypercholesterolemia, with ischemic heart disease

143

963

1.50

5.06

1.4

1.5

258.85

260.97

ug/g

0.04

590

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

849

5714

1.18

5.05

1.3

1.4

307.59

282.46

ug/g

2.78

487

3186

Other obstructive and reflux uropathy

366

1.83

5.04

1.3

1.4

249.02

300.68

ug/g

1.22

205

Other papulosquamous disorders

2.83

5.03

1.5

1.3

260.54

313.30

ug/g

0.54

Tetraplegia

3.28

5.02

1.3

266.67

297.82

ug/g

0.28

Certain conditions originating in the perinatal period

100

549

1.63

5.02

1.4

1.3

302.17

339.78

ug/g

0.81

274

Use of antiglaucoma preparations and miotics

122

796

1.55

5.01

1.4

262.70

276.98

ug/g

0.39

464

Early lumbar disc prolapse operation

139

932

1.51

5.00

1.3

1.4

287.24

300.70

ug/g

0.28

488

Pneumocystosis

168

2.27

4.97

1.4

1.5

241.87

284.03

ug/g

0.59

Eustachian salpingitis and obstruction

104

655

1.61

4.96

1.4

296.16

297.37

ug/g

0.02

334

Evidence of alcohol involvement determined by level of intoxication

2.87

4.96

1.3

1.5

261.56

281.17

ug/g

—

Malignant neoplasm of testis, including Hilmo

2.72

4.96

1.6

1.5

276.40

305.18

ug/g

0.22

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

124

2.49

4.95

1.4

1.5

216.45

312.33

ug/g

1.53

Ulcer of vagina/vulva

214

2.10

4.95

1.4

289.58

312.94

ug/g

0.24

121

Dermatitis due to ingested food

230

2.03

4.95

1.4

1.3

374.61

352.27

ug/g

0.29

106

Other and unspecified injuries of shoulder and upper arm

241

2.03

4.95

1.5

291.77

290.53

ug/g

0.01

133

Other and unspecified mononeuropathies of upper limb

255

2.00

4.94

1.5

258.17

281.53

ug/g

0.38

145

Disorders of porphyrin and bilirubin metabolism

3.01

4.94

1.5

315.74

276.01

ug/g

—

Carcinoma in situ of skin of upper limb, including shoulder

235

2.06

4.94

1.6

1.4

274.16

272.48

ug/g

0.02

134

Focal brain injury

487

1.70

4.92

1.5

1.3

297.35

260.40

ug/g

0.71

284

Other specified/unspecified deforming dorsopathies

143

2.37

4.91

1.2

1.3

246.76

300.00

ug/g

0.83

Gingival hyperplasia

319

1.89

4.91

1.4

1.5

257.55

280.15

ug/g

0.26

190

Pustulosis palmaris et plantaris

399

1.79

4.91

1.7

1.4

241.59

298.40

ug/g

1.45

223

Viral haemorrhagic fevers, not elsewhere classified/unspecified

233

1722

1.36

4.87

1.5

1.4

261.96

278.60

ug/g

0.59

138

982

Adenocarcinoma and papilloma adenocarcinoma of rectum

126

833

1.53

4.87

1.3

1.5

256.15

284.72

ug/g

0.89

511

Burns and corrosions

188

1343

1.41

4.85

1.5

1.4

287.23

284.13

ug/g

0.07

117

758

Colon adenocarcinoma

156

1078

1.46

4.84

1.4

230.85

283.56

ug/g

2.51

650

Laparoscopic right hemicolectomy

583

1.64

4.84

1.4

1.5

246.41

270.57

ug/g

0.55

343

Pleural plaque

132

883

1.51

4.83

1.4

1.5

271.25

253.95

ug/g

0.47

557

Intentional self-harm by unspecified means

2.75

4.81

1.9

1.3

306.87

303.05

ug/g

0.03

Olecranon bursitis

506

1.68

4.81

1.5

1.4

320.66

259.11

ug/g

1.51

311

Contraceptive management

576

3327

1.22

4.81

1.3

1.4

314.14

281.77

ug/g

1.30

293

1890

Other juvenile arthritis

264

1.96

4.81

1.4

1.3

282.10

312.07

ug/g

0.32

134

Recurrent dislocation of patella

335

1.84

4.80

1.3

306.30

305.82

ug/g

0.00

165

Arterial embolism and thrombosis of lower extremity artery

307

1.89

4.80

1.5

228.37

278.36

ug/g

1.01

193

Left bundle-branch block

110

709

1.57

4.79

1.6

1.4

248.73

275.06

ug/g

0.80

410

Synovial cyst of popliteal space [Baker]

103

654

1.59

4.78

1.4

280.98

277.60

ug/g

0.06

399

Other mental disorders due to brain damage and dysfunction and to physical disease

171

1206

1.43

4.77

1.4

256.35

266.34

ug/g

0.24

746

Other disorders of optic [2nd] nerve and visual pathways

600

1.62

4.77

1.4

267.57

289.70

ug/g

0.40

343

Other specified/unspecified disorders of bone/cartilage

259

1.98

4.75

1.4

1.5

283.36

275.17

ug/g

0.09

155

Toxic effect of other and unspecified substances

2.79

4.74

1.4

265.45

278.90

ug/g

0.09

Other and unspecified medical devices associated with adverse incidents

3.56

4.72

1.4

1.5

299.91

263.55

ug/g

0.26

Other and unspecified psoriasis

102

649

1.59

4.71

1.4

276.06

286.45

ug/g

0.22

378

Hypermetropia

102

648

1.59

4.71

1.3

1.4

299.86

301.81

ug/g

0.03

367

Malignant neoplasm of oesophagus

178

2.18

4.71

1.4

1.5

288.53

280.73

ug/g

0.10

108

Malignant neoplasm of tonsil

2.66

4.70

1.5

1.4

197.95

322.25

ug/g

1.67

Manic episode

225

2.04

4.70

1.4

1.5

334.63

285.61

ug/g

0.87

126

Abnormality of white blood cells, not elsewhere classified

3.03

4.69

1.3

1.6

180.80

291.05

ug/g

—

Scleritis and episcleritis

564

1.64

4.69

1.5

1.4

285.79

297.53

ug/g

0.22

305

Infective bursitis

212

2.07

4.67

1.3

1.5

251.51

277.75

ug/g

0.28

129

Examination and encounter for administrative purposes

331

1.84

4.67

1.4

272.44

256.63

ug/g

0.20

197

Otitis media, unspecified

137

854

1.49

4.66

1.5

1.4

302.20

308.33

ug/g

0.12

430

Other and unspecified injuries of ankle and foot

361

1.80

4.65

1.4

300.55

307.60

ug/g

0.09

203

Autism spe, excluding more controls

103

2.56

4.65

1.7

1.3

328.73

354.14

ug/g

0.19

Other disorders starting during childhood or adolescence

350

1.80

4.63

1.2

1.4

363.79

352.98

ug/g

0.13

161

Disorders of optic nerve and visual pathways

133

900

1.49

4.62

1.4

287.35

295.64

ug/g

0.16

486

Contact with heat and hot substances

467

1.69

4.60

1.3

1.5

283.68

290.22

ug/g

0.09

261

Causalgia

135

2.36

4.59

1.5

1.4

275.93

324.98

ug/g

0.50

Calcific tendinitis of shoulder

498

1.67

4.58

1.5

1.4

269.10

283.83

ug/g

0.23

299

Asthma and opportunity respiratory infection

469

1.69

4.56

1.3

1.4

296.48

279.50

ug/g

0.33

263

Mantle cell lymphoma

3.27

4.55

1.1

1.3

284.00

316.41

ug/g

—

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

2.60

4.53

1.4

1.3

313.02

320.55

ug/g

0.06

Rheumatic fever with heart involvement

4.33

4.53

1.4

1.3

357.11

299.36

ug/g

—

Anomalies of dental arch relationship, including avohilmo

259

1771

1.33

4.52

1.4

313.41

300.59

ug/g

0.47

136

959

Lesion of sciatic nerve

372

1.78

4.51

1.5

1.4

252.04

275.30

ug/g

0.41

217

Prolonged pregnancy

1162

0.62

4.51

1.2

1.3

363.19

317.98

ug/g

1.07

576

Complications of cardiac and vascular prosthetic devices, implants and grafts

149

2.27

4.49

1.6

1.5

250.12

297.08

ug/g

0.74

Retinal detachments and breaks

528

4367

1.22

4.49

1.4

260.63

267.42

ug/g

0.34

315

2596

Lichen sclerosus et atrophicus

165

1171

1.43

4.49

1.4

283.46

288.76

ug/g

0.12

679

Spontaneous rupture of synovium and tendon

114

752

1.53

4.49

1.4

300.24

268.84

ug/g

0.98

465

Benign neoplasm: Oesophagus

112

2.50

4.48

1.6

1.5

307.30

284.79

ug/g

0.27

Pilonidal cyst

108

704

1.55

4.48

1.5

1.4

283.30

295.38

ug/g

0.24

393

Combined immunodeficiencies

2.65

4.47

1.7

1.3

296.47

300.63

ug/g

0.04

Poisoning by medicine, drug-induced

112

2.49

4.47

1.5

251.00

309.37

ug/g

0.61

Malignant neoplasm of testis

2.74

4.46

1.5

245.58

320.13

ug/g

0.58

Bell's palsy

160

1130

1.43

4.45

1.4

286.78

282.99

ug/g

0.09

631

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

342

1701

1.28

4.44

1.3

340.27

329.25

ug/g

0.36

157

812

Preterm labour and delivery

360

2862

1.27

4.43

1.3

1.4

314.18

292.22

ug/g

1.24

190

1567

Wet age-related macular degeneration

252

1856

1.33

4.43

1.5

1.4

251.91

268.07

ug/g

0.62

146

1134

Abnormal findings on diagnostic imaging of central nervous system

442

1.70

4.42

1.4

315.75

293.76

ug/g

0.44

246

Status epilepticus

294

1.87

4.42

1.3

1.4

257.25

285.26

ug/g

0.44

171

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

352

1.79

4.42

1.3

1.4

286.93

282.99

ug/g

0.05

202

Acute lymphadenitis

503

1.65

4.41

1.4

295.26

303.11

ug/g

0.12

267

Habitual aborter

100

2.54

4.41

1.4

1.2

270.91

352.10

ug/g

0.77

Other and unspecified coagulation defects

450

1.69

4.41

1.5

1.4

288.30

302.49

ug/g

0.21

245

Chronic myeloid leukaemia, including Hilmo

2.99

4.41

1.6

1.3

226.50

320.88

ug/g

1.04

Pneumonia derived septicemia

302

1.86

4.40

1.5

1.4

275.32

286.26

ug/g

0.13

174

Endometriosis ASRM stages 3,4

333

2628

1.28

4.38

1.4

303.25

290.71

ug/g

0.48

165

1463

Behavioural disorders, excluding more controls

100

2.54

4.38

1.5

296.46

330.34

ug/g

0.28

Other specified and unspecified disorders of eye and adnexa

361

1.78

4.38

1.4

1.5

276.16

289.91

ug/g

0.22

209

Benign neoplasm of bone and articular cartilage

119

797

1.51

4.38

1.4

256.78

292.83

ug/g

0.98

441

Acquired absence of organs, not elsewhere classified

2.67

4.37

1.6

1.3

228.64

289.64

ug/g

0.71

Meningitis

451

1.69

4.37

1.4

1.5

262.28

287.41

ug/g

0.53

251

Psoriatic arthropathies, ICD10

152

1068

1.44

4.37

1.5

1.4

276.75

285.00

ug/g

0.21

604

Impetigo

376

1.75

4.36

1.5

1.4

280.56

309.57

ug/g

0.48

202

Abnormal findings in peritoneal fluid saliva

4.46

4.35

1.6

1.4

337.75

245.49

ug/g

—

Fall on and from ladder

109

718

1.54

4.35

1.5

1.4

264.95

263.81

ug/g

0.02

445

Juvenile arthritis (FINNGEN)

332

1.80

4.33

1.4

283.88

311.20

ug/g

0.35

174

Congenital malformations of the circulatory system

194

1379

1.38

4.33

1.5

1.4

292.25

294.34

ug/g

0.05

113

768

Haemolytic anaemias

311

1.84

4.33

1.4

1.5

263.41

288.07

ug/g

0.47

183

Other and unspecified epidermal thickening

219

2.01

4.31

1.4

1.5

228.74

292.02

ug/g

1.09

127

Gastrointestinal stromal tumor and sarcoma

2.72

4.31

1.5

1.3

218.77

299.18

ug/g

0.83

Hypersomnia

114

2.44

4.30

1.5

301.60

297.19

ug/g

0.03

Mental disorders, not otherwise specified

104

679

1.55

4.30

1.4

275.70

299.14

ug/g

0.55

353

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

128

873

1.48

4.30

1.3

1.4

258.59

284.03

ug/g

0.76

533

Liposarcoma, including Hilmo

2.94

4.29

1.4

1.3

225.45

312.96

ug/g

0.78

Malignant neoplasm of rectum

125

849

1.49

4.29

1.3

1.4

256.46

286.68

ug/g

0.92

516

Malignant neoplasm of oropharynx

108

2.47

4.28

1.5

1.4

194.53

303.46

ug/g

1.58

Blood alcohol or alcohol intoxication level

199

2.05

4.28

1.5

241.00

289.30

ug/g

0.66

110

Other diseases of pericardium

401

1.72

4.27

1.4

233.65

286.57

ug/g

1.34

231

Seminoma of testis

3.99

4.26

1.7

1.4

261.86

320.62

ug/g

—

Nonspecific lymphadenitis

516

1.63

4.25

1.8

1.4

275.16

298.92

ug/g

0.48

295

Muscle strain

241

1.94

4.24

1.3

1.4

299.38

293.28

ug/g

0.05

140

Assault by other specified means

2.89

4.18

1.5

1.4

179.17

280.14

ug/g

—

Inflammatory disease of cervix uteri

100

653

1.55

4.18

1.2

1.3

284.71

292.83

ug/g

0.15

357

Myopia

156

1110

1.42

4.18

1.5

1.4

261.21

304.71

ug/g

1.54

586

Sarcoidosis

195

1441

1.37

4.18

1.4

286.33

276.38

ug/g

0.26

114

830

Sudden idiopathic hearing loss

149

1053

1.43

4.18

1.5

1.4

273.52

268.34

ug/g

0.12

633

Background retinopathy and retinal vascular changes

174

2.12

4.17

1.7

1.4

291.04

297.35

ug/g

0.07

101

Malignant cancer of tonsil and base of tongue

141

2.25

4.17

1.4

231.34

303.23

ug/g

0.84

Peritonsillar abscess

257

1975

1.31

4.17

1.4

291.84

275.07

ug/g

0.53

137

1110

ILD-related respiratory insufficiency

308

1.82

4.16

1.4

1.5

264.36

274.46

ug/g

0.12

193

Toxic liver disease

135

2.29

4.16

1.7

1.4

324.26

321.98

ug/g

0.02

Hypogonadotropic hypogonadism

215

1.99

4.16

1.5

296.58

261.76

ug/g

0.48

124

Progressive vascular leukoencephalopathy

345

1.77

4.15

1.5

235.64

263.55

ug/g

0.52

214

Congenital malformations of gallbladder, bile ducts and liver

2.56

4.15

1.5

1.4

222.81

300.09

ug/g

0.94

Benign neoplasm: Tongue

258

1.90

4.14

1.5

255.23

283.77

ug/g

0.44

150

Poisoning by narcotics and psychodysleptics [hallucinogens]

116

2.38

4.14

1.4

291.92

307.89

ug/g

0.17

Other disorders of the genitourinary system

202

1505

1.36

4.12

1.4

290.34

279.77

ug/g

0.33

114

876

Meralgia paraesthetica

287

1.85

4.11

1.5

319.61

289.17

ug/g

0.58

157

Hyperfunction of pituitary gland

413

1.69

4.11

1.4

254.63

300.97

ug/g

1.14

215

Visual field defects

120

818

1.48

4.08

1.3

1.4

284.80

275.95

ug/g

0.19

475

Anxious personality disorder

149

2.20

4.07

1.7

1.4

528.11

316.31

ug/g

0.39

Crystalline deposits in vitreous body

2.78

4.07

1.6

1.5

242.74

272.96

ug/g

0.30

Orthopaedic devices associated with adverse incidents

190

2.06

4.07

1.4

1.5

282.71

272.09

ug/g

0.11

118

Hypertension, portal

4.83

4.07

1.3

240.86

272.39

ug/g

—

Amyloidosis

176

2.09

4.06

1.4

1.5

412.73

278.99

ug/g

0.35

112

Dislocation, sprain and strain of joint and ligaments of hip

340

1.77

4.05

1.5

244.85

279.33

ug/g

0.75

210

Sequelae of cerebrovascular disease

528

3801

1.20

4.05

1.5

1.4

246.02

263.48

ug/g

1.26

335

2310

Assault by sharp object

130

2.29

4.05

1.4

187.88

309.18

ug/g

1.96

Social disorders starting during childhood or adolecense, excluding more controls

5.14

4.04

1.1

1.3

407.00

334.57

ug/g

—

Diabetes mellitus in pregnancy

364

1863

1.26

4.04

1.4

1.3

299.10

320.29

ug/g

1.05

203

922

Acquired haemolytic anaemia

225

1.96

4.03

1.3

1.5

260.76

283.83

ug/g

0.36

133

Selective deficiency of immunoglobulin A [IgA]y

4.71

4.02

1.4

387.43

327.48

ug/g

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

400

1.69

4.02

1.2

1.4

337.53

339.28

ug/g

0.02

198

Microscopic polyangiitis

3.29

4.01

1.6

1.5

234.50

269.31

ug/g

—

Abscess of Bartholin gland

211

1.98

4.01

1.3

305.16

327.43

ug/g

0.22

115

Chloasma

3.47

4.01

1.3

287.29

314.75

ug/g

—

Oral lichen planus

254

1.89

4.01

1.4

1.5

280.41

292.09

ug/g

0.15

154

Injury of nerves at wrist and hand level

319

1.78

4.00

1.6

1.5

282.76

283.53

ug/g

0.01

186

Diffuse brain injury

239

1.91

3.99

1.6

1.4

262.33

278.39

ug/g

0.16

142

Other obstetric conditions, not elsewhere classified

349

1769

1.26

3.99

1.3

344.18

327.17

ug/g

0.63

159

853

Open wound of hip and thigh

254

1.88

3.97

1.5

281.52

306.00

ug/g

0.37

140

Other keratitis

150

1071

1.41

3.97

1.4

301.68

292.89

ug/g

0.07

601

Progressive systemic sclerosis

3.17

3.97

1.3

1.5

225.88

272.11

ug/g

—

Hepatocellular carcinoma

131

2.26

3.97

1.1

1.4

337.20

282.38

ug/g

0.70

Non-Hodgkin lymphoma, all

305

1.80

3.96

1.3

1.4

237.54

292.59

ug/g

1.48

188

Benign lipomatous neoplasm of other sites/unspecified

129

898

1.45

3.95

1.4

256.19

276.38

ug/g

0.57

515

Pustular psoriasis

449

1.65

3.95

1.6

1.4

248.02

293.71

ug/g

1.14

257

Other specified disorders of kidney and ureter

306

1.80

3.94

1.7

1.5

237.24

280.15

ug/g

0.83

184

Suggestive for eosinophilic asthma

130

907

1.45

3.93

1.3

1.4

290.58

277.50

ug/g

0.29

518

HSIL lesion of the vulva

172

2.10

3.93

1.2

1.4

368.05

310.40

ug/g

0.65

Prurigo nodularis

220

1.95

3.93

1.3

1.4

212.66

303.86

ug/g

2.97

119

116

792

1.48

3.93

1.4

1.5

249.39

256.80

ug/g

0.11

494

All dysplastic lesions of the cervix uteri, vagina or vulva

369

2942

1.24

3.92

1.3

332.54

303.30

ug/g

1.71

215

1505

Intermittent heterotropia

511

1.60

3.92

1.5

1.4

301.93

321.16

ug/g

0.34

274

Retinal detachment with retinal break

181

1337

1.37

3.91

1.3

1.4

265.30

269.55

ug/g

0.10

108

800

Oral lichen planus, including avohilmo , including avohilmo

105

704

1.51

3.91

1.3

1.4

291.86

286.31

ug/g

0.10

405

Hyphaema and other vascular disorders of iris and ciliary body

172

2.08

3.91

1.7

1.5

207.34

285.60

ug/g

1.60

103

LSIL lesion of the cervix uteri, vagina or vulva

185

1371

1.36

3.91

1.4

325.53

306.14

ug/g

0.66

117

712

Ectopic pregnancy

236

1813

1.31

3.89

1.4

287.51

292.50

ug/g

0.12

116

964

Nonalcoholic steatohepatitis

2.71

3.89

1.2

1.3

344.56

306.61

ug/g

—

Neovascular glaucoma

352

1.73

3.88

1.4

251.26

295.61

ug/g

1.00

210

Bullous disorders

561

1.57

3.87

1.5

1.4

258.86

282.91

ug/g

0.42

333

Disorder of external ear, unspecified

293

1.81

3.87

1.5

245.32

284.43

ug/g

0.64

172

L01XE Protein kinase inhibitors

546

1.58

3.86

1.3

1.5

239.57

277.46

ug/g

0.92

328

Amoebiasis

3.34

3.85

2.0

1.4

230.63

339.20

ug/g

—

Varicella [chickenpox]

406

1.67

3.84

1.5

1.4

260.46

284.85

ug/g

0.42

237

Multiple myeloma and malignant plasma cell neoplasms

445

1.64

3.84

1.4

1.5

223.51

274.27

ug/g

1.37

272

Bacterial, viral and other infectious agents

125

870

1.45

3.84

1.4

297.38

285.54

ug/g

0.25

496

Contact with and exposure to communicable diseases

369

2984

1.24

3.80

1.3

1.4

319.71

298.17

ug/g

1.08

208

1558

Other congenital malformations of intestine

2.48

3.79

1.7

1.4

327.99

301.69

ug/g

0.23

Secondary polycythaemia

202

1.97

3.78

1.7

1.5

292.91

276.81

ug/g

0.16

123

Other contact dermatitis

108

733

1.49

3.78

1.4

292.57

298.78

ug/g

0.11

398

Disorders of puberty, all

102

2.40

3.78

1.4

1.3

290.54

367.40

ug/g

—

Psoriasis (vulgaris), strict definition

288

1.80

3.77

1.3

1.4

249.23

287.57

ug/g

0.80

161

Pneumonia due to other infectious organisms, not elsewhere classified

288

1.80

3.77

1.4

1.5

252.04

286.85

ug/g

0.50

174

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

141

2.19

3.77

1.5

1.3

211.00

309.79

ug/g

1.83

Disorders of purine and pyrimidine metabolism

4.01

3.77

1.4

1.5

346.71

260.07

ug/g

—

Tic and related disorders

2.97

3.76

1.7

1.3

317.57

342.10

ug/g

—

Malignant melanoma

188

1406

1.35

3.76

1.4

282.00

294.22

ug/g

0.39

119

848

Motor disorders, excluding more controls

2.57

3.75

1.3

1.5

328.13

362.64

ug/g

0.37

141

2.17

3.74

1.7

1.3

312.31

319.93

ug/g

0.08

Other lack of coordination

155

2.12

3.73

1.6

1.4

254.65

288.42

ug/g

0.38

Carbimazole or st.post thyroidectomy, condition for graves disease

301

2398

1.26

3.73

1.4

291.12

283.40

ug/g

0.26

176

1335

Other and unspecified nail disorders

203

1.97

3.73

1.5

1.4

249.90

297.55

ug/g

0.73

119

Burns and corrosions of external body surface, specified by site

143

1025

1.41

3.73

1.4

289.61

286.90

ug/g

0.05

573

Abscess of lung

122

2.27

3.73

1.8

1.5

151.19

274.24

ug/g

2.44

Acute alcohol intoxication ICD-9

282

1.80

3.72

1.6

1.5

271.19

269.37

ug/g

0.02

175

3.22

3.70

1.5

228.22

363.84

ug/g

—

Disorders of iron metabolism

116

2.30

3.69

1.2

1.4

323.00

277.25

ug/g

0.50

Infection due to other mycobacteria

129

2.23

3.69

1.5

1.3

242.63

301.94

ug/g

0.80

Other bacterial agents as the cause of diseases classified to other chapters

110

2.35

3.68

1.3

1.4

240.73

272.25

ug/g

0.26

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

4.22

3.67

1.4

1.5

346.71

248.33

ug/g

—

Convergent concomitant strabismus

489

1.59

3.67

1.5

1.4

285.13

310.78

ug/g

0.41

262

Disorders of puberty

2.52

3.66

1.4

1.3

300.55

363.37

ug/g

—

Additional codes for the location of defect, injury or illness

553

1.56

3.66

1.4

1.5

321.49

279.96

ug/g

0.98

311

Other psoriatic arthropathies

145

1047

1.40

3.64

1.5

1.4

279.93

285.21

ug/g

0.13

590

Benign neoplasm: Skin of other and unspecified parts of face

151

1098

1.39

3.64

1.6

1.4

240.20

274.32

ug/g

1.36

643

Renal cell carcinoma of kidney

233

1.87

3.63

1.4

238.58

291.00

ug/g

0.87

132

Calcaneal spur

2.42

3.63

1.4

238.80

303.58

ug/g

0.96

Malignant cancer of tonsil and base of tongue, including Hilmo

177

2.02

3.63

1.5

1.4

264.67

304.17

ug/g

0.46

107

Episcleritis

475

1.60

3.63

1.4

292.96

300.47

ug/g

0.12

259

Other noninflammatory disorders of cervix uteri

444

1.62

3.62

1.4

1.3

278.52

278.67

ug/g

0.00

243

Peroneal tendinitis

117

2.27

3.62

1.2

1.4

246.00

291.04

ug/g

0.47

Separation of retinal layers (serosa)

375

1.68

3.61

1.4

1.5

242.08

284.28

ug/g

1.01

214

Other maternal disorders predominantly related to pregnancy

792

4313

1.16

3.60

1.3

1.4

296.25

295.61

ug/g

0.03

441

2303

Personal history of risk-factors, not elsewhere classified

2.45

3.60

1.6

1.3

280.59

303.04

ug/g

0.14

Exposure to other and unspecified animate mechanical forces

263

1.82

3.60

1.2

1.4

342.79

305.46

ug/g

0.77

149

Abnormal blood-pressure reading, without diagnosis

368

1.68

3.58

1.3

1.4

296.53

280.85

ug/g

0.24

214

Fall involving bed

301

1.76

3.57

1.4

223.18

281.88

ug/g

1.19

177

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

191

1445

1.33

3.56

1.4

295.22

282.33

ug/g

0.36

108

829

Carcinoma in situ of skin of scalp and neck

214

1.91

3.55

1.5

1.4

269.58

263.67

ug/g

0.07

133

Sequelae of injuries of head

470

1.59

3.54

1.6

1.4

227.00

285.42

ug/g

1.48

270

Behçet disease

4.89

3.52

1.1

1.5

413.80

241.92

ug/g

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

200

1.93

3.51

1.4

240.68

307.77

ug/g

1.10

102

Benign neoplasm: Kidney

325

1.72

3.51

1.5

243.80

287.96

ug/g

0.68

195

Other specified and unspecified retinal disorders

325

1.72

3.51

1.4

1.5

229.25

280.59

ug/g

1.16

183

Other arterial embolism and thrombosis

229

1.87

3.50

1.5

260.55

278.94

ug/g

0.24

147

Other disorders of male genital organs

258

1.81

3.49

1.5

258.17

255.52

ug/g

0.03

155

Other orthopaedic follow-up care

472

1.59

3.48

1.6

1.4

282.90

297.33

ug/g

0.25

264

Myeloid leukaemia

237

1.85

3.48

1.4

1.5

242.19

280.09

ug/g

0.60

139

Status post-ami

367

2288

1.23

3.48

1.5

1.4

250.95

257.02

ug/g

0.23

221

1388

Persons encountering health services in circumstances related to reproduction

823

4847

1.15

3.46

1.4

290.20

281.49

ug/g

0.33

448

2771

Pyoderma gangrenosum

2.68

3.45

1.3

1.4

252.38

308.56

ug/g

—

Tooth eruption problems

152

1087

1.37

3.45

1.2

1.3

293.69

323.40

ug/g

0.84

520

Malignant neoplasm of bladder

512

1.56

3.45

1.5

226.34

272.11

ug/g

1.21

321

Other condition

190

1444

1.33

3.44

1.5

1.4

267.74

286.76

ug/g

0.64

103

810

Malignant neoplasm of head and neck

666

1.48

3.43

1.5

256.91

285.75

ug/g

0.82

402

Impaction of intestines

3.88

3.43

1.5

1.3

230.71

331.31

ug/g

—

Dislocation, sprain and strain of joints and ligaments of head

342

1.69

3.43

1.4

309.52

309.14

ug/g

0.00

190

Vascular dementia (other)

2.94

3.42

1.6

1.4

293.83

286.10

ug/g

—

Hypoplasia of dental enamel

2.58

3.41

1.3

1.4

381.91

365.42

ug/g

0.15

Malignant neoplasm of cervix uteri, including Hilmo

217

1.88

3.41

1.3

1.4

308.39

318.62

ug/g

0.12

120

Personality and behavioural disorders due to brain disease, damage and dysfunction

127

2.18

3.40

2.2

1.5

234.21

286.95

ug/g

0.55

Deep endometriosis

135

976

1.40

3.40

1.3

1.4

322.52

289.78

ug/g

0.90

509

Spinal enthesopathy

167

1.99

3.39

1.5

1.4

228.66

258.41

ug/g

0.36

Ovarian dysfunction

563

1.52

3.38

1.5

1.3

328.55

325.99

ug/g

0.03

259

Ménière disease

138

1003

1.39

3.37

1.4

286.89

277.10

ug/g

0.21

579

Lung transplant status

2.65

3.37

1.0

1.5

257.13

292.17

ug/g

—

Idiopathic pulmonary fibrosis

104

719

1.46

3.37

1.3

1.5

250.75

271.18

ug/g

0.53

441

Presbyopia

621

1.50

3.36

1.4

297.80

286.78

ug/g

0.20

348

Thyrotoxicosis with diffuse goitre

187

1423

1.32

3.36

1.5

1.4

278.55

287.03

ug/g

0.23

118

774

Acquired absence of limb

2.61

3.35

1.4

1.5

300.60

270.16

ug/g

—

Contracture of joint

102

2.31

3.34

1.8

1.4

214.25

272.74

ug/g

0.57

Non-follicular lymphoma

137

997

1.39

3.33

1.5

1.4

253.75

270.38

ug/g

0.43

607

Erythema multiforme

183

1.95

3.33

1.3

1.5

330.56

301.38

ug/g

0.39

106

Other disorders of bone density and structure

226

1.85

3.33

1.5

1.4

258.43

299.26

ug/g

0.60

136

Nontoxic diffuse goitre

285

1.75

3.32

1.5

1.4

278.69

305.60

ug/g

0.45

159

100

687

1.47

3.32

1.3

341.81

328.81

ug/g

0.22

321

Specific development disorders of scholastic skills

288

1.73

3.31

1.2

1.4

367.96

332.07

ug/g

0.47

140

Hyperosmolality and hypernatraemia

2.35

3.31

1.5

1.3

209.31

294.67

ug/g

1.24

conjunctival degenerations and deposits

198

1.91

3.30

1.6

1.5

250.03

288.70

ug/g

0.46

121

ILD medications: nintedanib

3.50

3.29

1.5

230.63

280.12

ug/g

—

Drug-induced polyneuropathy

2.53

3.28

1.3

1.5

237.21

277.92

ug/g

0.36

Perforation of tympanic membrane

134

974

1.39

3.28

1.3

1.4

251.85

285.86

ug/g

1.14

542

Autoimmune hepatitis

2.75

3.28

1.3

1.4

278.75

311.27

ug/g

0.36

Endometriosis of intestine

2.38

3.27

1.4

1.2

479.38

349.01

ug/g

—

Other disorders of iris and ciliary body

235

1.82

3.25

1.7

1.4

229.88

288.03

ug/g

0.90

143

Chronic conjunctivitis

272

1.76

3.25

1.3

1.5

292.14

294.93

ug/g

0.03

165

Dyshidrosis [pompholyx]

123

2.16

3.24

1.6

1.3

197.92

341.64

ug/g

2.43

Diffuse large B-cell lymphoma, helper endpoint

356

1.65

3.22

1.7

1.5

227.88

296.92

ug/g

1.94

209

Diffuse large B-cell lymphoma, including Hilmo

356

1.65

3.22

1.7

1.5

227.88

296.92

ug/g

1.94

209

Diffuse large B-cell lymphoma

356

1.65

3.22

1.7

1.5

227.88

296.92

ug/g

1.94

209

2.37

3.22

1.4

1.5

265.31

294.75

ug/g

0.23

Amyloidosis, other/unspecified

144

2.06

3.20

1.4

439.48

273.04

ug/g

0.41

Tibial collateral bursitis [Pellegrini-Stieda]

2.42

3.20

1.4

265.33

287.68

ug/g

—

Lung transplantation

2.57

3.20

1.0

1.4

257.13

292.17

ug/g

—

Defects in the complement system

2.73

3.20

1.7

1.3

336.86

299.56

ug/g

—

Chronic myeloid leukaemia [CML], BCR/ABL-positive

2.49

3.20

1.6

1.5

226.50

301.42

ug/g

0.78

Inguinal hernia, bilateral

133

970

1.38

3.19

1.4

1.5

291.17

248.51

ug/g

0.37

614

Other hyperalimentation

3.93

3.18

1.4

179.67

316.72

ug/g

—

Carrier of infectious disease

208

1.86

3.17

1.5

243.95

290.98

ug/g

0.65

110

Pedestrian injured in transport accident

654

1.47

3.17

1.4

279.16

292.48

ug/g

0.26

376

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

595

1.49

3.16

1.4

345.28

325.53

ug/g

0.37

302

Non-allergic asthma

118

845

1.41

3.15

1.4

280.47

280.67

ug/g

0.00

482

Personal history of allergy to drugs, medicaments and biological substances

2.35

3.15

1.4

1.2

312.26

317.91

ug/g

—

Myasthenia gravis

159

2.00

3.15

1.5

256.90

286.46

ug/g

0.39

Wide developmental disorders

222

1.82

3.15

1.5

1.4

353.41

354.62

ug/g

0.01

115

Femoral hernia

382

1.62

3.14

1.7

1.4

263.68

276.63

ug/g

0.22

225

Otorrhagia

2.90

3.14

1.6

1.4

332.78

281.64

ug/g

—

Inguinal or femoral hernia, bilateral

136

999

1.37

3.13

1.4

1.5

291.17

251.28

ug/g

0.34

632

Atypical mycobacterium lung infection

112

2.21

3.12

1.4

276.42

284.03

ug/g

0.06

Bitten or struck by other mammals

143

1059

1.36

3.12

1.3

1.4

291.15

302.24

ug/g

0.28

559

Spasmodic torticollis

306

1.70

3.12

1.3

1.4

309.08

302.28

ug/g

0.08

170

Bacterial, viral and other infectious agents

114

814

1.41

3.12

1.4

288.60

282.55

ug/g

0.11

463

Glaucoma secondary to other eye disorders

376

1.62

3.09

1.4

1.5

251.26

286.87

ug/g

0.73

223

3.52

3.09

1.2

1.4

365.00

285.83

ug/g

—

Neuroendocrine tumor and carcinoma of stomach

3.51

3.09

1.3

274.43

298.07

ug/g

—

Unspecified lump in breast

230

1822

1.27

3.08

1.4

271.50

287.49

ug/g

0.58

146

1012

Synovial hypertrophy, not elsewhere classified

2.57

3.08

1.4

1.3

391.50

358.51

ug/g

0.27

Adenocarcinoma and Papillary adenocarcinoma of kidney

2.57

3.08

1.5

1.4

326.20

314.40

ug/g

—

Varicella [chickenpox]

479

1.54

3.07

1.4

269.39

292.87

ug/g

0.40

275

Foreign body in respiratory tract

472

1.54

3.06

1.5

291.75

291.65

ug/g

0.00

270

Dependence on enabling machines and devices, not elsewhere classified

2.31

3.05

1.5

1.4

344.03

303.84

ug/g

0.35

Other sexually transmitted chlamydial diseases

448

1.55

3.04

1.3

249.97

327.22

ug/g

1.59

210

Idiopathic urticaria

168

1.94

3.03

1.5

1.4

328.51

312.54

ug/g

0.13

Amiodarone users

137

1014

1.36

3.03

1.4

1.5

250.74

262.53

ug/g

0.32

613

2.49

3.03

1.7

1.3

338.18

333.58

ug/g

0.04

Calculus of lower urinary tract

441

1.56

3.03

1.4

1.5

257.58

260.34

ug/g

0.04

284

Malignant neoplasm of larynx, including Hilmo

113

2.16

3.03

1.6

1.4

297.36

287.55

ug/g

0.08

Other vitreous opacities

363

1.62

3.02

1.4

1.5

283.63

285.86

ug/g

0.02

217

Contusion of toe(s) without damage to nail

197

1.86

3.01

1.3

1.4

322.83

316.33

ug/g

0.05

113

Hereditary motor and sensory neuropathy

2.54

3.01

1.3

277.65

296.66

ug/g

0.14

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

107

2.20

3.00

1.6

1.5

238.27

303.70

ug/g

0.79

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

176

1.92

3.00

1.7

1.4

295.05

277.34

ug/g

0.21

106

Malignant melanoma, including Hilmo

221

1748

1.27

3.00

1.4

281.85

290.82

ug/g

0.30

140

1035

Other pulmonary heart/vessel disease

443

1.56

2.99

1.5

1.4

261.79

286.68

ug/g

0.50

267

Infection of intervertebral disc (pyogenic)

2.33

2.97

1.5

1.4

189.02

277.60

ug/g

—

Pneumococcal septicemia

295

1.69

2.97

1.4

1.5

298.08

291.41

ug/g

0.07

175

Hypothyroidism, autoimmune, DX-based

3.63

2.97

1.2

1.3

306.20

318.00

ug/g

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

663

4374

1.15

2.97

1.3

1.4

314.78

295.72

ug/g

1.47

378

2336

Molar incisor enamel hypoplasia, with caries

2.61

2.97

1.4

381.25

372.37

ug/g

—

Gangrene, not elsewhere classified

2.91

2.96

2.1

1.4

92.67

281.13

ug/g

—

Injury of muscle and tendon at wrist and hand level

179

1382

1.30

2.95

1.4

315.45

267.92

ug/g

2.19

814

Open wound of abdomen, lower back and pelvis

250

1.75

2.95

1.7

1.5

292.02

293.77

ug/g

0.02

143

Melanocytic naevi

400

3370

1.19

2.95

1.4

287.90

280.50

ug/g

0.32

234

1913

Helminthiases

142

2.01

2.94

1.4

294.61

291.37

ug/g

0.02

Other abnormal findings of blood chemistry

429

1.56

2.93

1.4

1.5

296.19

279.48

ug/g

0.22

248

Hereditary deficiency of other clotting factors

2.50

2.92

1.7

1.4

338.35

322.71

ug/g

0.09

Juvenile rheumatoid arthirtis

149

1.98

2.92

1.3

1.4

300.87

314.83

ug/g

0.10

Osteonecrosis due to drugs

122

2.10

2.92

1.6

1.5

208.14

270.35

ug/g

0.86

Other complications of labour and delivery, not elsewhere classified

860

0.65

2.92

1.2

1.3

391.08

326.13

ug/g

0.97

414

3.32

2.92

1.6

1.5

344.00

249.45

ug/g

—

Carcinoma in situ of colon

178

1.90

2.92

1.2

1.5

230.49

272.66

ug/g

0.50

105

Other specified and unspecified strabismus

102

2.22

2.92

1.9

1.4

299.36

300.09

ug/g

0.00

Burns and corrosions of multiple body regions

2.66

2.91

1.4

1.6

158.22

255.23

ug/g

—

Discitis, unspecified

122

2.09

2.91

1.5

1.4

238.31

282.36

ug/g

0.46

Family history of other specific disorders

102

2.21

2.91

1.6

1.3

243.91

306.79

ug/g

0.60

Contact with other sharp object(s)

575

1.47

2.91

1.3

1.4

286.55

303.05

ug/g

0.32

312

Melanocytic naevi, other sites/unspecified

106

758

1.41

2.90

1.3

1.4

298.37

287.90

ug/g

0.21

420

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

116

843

1.39

2.90

1.5

1.4

330.12

284.46

ug/g

1.59

475

Artificial joint re-operation

105

751

1.41

2.89

1.4

1.5

328.30

267.06

ug/g

2.21

435

Spontaneous abortion

623

3655

1.15

2.89

1.3

301.52

293.05

ug/g

0.42

337

2004

Myelodysplastic syndrome, including Hilmo

222

1.78

2.88

1.3

1.4

240.47

294.38

ug/g

0.79

131

Thiamine deficiency

2.89

2.87

1.6

307.80

260.88

ug/g

—

Other and unspecified diseases of blood and blood-forming organs

245

1.75

2.87

1.3

1.5

290.21

288.98

ug/g

0.01

146

Benign neoplasm of eye and adnexa

144

1084

1.34

2.87

1.4

296.35

276.41

ug/g

0.61

628

Other bacterial agents as the cause of diseases classified to other chapters

2.29

2.85

1.4

212.27

268.70

ug/g

0.54

False labour

345

1783

1.21

2.85

1.3

339.98

307.25

ug/g

1.69

152

918

Single delivery by caesarean section

141

1076

0.75

2.84

1.3

313.54

302.65

ug/g

0.23

541

Effects of other external causes

223

1.77

2.84

1.4

328.13

302.24

ug/g

0.33

124

Other surgical follow-up care

253

1.72

2.84

1.8

1.5

226.74

308.08

ug/g

2.01

139

Symptoms and signs involving appearance and behaviour

2.53

2.83

1.3

1.6

355.67

257.98

ug/g

—

Disorders of orbit

401

1.57

2.83

1.4

255.97

300.62

ug/g

0.91

223

Viral encephalitis, not elsewhere classified/unspecified

180

1.87

2.82

1.2

1.4

306.06

303.44

ug/g

0.02

109

Other and/or unspecified nontoxic goitre

119

873

1.38

2.82

1.4

310.61

281.18

ug/g

0.95

495

Congenital malformations of genital organs

110

791

1.39

2.81

1.5

1.4

335.01

321.10

ug/g

0.31

394

Carcinoma in situ of other and unspecified digestive organs

308

1.65

2.80

1.2

1.5

256.63

265.54

ug/g

0.11

187

Disorders of speech understanding and production

355

1.59

2.80

1.5

1.4

307.28

328.68

ug/g

0.37

181

Other nonthrombocytopenic purpura

2.38

2.79

1.7

1.4

282.09

308.74

ug/g

0.22

Other and unspecified trigeminal disorders

138

2.00

2.79

1.5

1.4

222.69

313.55

ug/g

1.56

Acute otitis externa, noninfective

138

2.00

2.79

1.4

1.5

213.08

283.99

ug/g

1.07

Presbycusis

180

1389

1.29

2.79

1.4

278.31

258.53

ug/g

0.58

102

870

Viral meningitis

316

1.64

2.78

1.5

1.4

260.76

307.63

ug/g

0.89

183

Exposure to other and unspecified forces of nature

2.81

2.77

1.7

1.4

219.29

320.65

ug/g

—

433

1.53

2.77

1.5

1.4

243.00

272.39

ug/g

0.57

257

Multifocal fibrosclerosis

2.61

2.76

1.8

1.5

235.49

275.87

ug/g

—

Colorectal neuroendocrine tumor and carcinoma

118

2.08

2.76

1.5

1.4

241.62

321.04

ug/g

0.96

Other and unspecified vaccines and biological substances

2.69

2.75

1.2

1.4

350.43

311.88

ug/g

—

Other abnormal immunological findings in serum

167

1.89

2.75

1.3

1.4

342.24

304.76

ug/g

0.41

Aortic aneurysm

293

2369

1.22

2.75

1.5

252.62

260.64

ug/g

0.28

175

1435

Enteritis due to Yersinia enterocolitica

3.13

2.75

1.8

1.5

146.50

302.32

ug/g

—

Unspecified visual impairment (binocular)

132

2.01

2.74

1.4

306.80

286.19

ug/g

0.18

Major anomalies of jaw size

226

1.75

2.73

1.4

1.5

295.02

301.91

ug/g

0.07

129

Motorcycle rider injured in noncollision transport accidents

241

1.72

2.73

1.5

239.91

290.82

ug/g

0.67

137

Other disorders of pigmentation

421

1.54

2.72

1.6

1.5

269.44

285.73

ug/g

0.28

247

Long labour

191

2066

0.79

2.72

1.3

1.4

363.65

305.78

ug/g

3.03

1096

Drug-induced neutropenia

102

735

1.40

2.71

1.4

253.25

280.57

ug/g

0.77

421

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

2.91

2.70

1.5

158.86

257.89

ug/g

—

Pathological resorption of teeth

312

1.63

2.67

1.4

276.92

295.87

ug/g

0.22

173

Drug-induced headache, not elsewhere classified

3.04

2.67

1.4

1.3

338.29

304.36

ug/g

—

Other and unspecified hypertrophic disorders of skin

2.64

2.66

1.5

1.3

242.71

318.08

ug/g

—

Mixed specific developmental disorders

142

1.91

2.66

1.1

1.4

394.22

382.15

ug/g

0.12

Undescended testis, unilateral

2.53

2.66

1.3

1.5

360.00

308.87

ug/g

—

Vascular dementia

109

767

1.38

2.66

1.6

1.5

248.16

257.61

ug/g

0.20

489

Epiphora

221

1.75

2.66

1.4

1.5

278.06

294.51

ug/g

0.19

134

Severe visual impairment, monocular

2.32

2.65

1.4

339.01

315.15

ug/g

—

Benign neoplasm: Other/unspecified site

148

1.94

2.65

1.5

1.4

265.65

294.83

ug/g

0.39

Diastasis of muscle

2.61

2.65

1.8

1.3

309.44

330.37

ug/g

—

Congenital malformations of heart and great arteries

161

1207

1.30

2.65

1.5

1.4

278.14

301.45

ug/g

0.75

670

Injury of nerves at shoulder and upper arm level

2.31

2.64

1.8

1.3

187.60

313.61

ug/g

—

Retinal vascular disorders

160

1238

1.30

2.64

1.5

1.4

239.50

271.95

ug/g

1.30

101

750

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

313

1.62

2.64

1.4

285.28

300.75

ug/g

0.22

185

Thoracic aortic aneurysm

184

1450

1.28

2.64

1.5

256.38

269.74

ug/g

0.37

113

884

Intentional self-harm by sharp object

184

1.82

2.63

1.3

1.4

289.06

303.40

ug/g

0.13

Dislocation, sprain and strain of joints and ligaments of thorax

290

1.64

2.63

1.4

274.99

287.98

ug/g

0.17

165

Myositis

199

1.79

2.63

1.3

1.5

327.09

294.68

ug/g

0.37

111

Use of rotigotine

107

2.12

2.62

1.5

1.4

245.47

286.11

ug/g

0.41

Myocarditis

360

1.57

2.62

1.6

1.3

215.81

300.45

ug/g

2.41

215

Primary open-angle glaucoma, strict

378

3200

1.18

2.62

1.5

1.4

256.94

265.75

ug/g

0.39

225

1941

Benign neoplasm of other and unspecified sites

314

1.62

2.61

1.5

248.74

284.68

ug/g

0.72

192

Palindromic rheumatism

2.24

2.61

1.6

1.4

301.00

291.80

ug/g

—

Retinal vascular occlusion

157

1214

1.30

2.61

1.5

1.4

241.60

272.33

ug/g

1.20

100

734

Malignant melanoma of skin

136

1031

1.33

2.61

1.4

289.91

287.18

ug/g

0.06

616

Malignant neoplasm of oral cavity, including Hilmo

353

1.58

2.61

1.5

1.4

261.24

294.52

ug/g

0.67

208

ILD and respiratory illness in diseases classified elsewhere

2.85

2.60

1.6

1.4

344.00

271.58

ug/g

—

Other nonscarring hair loss

2.19

2.60

1.5

1.4

293.50

340.54

ug/g

0.49

Other injuries of spine and trunk, level unspecified

2.42

2.60

1.3

1.4

258.44

285.31

ug/g

—

Hyperprolactinaemia

291

1.64

2.59

1.4

252.62

305.67

ug/g

1.03

150

Cardiomyopathies, Primary/intrinsic

154

1189

1.30

2.59

1.4

253.76

261.60

ug/g

0.19

102

705

Epileptic seizures related to alcohol

2.83

2.59

1.3

1.6

138.67

286.51

ug/g

—

Childhood allergy (age < 16)

131

811

1.34

2.59

1.4

1.3

351.41

340.28

ug/g

0.19

344

Acute epiglottitis

128

1.99

2.59

1.6

1.4

265.24

279.28

ug/g

0.15

Thrombotic microangiopathy

2.82

2.59

1.5

320.43

282.58

ug/g

—

Primary open-angle glaucoma

460

3836

1.16

2.58

1.5

1.4

251.47

266.25

ug/g

0.89

277

2314

Crushed, pushed or stepped on by crowd or human stampede

615

1.43

2.58

1.4

303.74

310.80

ug/g

0.12

320

L02BG Aromatase inhibitors

343

4049

0.84

2.57

1.4

279.20

278.14

ug/g

0.03

203

2342

Medicines for HER+ breast cancer

425

4681

0.86

2.56

1.4

281.48

282.01

ug/g

0.02

257

2676

Other forms of systemic lupus erythematosus

2.34

2.56

1.5

1.4

387.82

314.45

ug/g

1.06

Patellar tendinitis

101

2.11

2.55

1.7

1.3

242.48

290.20

ug/g

0.52

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

525

0.56

2.55

1.4

1.5

290.81

293.66

ug/g

0.02

306

Schizophrenia, schizotypal and delusional disorders

413

3538

1.17

2.54

1.4

284.22

277.48

ug/g

0.27

241

1986

Overexertion and strenuous or repetitive movements

126

949

1.34

2.54

1.3

1.4

281.40

290.61

ug/g

0.21

536

Dissocial personality disorder

115

2.04

2.54

1.2

1.6

285.31

267.45

ug/g

0.15

Delayed puberty

3.04

2.51

1.5

1.3

286.48

406.73

ug/g

—

Secondary right heart disease

389

1.54

2.51

1.4

259.61

282.57

ug/g

0.41

239

Other ill-defined and unspecified causes of mortality

720

1.39

2.51

1.4

1.5

221.59

268.29

ug/g

1.43

445

Adult respiratory distress syndrome

102

2.11

2.51

1.5

247.83

278.58

ug/g

0.26

Oral lichen planus and hypothyroidism or thyroxine medication

173

1.83

2.51

1.3

1.4

271.16

298.15

ug/g

0.30

Malignant neoplasm, without specification of site

217

1.73

2.50

1.5

234.70

286.74

ug/g

0.65

135

Aspergillosis

2.45

2.50

1.3

1.7

289.10

273.41

ug/g

—

Allergic contact dermatitis due to drugs in contact with skin

195

1.78

2.50

1.3

1.4

278.00

297.60

ug/g

0.19

120

Malignant neoplasm of endocrine gland

636

1.41

2.50

1.4

320.29

312.25

ug/g

0.15

347

Hypertrophy of tongue papillae

116

2.03

2.50

2.1

1.4

342.71

312.65

ug/g

0.23

Malignant neoplasm of bronchus and lung

141

1517

0.77

2.49

1.3

1.4

273.17

280.42

ug/g

0.15

914

Galactorrhea

2.19

2.49

1.2

1.3

305.56

316.44

ug/g

—

Other lesions of median nerve

256

1.67

2.49

1.4

279.95

286.20

ug/g

0.06

140

Atopic conjunctivitis

398

1.52

2.48

1.5

1.4

286.16

303.69

ug/g

0.27

224

Other articular cartilage disorders

188

1.78

2.48

1.5

1.4

168.31

276.70

ug/g

1.69

115

Other or ill-defined heart diseases

455

1.49

2.46

1.4

263.26

285.95

ug/g

0.47

259

Uterine polyps

118

885

1.34

2.46

1.4

1.3

271.33

274.89

ug/g

0.07

474

Specific development disorders of speech and language

462

1.47

2.45

1.4

302.49

312.32

ug/g

0.18

237

Lesion of plantar nerve

614

1.42

2.45

1.5

1.4

290.08

286.63

ug/g

0.05

341

Foreign body on external eye

182

1447

1.26

2.44

1.5

253.59

266.38

ug/g

0.35

105

850

Arthropathy in ulcerative colitis

117

2.01

2.44

1.7

1.4

276.33

303.29

ug/g

0.26

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

646

1.40

2.44

1.4

260.81

279.63

ug/g

0.39

390

Malignant neoplasm of other and ill-defined sites, including Hilmo

117

2.00

2.43

1.3

1.4

150.86

315.70

ug/g

5.42

Other other unspecified disorders of the circulatory system

352

1.56

2.43

1.6

1.4

251.66

280.50

ug/g

0.52

203

Intracranial and intraspinal abscess and granuloma

2.16

2.42

1.3

1.4

201.83

284.62

ug/g

1.19

Toxic effect of ethanol

344

1.56

2.42

1.5

1.4

215.04

303.80

ug/g

1.81

198

Other sexually transmitted chlamydial diseases

682

1.39

2.41

1.3

260.56

332.61

ug/g

1.95

309

Vasculitis limited to skin, not elsewhere classified

243

1.67

2.41

1.4

1.5

273.88

296.21

ug/g

0.29

148

Collapsed vertebra, not elsewhere classified

2.49

2.41

1.6

1.4

246.22

289.66

ug/g

—

Optic atrophy

168

1.82

2.40

1.4

330.77

298.22

ug/g

0.29

102

Other localized connective tissue disorders

183

1.78

2.39

1.5

1.4

235.85

303.47

ug/g

1.20

106

Endometriosis of fallopian tube

2.57

2.39

1.2

1.3

324.83

320.32

ug/g

—

Any dementia, excluding more controls

475

2836

1.16

2.39

1.3

1.4

272.40

253.03

ug/g

1.28

254

1770

Vascular dementia (mixed)

132

1.93

2.38

1.4

286.18

270.42

ug/g

0.20

Systemic sclerosis,strict definition

2.11

2.37

1.9

1.3

229.18

307.37

ug/g

—

Cardiomyopathy (excluding other)

161

1269

1.28

2.34

1.4

250.07

261.71

ug/g

0.31

107

745

Previous suicide attempt

2.23

2.34

1.6

1.4

256.57

308.53

ug/g

—

Pedestrian injured in collision with pedal cycle

276

1.62

2.34

1.4

300.73

292.97

ug/g

0.10

169

Complications of genitourinary prosthetic devices, implants and grafts

222

1.69

2.34

1.4

247.46

306.97

ug/g

1.06

130

Other specified congenital malformation syndromes affecting multiple systems

133

1.91

2.34

1.3

1.4

355.50

313.58

ug/g

0.56

Fistulae involving female genital tract

126

1.94

2.34

1.5

1.4

311.00

283.58

ug/g

0.25

Osteomalacia

2.18

2.33

1.4

314.30

285.29

ug/g

—

Other specific arthropathies, wide

177

1.78

2.33

1.5

302.41

290.70

ug/g

0.09

106

Undescended testicle

2.23

2.33

1.3

1.4

386.55

354.16

ug/g

0.27

Other deformities of toe(s)

300

1.59

2.32

1.6

1.4

316.96

267.88

ug/g

0.87

175

Other disorders of peripheral nervous system

2.54

2.32

1.6

1.5

306.25

300.25

ug/g

—

Periodontal disease, other/unspecified

238

1.66

2.32

1.2

1.5

355.05

296.39

ug/g

0.85

132

Unspecified event, undetermined intent

215

1.70

2.31

1.5

255.30

305.92

ug/g

0.77

126

Mental retardation, excluding more controls

261

1.62

2.31

1.3

1.5

313.93

313.13

ug/g

0.01

163

Disturbances of smell and taste

397

1.50

2.31

1.7

1.4

296.02

292.14

ug/g

0.05

236

Obstructed labour due to malposition and malpresentation of fetus

174

2026

0.80

2.30

1.2

1.4

340.12

306.28

ug/g

1.26

1071

Bacterial meningitis

317

1.57

2.30

1.4

257.65

285.32

ug/g

0.48

185

Inflammatory disorders of male genital organs, not elsewhere classified

2.11

2.30

1.8

1.6

276.07

262.08

ug/g

0.11

Delayed milestone in childhood

146

1.82

2.29

1.4

342.03

394.70

ug/g

0.71

Allergic purpura

262

1.62

2.29

1.4

313.32

309.23

ug/g

0.04

149

Postpartum haemorrhage

201

2080

0.81

2.28

1.2

1.4

319.00

308.11

ug/g

0.32

1092

Contact with lifting and transmission devices, not elsewhere classified

149

1.85

2.27

1.8

1.5

201.47

280.29

ug/g

1.13

Conductive hearing loss, unspecified

110

828

1.34

2.27

1.4

288.19

275.13

ug/g

0.24

478

Exclusion endpoint for clefts

156

1.82

2.27

1.4

364.52

323.53

ug/g

0.62

Herpesviral keratitis and keratoconjunctivitis

407

1.49

2.26

1.6

1.4

198.29

287.88

ug/g

3.06

239

Benign neoplasm: Pituitary gland, craniopharyngeal duct

481

1.45

2.26

1.4

1.5

261.26

288.01

ug/g

0.65

271

Dementia in other diseases classified elsewhere

407

1.49

2.26

1.4

1.5

287.41

259.84

ug/g

0.47

245

Carcinoma in situ of skin of trunk

295

1.58

2.25

1.2

1.5

258.88

258.85

ug/g

0.00

185

Torsion of ovary, ovarian pedicle and fallopian tube

142

1.85

2.25

1.5

1.3

363.00

323.78

ug/g

0.38

Schizophrenia or delusion

407

3522

1.16

2.25

1.4

283.80

276.74

ug/g

0.28

238

1976

Brain meningioma, including Hilmo

457

1.46

2.24

1.4

285.79

303.91

ug/g

0.27

262

Marginal zone B-cell lymphoma, including Hilmo

121

1.94

2.24

1.5

1.4

282.56

311.94

ug/g

0.27

Malignant neoplasm of respiratory system and intrathoracic organs

168

1746

0.80

2.23

1.3

1.4

271.58

279.65

ug/g

0.20

101

1050

Anisometropia and aniseikonia

296

1.58

2.22

1.5

284.94

299.98

ug/g

0.22

178

Cutaneous lupus erythematosus

218

1.68

2.22

1.3

1.5

297.43

297.45

ug/g

0.00

125

Dronedarone medication

257

1.62

2.21

1.7

1.4

246.10

267.56

ug/g

0.42

140

Other disorders of cornea

128

989

1.30

2.21

1.4

284.02

284.64

ug/g

0.01

574

Autonomic disorders

203

1.70

2.20

1.4

332.19

305.53

ug/g

0.25

120

Contact with other hot fluids

265

1.61

2.20

1.3

1.4

298.03

297.00

ug/g

0.01

151

Injury of muscle and tendon at lower leg level

191

1549

1.24

2.19

1.5

1.4

297.85

270.66

ug/g

1.12

124

895

Generalized epilepsy, strict definition

188

1.73

2.19

1.3

300.72

315.84

ug/g

0.15

105

Coxarthrosis, primary, with hip surgery

696

5842

1.12

2.19

1.4

267.96

262.15

ug/g

0.32

422

3509

Granuloma annulare

122

1.92

2.19

1.1

1.4

320.85

318.61

ug/g

0.02

Use of rivastigmine

193

1563

1.24

2.19

1.4

248.62

263.94

ug/g

0.51

104

980

Spermatocele

593

1.39

2.19

1.6

1.5

220.29

239.54

ug/g

0.42

362

Other and unspecified nonscarring hair loss

2.37

2.18

1.3

323.44

330.65

ug/g

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

313

1.55

2.18

1.5

1.4

325.73

354.73

ug/g

0.42

165

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

250

1.62

2.18

1.6

1.5

264.92

297.27

ug/g

0.51

149

Other misadventures during surgical and medical care

204

1.69

2.17

1.4

1.5

250.21

287.72

ug/g

0.34

123

Macular hole

578

1.40

2.17

1.5

1.4

275.73

278.53

ug/g

0.04

343

Other secondary gonarthrosis

519

1.42

2.17

1.5

310.15

272.97

ug/g

0.74

317

Disorders of optic nerve, not elsewhere classified

189

1.72

2.17

1.5

204.20

285.04

ug/g

1.44

110

Malignant melanoma of skin, including Hilmo

174

1399

1.25

2.17

1.4

286.25

287.24

ug/g

0.02

115

838

Inflammation of lacrimal passages (acute and unspecified)

159

1.79

2.17

1.6

1.4

318.11

308.97

ug/g

0.09

Benign neoplasm: Skin of ear and external auricular canal

346

1.52

2.16

1.5

266.34

284.81

ug/g

0.26

212

Benign neoplasm: Long bones of lower limb

290

1.57

2.16

1.5

254.30

290.28

ug/g

0.57

171

Other and unspecified mononeuropathies of lower limb

243

1.63

2.16

1.2

1.5

273.26

296.73

ug/g

0.21

137

Contusion of toe(s) with damage to nail

2.09

2.14

1.9

1.3

285.64

310.12

ug/g

0.22

Benign neoplasm of other and unspecified intrathoracic organs

2.05

2.14

1.5

1.4

252.23

306.01

ug/g

0.45

Dislocation of lens

123

1.90

2.14

1.3

1.6

241.71

257.98

ug/g

0.14

Burns and corrosions confined to eye and internal organs

236

1.63

2.13

1.6

1.4

307.60

283.60

ug/g

0.35

137

Patent foramen ovale

190

1.71

2.13

1.5

1.4

293.71

320.83

ug/g

0.32

112

Vertigo of central origin

138

1.85

2.12

1.5

223.39

279.92

ug/g

0.81

Primary angle-closure glaucoma

430

1.46

2.11

1.5

1.4

242.81

282.63

ug/g

0.93

247

Right ventricular outflow tract obstruction

2.32

2.11

1.4

1.5

232.67

324.38

ug/g

—

Contusion of ankle

324

1.53

2.10

1.8

1.4

254.51

302.56

ug/g

0.89

180

Other specified and unspecified disorders of conjunctiva

2.12

2.10

1.2

1.4

286.00

320.89

ug/g

—

Melanocytic naevi of trunk

149

1182

1.27

2.10

1.4

279.08

284.54

ug/g

0.12

661

Congenital malformations of trachea and bronchus

2.08

2.10

1.8

1.3

304.45

295.58

ug/g

0.08

Other and unspecified vasculitis limited to skin

214

1.66

2.09

1.4

264.32

296.13

ug/g

0.41

132

Chorioretinal inflammation

245

1.61

2.09

1.6

1.4

255.40

309.57

ug/g

1.07

142

Other and unspecified bullous disorders

2.07

2.09

1.5

1.3

187.90

309.80

ug/g

—

Autism

153

1.78

2.09

1.6

1.4

328.73

347.83

ug/g

0.14

Drug-induced systemic lupus erythematosus

2.25

2.09

1.1

1.4

353.78

322.28

ug/g

—

Optic atrophy

161

1.77

2.09

1.4

327.29

300.22

ug/g

0.21

Other factor of the environment

110

1.95

2.09

1.4

381.57

289.23

ug/g

—

Open wound of thorax

117

1.91

2.09

1.5

257.02

289.12

ug/g

0.34

Pyoderma

161

1.77

2.08

1.3

1.4

189.95

304.78

ug/g

1.79

Fasciculation

2.02

2.08

1.5

1.4

330.65

313.76

ug/g

0.13

Other/unspecified disorders of vestibular function

382

1.48

2.08

1.6

1.4

266.37

286.56

ug/g

0.28

222

Polymyositis

2.24

2.08

1.2

1.4

324.89

252.51

ug/g

—

Asthma mixed form (mode), excluding more controls

390

1.47

2.07

1.5

1.4

314.92

291.03

ug/g

0.42

209

Supervision of normal pregnancy

165

1173

0.80

2.06

1.3

1.4

349.68

303.83

ug/g

1.63

606

Malignant neoplasm of thyroid gland, including Hilmo

695

1.35

2.05

1.4

327.83

313.04

ug/g

0.33

378

Benign neoplasm: Pelvic bones, sacrum and coccyx

2.74

2.04

1.2

1.4

296.80

321.20

ug/g

—

Corneal scars and opacities

239

1.61

2.04

1.5

205.24

288.18

ug/g

2.01

147

Other and unspecified disease of Bartholin gland

263

1.58

2.03

1.3

1.4

307.14

306.92

ug/g

0.00

151

Burn and corrosion of trunk

247

1.60

2.03

1.4

1.5

284.48

295.19

ug/g

0.11

144

Social disorders starting during childhood or adolescence

2.55

2.03

1.1

1.4

407.00

384.49

ug/g

—

Other acute skin changes due to ultraviolet radiation

311

1.53

2.03

1.4

1.5

297.07

285.72

ug/g

0.12

182

Pervasive developmental disorders excl. Autism + Asperger

2.04

2.02

1.7

1.3

357.00

366.36

ug/g

—

Dermatopolymyositis (FG)

126

1.86

2.01

1.3

1.5

295.13

285.51

ug/g

0.08

Inguinal hernia, unilateral

240

1.61

2.01

1.8

1.4

264.19

280.83

ug/g

0.23

143

Inguinal of femoral hernia, unilateral

240

1.61

2.01

1.8

1.4

264.19

280.83

ug/g

0.23

143

Femoral hernia, unilateral

240

1.61

2.01

1.8

1.4

264.19

280.83

ug/g

0.23

143

Benign leiomyoma with endometriosis

227

1894

1.21

2.01

1.5

1.4

284.30

280.89

ug/g

0.10

130

1091

Specific developmental disorder of motor function

116

1.88

2.00

1.3

1.4

328.13

378.54

ug/g

0.64

Abscess of external ear

112

1.91

1.99

1.2

1.4

338.07

307.40

ug/g

0.30

Dermatopolymyositis

134

1.83

1.98

1.3

1.4

300.94

294.50

ug/g

0.06

Traumatic amputation of lower leg

4.78

1.97

1.4

1.8

294.00

207.67

ug/g

—

Benign neoplasm of major salivary glands

128

1007

1.28

1.96

1.4

259.77

276.09

ug/g

0.42

591

Respiratory conditions due to other external agents

195

1.67

1.96

1.2

1.5

274.81

280.81

ug/g

0.05

117

Asthma mixed form (mode)

395

1.45

1.96

1.5

1.3

314.92

296.83

ug/g

0.30

209

Burn and corrosion confined to eye and adnexa

195

1.66

1.95

1.6

1.4

307.18

285.09

ug/g

0.31

117

Pulmonary eosinophilia, not elsewhere classified

113

1.90

1.95

1.6

1.4

243.40

294.46

ug/g

—

Other facial nerve disorders

234

1.60

1.95

1.4

1.5

288.82

297.48

ug/g

0.09

132

Cyst of Bartholin Gland

314

1.51

1.95

1.4

1.3

291.11

317.67

ug/g

0.33

169

Benign neoplasm: Choroid

633

1.36

1.94

1.4

298.04

279.90

ug/g

0.35

376

Pedal cyclist injured in other and unspecified transport accidents

137

1088

1.27

1.94

1.4

248.50

284.13

ug/g

1.34

609

Arthropod-borne viral fevers and viral haemorrhagic fevers

119

929

1.29

1.94

1.3

1.4

287.10

277.27

ug/g

0.18

551

Female infertility, associated with anovulation

454

1.42

1.93

1.2

1.3

340.28

316.88

ug/g

0.42

205

Vitiligo

2.00

1.93

1.3

1.4

241.84

317.71

ug/g

0.79

Pneumothorax

625

1.35

1.93

1.4

252.06

273.48

ug/g

0.44

376

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

2.04

1.92

1.4

1.3

323.67

315.64

ug/g

—

Other and unspecified iridocyclitis

422

1.44

1.92

1.3

1.5

251.69

285.52

ug/g

0.62

246

Carcinoma in situ of skin of lower limb, including hip

204

1.65

1.92

1.1

1.5

305.00

269.81

ug/g

0.41

119

Antenatal screening

177

1217

0.81

1.92

1.3

1.4

355.65

304.53

ug/g

1.90

627

Malignant neoplasm of thyroid gland

600

1.36

1.91

1.4

325.73

313.32

ug/g

0.24

326

Single spontaneous delivery

489

2925

0.88

1.91

1.3

1.4

299.47

281.75

ug/g

1.06

268

1610

Use of rasagiline

244

1.58

1.90

1.2

1.5

285.80

273.54

ug/g

0.15

148

Lesion of femoral nerve

2.14

1.90

1.5

1.3

328.30

286.86

ug/g

—

Hypotension due to drugs

114

1.88

1.90

1.6

1.4

318.85

257.92

ug/g

0.53

Burns classified according to extent of body surface involved

2.13

1.89

1.3

1.5

213.89

324.75

ug/g

—

Diabetes insipidus

2.08

1.88

1.7

1.3

257.82

294.03

ug/g

0.34

Infliximab

129

1.81

1.87

1.3

1.4

310.27

307.53

ug/g

0.02

Other osteochondrodysplasias

2.02

1.87

1.3

1.4

385.25

299.09

ug/g

—

Haemorrhagic and haematological disorders of fetus and newborn

130

1.79

1.87

2.0

1.3

337.33

382.93

ug/g

0.47

Myeloproliferative diseases

110

855

1.30

1.87

1.4

281.81

274.57

ug/g

0.15

502

Gonococcal infection

293

1.52

1.87

1.5

1.4

229.24

305.50

ug/g

1.51

166

Other abnormal findings in urine

137

1.78

1.86

1.8

1.4

280.47

302.49

ug/g

0.18

Cardiodefibrillation

496

4407

1.13

1.85

1.4

253.30

259.75

ug/g

0.31

302

2696

Other and unspecified primary disorders of muscles

2.18

1.85

1.4

258.00

310.36

ug/g

—

Gonococcal infection

310

1.50

1.85

1.5

1.4

230.62

304.57

ug/g

1.52

176

Embedded teeth, including avohilmo

699

1.32

1.84

1.2

1.3

283.21

318.44

ug/g

0.82

346

Retained placenta and membranes, without haemorrhage

159

1294

1.24

1.83

1.3

1.4

284.38

291.52

ug/g

0.17

710

Other congenital malformations of intestine

2.11

1.83

1.4

1.3

342.00

297.84

ug/g

—

Endometriosis diagnosis and infertility diagnosis occurring together

122

963

1.27

1.83

1.3

330.59

313.42

ug/g

0.34

495

Congenital malformations of the respiratory system

191

1.65

1.83

1.6

1.4

293.67

309.57

ug/g

0.18

109

Rheumatic fever incl heart disease

262

1.54

1.83

1.5

287.85

276.31

ug/g

0.15

153

Calcific tendinitis

2.05

1.83

1.3

1.4

387.90

317.10

ug/g

—

Other and unspecified nonorganic psychotic disorders

224

1885

1.19

1.82

1.4

296.63

284.57

ug/g

0.36

135

1040

Malignant neoplasm of cervix uteri

138

1.77

1.82

1.2

1.4

310.53

317.99

ug/g

0.07

Brain meningioma

444

1.41

1.82

1.4

285.79

301.40

ug/g

0.22

253

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

2.42

1.81

2.0

1.3

222.33

271.36

ug/g

—

Isolated growth hormone deficiency

2.23

1.81

1.2

1.5

412.00

352.13

ug/g

—

Vascular dementia (undefined)

308

1.49

1.80

1.7

1.4

268.54

253.38

ug/g

0.21

193

Papilloedema, unspecified

184

1.65

1.80

1.5

1.4

263.60

321.54

ug/g

0.64

104

Ankylosing spondylitis, ICD10

108

842

1.29

1.80

1.4

257.70

288.79

ug/g

0.76

479

Benign mammary dysplasia

204

1706

1.20

1.80

1.4

305.72

283.69

ug/g

0.94

124

970

Other secondary coxarthrosis

312

1.49

1.80

1.6

1.5

268.72

290.53

ug/g

0.30

185

Contact with machinery

133

1064

1.26

1.80

1.5

274.53

258.91

ug/g

0.43

651

Respiratory and cardiovascular disorders specific to the perinatal period

157

1.67

1.79

1.2

1.3

399.31

363.90

ug/g

0.41

Motor disorders

123

1.81

1.79

1.3

1.4

328.13

385.98

ug/g

0.80

Chondromalacia

272

1.53

1.79

1.4

1.5

301.99

303.39

ug/g

0.02

162

Malignant neoplasm of bone and articular cartilage

2.14

1.78

1.6

1.3

276.14

308.64

ug/g

—

Helminthiases

346

1.46

1.77

1.5

1.4

257.90

312.63

ug/g

0.92

184

Glaucoma-related operations

592

1.35

1.77

1.5

247.64

272.00

ug/g

0.56

354

Tic disorders

2.06

1.76

1.6

1.4

302.50

311.05

ug/g

—

Hypothermia

147

1.73

1.76

1.6

1.5

204.64

272.57

ug/g

0.84

Benign neoplasm: Cerebral meninges

129

1032

1.26

1.76

1.4

309.18

282.22

ug/g

0.75

600

Chronic Coagulation defects

209

1.60

1.76

1.6

1.4

341.17

309.47

ug/g

0.34

116

Mental and behavioural disorders due to cannabinoids

193

1.62

1.76

1.3

1.4

304.94

307.92

ug/g

0.02

Anomalies of pupillary function

170

1.67

1.75

1.4

301.46

315.90

ug/g

0.10

Complications associated with artificial fertilization

2.00

1.75

1.4

1.2

386.86

359.16

ug/g

—

Secondary parkinsonism+Parkinsonism in other disease

249

1.55

1.75

1.3

1.4

250.75

284.03

ug/g

0.44

142

Conduct disorder

147

1.72

1.75

1.5

1.4

308.25

327.39

ug/g

0.14

Benign neoplasm of meninges

143

1158

1.24

1.75

1.4

305.75

279.70

ug/g

0.79

675

Osteopathy in diseases classified elsewhere

2.19

1.74

1.7

1.3

132.57

280.31

ug/g

—

Burns and corrosions of multiple and unspecified body regions

186

1.63

1.74

1.3

1.5

216.06

295.02

ug/g

1.08

111

Transitory endocrine and metabolic disorders specific to fetus and newborn

115

1.82

1.74

1.7

1.4

348.70

376.19

ug/g

—

Other and unspecified pemphigoid

2.11

1.73

1.8

1.5

283.14

296.10

ug/g

—

Carcinoma in situ of skin, other sites/unspecified

118

1.81

1.73

1.3

1.4

288.00

246.73

ug/g

0.39

Congenital deformities of feet

202

1.60

1.73

1.3

1.4

256.47

300.51

ug/g

0.56

118

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

118

1.81

1.72

1.8

1.4

242.33

307.87

ug/g

0.62

HSIL lesion of the cervix uteri, vagina or vulva

226

1915

1.18

1.72

1.3

1.4

337.90

309.66

ug/g

0.98

126

986

Focal epilepsy

269

2311

1.17

1.72

1.4

260.45

277.70

ug/g

0.72

158

1349

Other bullous disorders

251

1.53

1.70

1.6

1.4

273.63

298.67

ug/g

0.25

152

Benign neoplasm: Tonsil

104

1.86

1.70

1.5

1.4

296.42

304.59

ug/g

0.06

Congenital malformations of pulmonary and tricuspid valves

2.23

1.70

1.3

1.5

217.00

292.64

ug/g

—

Acute and transient psychotic disorders

142

1153

1.24

1.70

1.4

255.59

290.32

ug/g

1.30

654

Generalized epilepsy

366

1.43

1.69

1.3

1.4

290.69

309.01

ug/g

0.28

203

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

366

3221

1.14

1.69

1.4

280.86

272.36

ug/g

0.36

216

1871

Polycystic ovarian syndrome

391

1.42

1.69

1.5

1.3

354.60

337.32

ug/g

0.17

176

Ill-defined and unknown causes of mortality

104

815

1.28

1.69

1.4

217.77

268.90

ug/g

1.77

500

Benign neoplasm: Parotid gland

101

789

1.29

1.68

1.4

255.92

279.81

ug/g

0.56

461

Infectious mononucleosis

631

1.32

1.68

1.4

326.17

311.66

ug/g

0.25

311

Open bite

409

1.40

1.67

1.4

313.84

330.74

ug/g

0.24

215

Hypoplasia of dental enamel , including avohilmo

221

1.55

1.66

1.2

1.4

359.06

358.35

ug/g

0.01

120

Congenital deformities of hip

165

1.66

1.2

1.3

319.67

333.21

ug/g

0.12

Viral agents as the cause of diseases classified to other chapters

197

1.60

1.65

1.5

1.4

297.51

306.98

ug/g

0.10

112

Viral agents as the cause of diseases classified to other chapters

229

1.55

1.64

1.5

1.4

305.35

300.22

ug/g

0.06

129

Puerperal sepsis

174

1449

1.21

1.64

1.4

296.30

291.54

ug/g

0.12

801

Benign neoplasm: Pharynx, unspecified

2.19

1.63

1.8

1.3

138.57

295.98

ug/g

—

Other intracranial haemorrhages

278

1.49

1.63

1.6

1.5

279.38

265.20

ug/g

0.18

170

Other appendicitis

107

846

1.27

1.63

1.3

1.4

274.97

289.96

ug/g

0.31

486

Other specified/unspecified hearing loss

108

855

1.27

1.63

1.4

260.73

266.28

ug/g

0.10

513

Transient global amnesia

129

1043

1.25

1.63

1.7

1.4

276.40

271.43

ug/g

0.11

629

Striae atrophicae

1.90

1.63

1.4

1.3

341.70

331.62

ug/g

—

158

1.65

1.62

1.7

1.3

342.88

384.97

ug/g

0.48

Benign neoplasm of middle ear and respiratory system

767

1.29

1.62

1.6

1.4

274.11

275.76

ug/g

0.03

460

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

116

927

1.26

1.62

1.2

1.4

318.04

290.92

ug/g

0.80

498

Paranoid personality disorder

151

1.68

1.62

1.4

301.50

308.32

ug/g

0.06

Spinal osteochondrosis

2.10

1.61

1.8

1.3

291.38

307.79

ug/g

—

Toxic effect of carbon monoxide

159

1.66

1.61

1.6

1.5

220.22

289.07

ug/g

1.01

Delivery

499

2933

0.90

1.60

1.3

1.4

301.74

282.03

ug/g

1.25

273

1614

Autism spe

159

1.65

1.60

1.7

1.4

328.73

353.90

ug/g

0.19

Benign neoplasm: salivary glands, exclude unknown (D119)

113

902

1.26

1.60

1.4

264.70

278.85

ug/g

0.31

522

Benign neoplasm: Skin, unspecified

371

1.42

1.59

1.3

1.5

355.94

290.87

ug/g

1.53

219

Malignant neoplasm of oral cavity

263

1.50

1.59

1.5

1.4

251.60

303.03

ug/g

0.93

152

Secondary parkinsonism

239

1.52

1.59

1.3

1.4

238.58

280.69

ug/g

0.60

135

Burn and corrosion of hip and lower limb, except ankle and foot

183

1.60

1.59

1.4

325.85

291.64

ug/g

0.37

104

Panhypopituitarism

152

1.67

1.58

1.3

1.5

257.74

289.20

ug/g

0.25

Lymphoid leukaemia

499

1.35

1.58

1.4

1.5

273.19

271.98

ug/g

0.02

306

Hyperaldosteronism

272

1.49

1.58

1.4

286.82

280.82

ug/g

0.05

162

L02BA Anti-estrogens

169

2019

0.83

1.58

1.3

1.4

280.51

288.72

ug/g

0.22

107

1122

Acute myeloid leukaemia and myelodysplastic syndromes

129

1.73

1.58

1.3

1.4

250.64

301.17

ug/g

0.57

Other drug-induced secondary parkinsonism

1.93

1.57

1.3

1.4

293.86

278.66

ug/g

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

744

1.29

1.57

1.4

288.37

282.22

ug/g

0.09

437

All dysplastic lesions of the vagina

256

1.50

1.57

1.3

1.4

301.76

305.56

ug/g

0.04

140

Central retinal artery occlusion

176

1.61

1.56

1.4

1.6

243.07

264.63

ug/g

0.22

109

Pseudomembranous colitis

2.08

1.56

1.5

1.4

274.00

327.72

ug/g

—

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

2.07

1.56

1.7

1.3

221.38

320.68

ug/g

—

Postpartum hemorraghe, all women as controls

201

2327

0.85

1.55

1.2

1.3

319.00

316.58

ug/g

0.06

1190

Seropositive rheumatoid arthritis, wide

373

3309

1.13

1.55

1.4

281.34

271.37

ug/g

0.45

219

1926

Focal epilepsy, strict definition

249

2148

1.16

1.55

1.4

258.76

276.67

ug/g

0.70

144

1253

Neonatal jaundice from other and unspecified causes

111

1.77

1.55

2.1

1.3

335.83

386.12

ug/g

0.44

Thyrotropin deficiency

1.86

1.54

1.6

1.3

355.22

317.57

ug/g

—

Other congenital malformations of skin

729

1.28

1.53

1.4

324.65

302.00

ug/g

0.38

393

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

113

1.76

1.53

1.7

1.3

354.00

379.94

ug/g

—

Hyperkinetic disorders (excl. ADHD)

129

1.71

1.53

1.1

1.5

324.52

348.15

ug/g

0.19

Disorders in reading

1.85

1.53

1.1

1.4

357.14

339.34

ug/g

—

Molar incisor enamel hypoplasia

240

1.50

1.52

1.3

1.4

357.44

352.33

ug/g

0.05

125

Glaucoma, exfoliation

139

1142

1.22

1.52

1.5

1.4

238.14

274.49

ug/g

1.70

695

Dementia due to Parkinsons disease, excluding more controls

146

1.66

1.52

1.4

291.67

267.82

ug/g

0.19

Tic and related disorders

1.89

1.52

1.7

1.4

317.57

330.34

ug/g

—

Postdysenteric arthropathy

1.98

1.51

1.5

1.4

230.25

295.73

ug/g

—

Monoplegia

139

1.68

1.50

1.2

1.4

356.51

290.76

ug/g

0.96

Alzheimer’s disease (Atypical or mixed), excluding more controls

538

1.29

1.49

1.3

1.4

246.51

254.57

ug/g

0.15

327

Shoulder region

124

1.72

1.49

1.4

1.5

275.43

281.18

ug/g

0.05

Pterygium

251

1.49

1.3

1.5

343.68

274.16

ug/g

0.93

156

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

351

1.41

1.49

1.6

1.5

232.30

293.63

ug/g

1.56

206

Benign neoplasm of breast

165

1383

1.20

1.48

1.4

266.52

290.58

ug/g

0.86

787

Behavioural disorders

155

1.63

1.48

1.5

1.4

296.46

330.92

ug/g

0.30

Congenital malformations of the respiratory system

171

1.60

1.48

1.6

1.4

296.47

308.54

ug/g

0.12

Acute nephritic syndrome

179

1.58

1.47

1.4

1.5

263.40

282.45

ug/g

0.16

110

Nonischemic cardiomyopathy

123

1001

1.23

1.47

1.4

249.25

271.66

ug/g

0.60

596

Lifestyle-related condition

102

1.80

1.47

1.4

1.3

376.33

298.80

ug/g

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

335

1.41

1.47

1.4

1.5

239.09

291.62

ug/g

1.06

190

Amblyopia ex anopsia

335

1.41

1.47

1.5

1.4

306.61

299.25

ug/g

0.09

183

Non-seminoma of testis, including Hilmo

2.55

1.46

1.6

1.3

316.86

329.44

ug/g

—

102

1.78

1.45

1.3

281.57

343.66

ug/g

—

Parapsoriasis

156

1.62

1.45

1.2

1.4

252.75

296.20

ug/g

0.63

Localized skin eruption due to drugs and medicaments

1.82

1.45

1.1

1.4

384.62

295.52

ug/g

—

Mandibular retrognathia

549

1.32

1.44

1.4

283.44

309.90

ug/g

0.49

287

Congenital malformations of ovaries, fallopian tubes and broad ligaments

464

1.35

1.44

1.4

1.3

343.51

318.83

ug/g

0.44

221

Use of donepezil

190

2132

0.85

1.44

1.3

1.4

275.65

259.93

ug/g

0.52

100

1324

Inflammation of lacrimal passages (chronic)

141

1.66

1.43

1.4

297.00

285.77

ug/g

0.10

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

109

1.75

1.43

1.2

1.3

446.00

391.44

ug/g

—

Other degenerative diseases of the basal ganglia

157

1.62

1.43

1.6

1.5

179.92

263.96

ug/g

1.50

Schizoaffective disorder

675

1.28

1.43

1.4

317.10

297.94

ug/g

0.40

365

Chronic suppurative otitis media

622

1.29

1.42

1.4

274.19

290.02

ug/g

0.29

346

Thyroiditis

702

1.28

1.42

1.3

1.4

300.69

299.60

ug/g

0.02

379

Exposure to smoke, fire and flames

205

1.53

1.42

1.4

1.5

262.61

287.58

ug/g

0.26

119

Contact with other hot metals

126

1.69

1.42

1.5

270.58

290.88

ug/g

0.22

Alzheimer disease, including avohilmo

405

3180

0.89

1.41

1.3

1.4

256.63

259.75

ug/g

0.12

219

1979

Oral leukoplakia, including avohilmo

246

1.48

1.41

1.4

235.87

276.93

ug/g

0.60

142

Other/unspecified seropositive rheumatoid arthritis

367

3275

1.12

1.41

1.4

280.86

271.81

ug/g

0.39

216

1910

Blepharospasm

1.81

1.41

1.6

1.4

215.30

299.38

ug/g

—

Polypectomy (DHB20)

632

1.29

1.41

1.4

1.5

260.82

268.27

ug/g

0.11

383

Malignant neoplasm of larynx

1.87

1.41

1.7

1.4

252.30

300.07

ug/g

—

Exposure to unspecified smoke, fire and flames

1.93

1.41

1.0

1.4

250.38

283.80

ug/g

—

Burn and corrosion of ankle and foot

111

1.74

1.41

1.3

1.5

284.42

297.12

ug/g

0.07

Universal erythroderma, KELA reimbursement

111

1.74

1.41

1.4

1.5

241.82

261.49

ug/g

0.16

Generalized epilepsy, mode (most common among epilepsy diagnosis)

271

1.45

1.41

1.2

1.4

325.25

306.05

ug/g

0.27

155

Other bursitis of knee

111

1.74

1.41

1.3

1.4

280.37

289.44

ug/g

—

LSIL lesion of the cervix uteri

126

1035

1.22

1.40

1.3

325.82

310.35

ug/g

0.41

525

Respiratory tuberculosis, confirmed

134

1.66

1.40

1.7

1.4

330.38

276.73

ug/g

0.49

Other disorders of binocular vision

1.80

1.40

1.5

1.4

281.63

318.14

ug/g

—

Cauda equina syndrome

119

1.71

1.40

1.5

241.72

279.21

ug/g

0.37

Occupational exposure to risk-factors

305

1.42

1.40

1.4

1.5

288.62

275.67

ug/g

0.19

183

Cerebral aneurysm, nonruptured

116

946

1.23

1.39

1.5

1.4

289.04

280.02

ug/g

0.18

551

Other and unspecified mental retardation

149

1.62

1.39

1.2

1.3

356.02

340.64

ug/g

0.15

Malignant neoplasm of bronchus and lung, including Hilmo

188

1841

0.85

1.39

1.4

263.28

280.84

ug/g

0.57

113

1109

Hereditary corneal dystrophies

331

1.40

1.38

1.5

286.32

288.68

ug/g

0.03

200

Other and unspecified vascular occlusions

113

920

1.23

1.38

1.5

1.4

248.64

270.23

ug/g

0.58

547

Benign neoplasm: Conjunctiva

306

1.42

1.38

1.5

299.50

281.76

ug/g

0.23

176

Papillary adenocarcinoma of thyroid gland

434

1.35

1.37

1.3

1.4

342.13

315.75

ug/g

0.68

235

146

1.61

1.36

1.7

1.3

342.88

384.30

ug/g

0.47

Other specified/unspecified necrotizing vasculopathies

120

1.69

1.36

1.7

1.4

312.40

279.18

ug/g

0.46

Congenital deformities of hip

151

1.61

1.36

1.2

1.3

328.33

336.43

ug/g

—

Other disorders of binocular movement

183

1.55

1.36

1.5

1.4

245.06

324.02

ug/g

1.55

103

Dissection of aorta

265

1.45

1.35

1.5

205.10

277.14

ug/g

1.50

156

Sequelae of other and unspecified infectious and parasitic diseases

487

1.32

1.35

1.6

1.4

297.20

293.70

ug/g

0.05

272

Other osteochondrodysplasias

1.95

1.35

1.4

386.43

319.10

ug/g

—

Thyrotoxicosis with toxic multinodular goitre

646

1.28

1.35

1.3

1.5

297.07

284.08

ug/g

0.20

366

Malignant neoplasm of anus and anal canal, including Hilmo

1.81

1.34

1.3

1.4

203.99

302.36

ug/g

1.23

Other disorders of central nervous system

1.81

1.34

1.4

320.75

319.68

ug/g

—

All dysplastic lesions of the cervix uteri

286

2501

1.14

1.34

1.3

332.96

307.73

ug/g

1.18

165

1275

Chronic iridocyclitis

453

1.33

1.34

1.4

1.5

252.92

293.57

ug/g

0.96

267

Persistent delusional disorders

744

1.26

1.34

1.4

267.05

287.26

ug/g

0.43

419

Migraine without aura, drug-induced

1.76

1.33

1.7

1.4

356.17

323.75

ug/g

0.24

Prolapse and hernia of ovary and fallopian tube

322

1.40

1.32

1.3

294.25

274.79

ug/g

0.30

179

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

550

1.30

1.32

1.4

1.3

326.49

331.78

ug/g

0.08

259

Maternal care for known or suspected disproportion

356

0.64

1.32

1.2

1.3

360.58

313.33

ug/g

0.41

178

Drug-induced obesity

1.88

1.32

1.1

1.3

272.00

339.50

ug/g

—

Vestibular neuronitis

112

917

1.23

1.31

1.4

273.83

279.48

ug/g

0.09

539

Vertical strabismus

309

1.40

1.31

1.6

1.5

260.43

293.96

ug/g

0.40

180

Pemphigoid

259

1.45

1.31

1.5

1.4

267.35

276.46

ug/g

0.07

149

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

640

1.27

1.30

1.4

1.5

306.23

277.04

ug/g

0.46

383

Dislocation, sprain and strain of joints and ligaments of elbow

569

1.29

1.30

1.3

1.4

293.70

299.34

ug/g

0.09

310

Mixed disorders of conduct and emotions

137

1.62

1.30

1.2

1.3

243.41

381.07

ug/g

—

Malignant neoplasm of ovary

484

0.70

1.29

1.4

258.11

302.29

ug/g

0.67

278

Myelodysplastic syndrome

1.96

1.29

1.2

1.3

217.29

313.25

ug/g

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

230

2007

1.15

1.28

1.4

257.30

277.11

ug/g

0.79

134

1162

Congenital deformities of feet

319

1.39

1.28

1.3

1.5

295.64

296.19

ug/g

0.01

181

Crossbite

543

1.28

1.4

324.49

324.81

ug/g

0.00

282

Disorders of lacrimal system and orbit in diseases classified elsewhere

219

1.48

1.27

1.4

257.53

302.63

ug/g

0.57

126

Disorders of brain, other and unspecified

1.85

1.27

1.4

294.33

327.93

ug/g

—

Injury of nerves at forearm level

115

1.68

1.26

1.3

1.5

120.17

286.18

ug/g

—

Paralytic strabismus

679

1.26

1.4

270.74

278.99

ug/g

0.15

396

Congenital malformations of cardiac septa

631

1.27

1.26

1.5

1.4

273.91

312.89

ug/g

0.93

344

Melanoma in situ of trunk

131

1.63

1.25

1.5

277.77

283.32

ug/g

0.05

Ectropion of eyelid

329

1.38

1.25

1.5

299.34

269.55

ug/g

0.50

210

Use of levodopa decarboxylase inhibitor

172

1473

1.17

1.25

1.5

264.95

262.51

ug/g

0.05

112

894

Other injuries of upper limb, level unspecified

100

1.73

1.25

1.4

218.44

294.94

ug/g

—

Cerebral palsy

131

1.62

1.25

1.4

311.57

348.16

ug/g

0.43

Other and unspecified acne

100

1.72

1.24

1.3

1.4

201.02

317.70

ug/g

—

Unspecified contracted kidney

2.09

1.24

1.5

1.4

360.20

286.15

ug/g

—

Graves ophthalmopathy, strict

204

1.49

1.24

1.3

1.4

244.24

305.16

ug/g

0.95

120

Prepatellar bursitis

364

1.36

1.24

1.4

252.39

266.90

ug/g

0.19

229

malignant neoplasm of male genital organs

308

1667

1.13

1.23

1.4

1.5

253.62

270.79

ug/g

0.68

183

1019

Shigellosis

2.08

1.23

1.2

1.5

288.40

307.40

ug/g

—

Carcinoma in situ of vulva

1.83

1.23

1.2

1.3

392.25

285.14

ug/g

—

Operations 2 for CAVS

387

3390

1.11

1.22

1.4

247.96

260.21

ug/g

0.62

243

2071

Calcific aortic valvular stenosis, diagnosis (helper)

387

3390

1.11

1.22

1.4

247.96

260.21

ug/g

0.62

243

2071

Exophthalmic conditions

101

1.71

1.21

1.2

1.3

281.89

316.88

ug/g

—

Atrial septal defect

363

1.35

1.21

1.4

266.24

319.40

ug/g

0.88

210

Abdominal aortic aneurysm (AAA)

106

864

1.22

1.21

1.5

244.28

251.63

ug/g

0.16

548

Unspecified abortion

470

1.31

1.21

1.4

323.11

306.05

ug/g

0.25

260

Calcific aortic valvular stenosis, including rheumatic fever

388

3399

1.11

1.21

1.4

247.92

260.05

ug/g

0.62

244

2075

Malignant neoplasm of tongue, including Hilmo

197

1.49

1.20

1.4

253.20

298.27

ug/g

0.63

117

Parkinson's disease, including avohilmo

197

1711

1.16

1.20

1.4

273.06

262.03

ug/g

0.33

123

1047

Dilated cardiomyopathy

142

1202

1.19

1.20

1.5

256.82

263.71

ug/g

0.16

731

Septal defects

599

1.27

1.20

1.5

1.4

292.13

315.31

ug/g

0.45

331

Calcific aortic valvular stenosis, operated

387

3395

1.11

1.20

1.4

247.96

260.21

ug/g

0.62

243

2074

Calcific aortic valvular stenosis

387

3395

1.11

1.20

1.4

247.96

260.21

ug/g

0.62

243

2074

Congenital malformations of anterior segment of eye

1.91

1.19

1.6

1.4

264.40

316.77

ug/g

—

Pedestrian injured in collision with car, pick-up truck or van

214

1.46

1.19

1.6

1.4

280.11

301.37

ug/g

0.19

127

Non-small cell lung cancer, squamous, helper endpoint

359

0.66

1.19

1.0

1.5

206.86

258.50

ug/g

0.75

229

Other melanin hyperpigmentation

206

1.47

1.19

1.4

1.5

255.95

276.07

ug/g

0.24

131

Other and unspecified types of non-Hodgkin lymphoma, hilmo

393

1.33

1.19

1.4

1.5

242.82

284.45

ug/g

0.85

243

Other superficial mycoses

165

1.53

1.18

1.5

279.46

294.19

ug/g

0.13

101

Sixth [abducent] nerve palsy

307

1.38

1.18

1.3

1.5

262.11

269.74

ug/g

0.10

178

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

272

1.40

1.18

1.3

1.4

375.57

329.25

ug/g

0.73

144

Malignant neoplasm of base of tongue, including Hilmo

1.96

1.18

1.3

1.2

289.83

298.48

ug/g

—

Postpartum hemorraghe, parous women as controls

201

1963

0.87

1.18

1.2

1.3

319.00

321.30

ug/g

0.05

1023

Meckel's diverticulum

2.05

1.18

1.2

1.4

381.00

286.24

ug/g

—

Encephalitis

248

1.42

1.18

1.7

1.4

254.27

307.51

ug/g

0.59

140

Use of riluzole

0.00

1.18

0.0

1.4

—

313.52

—

Melanocytic naevi of lower limb, including hip

420

1.32

1.17

1.5

250.10

289.31

ug/g

0.78

242

Tetralogy of Fallot, a congenital heart defect.

0.00

1.17

0.0

1.3

—

324.97

—

Open wound of neck

1.84

1.17

1.5

1.3

247.51

299.94

ug/g

—

Follicular lymphoma, hilmo

412

1.32

1.16

1.4

1.5

283.34

281.28

ug/g

0.03

246

Evidence of alcohol involvement determined by blood alcohol level

118

1.63

1.16

1.8

1.4

224.18

302.08

ug/g

0.88

Perichondritis of external ear

150

1.55

1.16

1.2

1.4

291.23

282.37

ug/g

0.10

Constitutional tall stature

2.54

1.16

1.0

1.4

452.40

422.50

ug/g

—

Other and unspecified degenerative diseases of nervous system

224

1.44

1.15

1.9

1.5

222.29

268.82

ug/g

0.58

133

Unspecified parasitic disease

1.88

1.15

1.8

1.4

310.83

295.07

ug/g

—

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

1.87

1.14

1.1

1.3

302.17

332.01

ug/g

—

Donors of organs and tissues

103

1.67

1.14

1.5

1.4

306.75

332.05

ug/g

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

370

1.33

1.14

1.6

1.5

262.78

283.60

ug/g

0.32

211

Maternal care for cervical incompetence

379

1.33

1.13

1.4

243.72

312.00

ug/g

1.47

209

Other disorders originating in the perinatal period

1.73

1.13

1.4

1.3

335.50

366.96

ug/g

—

Pemphigus

2.00

1.13

1.7

1.4

146.80

273.93

ug/g

—

Superficial injury of neck

151

1.54

1.12

1.3

1.4

301.00

313.70

ug/g

0.11

Respiratory tuberculosis, bacteriologically and histologically confirmed

143

1.55

1.12

1.7

1.4

330.38

276.63

ug/g

0.49

Accidental poisoning by and exposure to alcohol

127

1.59

1.12

1.3

1.4

282.14

310.03

ug/g

—

Pneumoconiosis due to asbestos and other mineral fibres

143

1.55

1.12

1.5

300.13

245.84

ug/g

0.79

Other osteochondropathies

645

1.25

1.12

1.3

1.4

427.22

288.22

ug/g

0.75

355

Injury of muscle and tendon at hip and thigh level

115

963

1.20

1.11

1.3

1.4

296.74

282.18

ug/g

0.35

560

Other spirochaetal diseases

404

3682

1.10

1.11

1.4

293.53

273.31

ug/g

1.30

224

2141

Caught, crushed, jammed or pinched in or between objects

450

1.30

1.11

1.4

288.39

296.69

ug/g

0.12

255

Graves disease, strict definition

119

1000

1.20

1.11

1.6

1.4

280.68

302.64

ug/g

0.55

531

Carcinoma in situ of other and unspecified sites

311

1.36

1.11

1.4

1.5

228.18

252.93

ug/g

0.34

195

Other spirochaetal diseases

410

3741

1.10

1.3

1.4

293.87

272.75

ug/g

1.41

228

2176

Acute hepatitis A

2.00

1.10

1.9

1.5

263.75

258.16

ug/g

—

Hypertrophy of (infrapatellar) fat pad

1.76

1.10

1.4

1.3

227.00

324.90

ug/g

—

Disorders of synovium and tendon in diseases classified elsewhere

160

1.52

1.10

1.3

1.5

279.56

286.54

ug/g

0.06

Sequelae of other accidents

120

1.60

1.09

1.1

1.5

250.70

292.92

ug/g

—

Erythema nodosum

269

1.39

1.09

1.4

248.53

286.65

ug/g

0.56

157

Androgenic alopecia

1.72

1.09

1.3

306.56

329.98

ug/g

—

Other meningitis

136

1.56

1.09

1.2

1.4

225.50

312.56

ug/g

1.35

Other congenital malformations of circulatory system

244

1.41

1.09

1.6

1.5

350.91

301.38

ug/g

0.83

149

Benign neoplasm: Spinal meninges

1.68

1.08

1.8

1.3

300.18

305.79

ug/g

0.04

Toxic effect of alcohol

194

1.46

1.08

1.4

217.86

289.28

ug/g

0.78

114

Other/unspecified crystal arthropathies

1.97

1.08

1.6

1.5

275.80

260.18

ug/g

—

Iliotibial band syndrome

1.78

1.08

1.4

1.3

308.38

340.55

ug/g

—

Convergence insufficiency and excess

105

1.64

1.07

1.5

1.3

235.82

340.70

ug/g

2.38

Crushing injury of wrist and hand

129

1.57

1.07

1.5

1.6

216.85

285.23

ug/g

0.78

Chromosomal abnormalities, not elsewhere classified

194

1.45

1.06

1.3

331.94

328.20

ug/g

0.04

109

Unspecified threat to breathing

1.73

1.06

1.1

1.4

382.67

311.94

ug/g

—

Antepartum haemorrhage, not elsewhere classified

704

1.23

1.06

1.3

311.39

308.90

ug/g

0.04

361

Normotensive glaucoma

113

951

1.19

1.06

1.5

1.4

270.11

274.55

ug/g

0.08

568

Other encephalitis

237

1.40

1.05

1.7

1.4

257.55

306.92

ug/g

0.50

135

Dementia in Alzheimer disease

163

1584

0.87

1.04

1.3

1.4

245.16

259.73

ug/g

0.44

999

Multiple delivery

889

0.81

1.04

1.2

1.4

405.65

286.96

ug/g

4.13

466

Guillain-Barre syndrome

138

1.54

1.04

1.6

1.4

266.67

286.15

ug/g

0.15

Schizotypal disorder

204

1.43

1.04

1.4

277.00

308.89

ug/g

0.30

108

Parkinson's disease, strict definition

174

1518

1.15

1.04

1.4

1.5

274.33

261.90

ug/g

0.35

111

928

Chronic lymphocytic leukaemia, helper endpoint

204

1.43

1.04

1.4

240.04

305.80

ug/g

1.13

123

Chronic lymphocytic leukaemia

204

1.43

1.04

1.4

240.05

305.80

ug/g

1.13

123

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

204

1.43

1.04

1.4

240.04

305.80

ug/g

1.13

123

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

583

4707

1.08

1.03

1.4

1.3

303.15

295.91

ug/g

0.36

351

2515

Intrahepatic Cholestasis of Pregnancy (ICP)

572

1.25

1.02

1.4

1.3

326.49

327.13

ug/g

0.01

276

Sequelae of infectious and parasitic diseases

708

1.22

1.02

1.6

1.4

273.02

288.99

ug/g

0.32

402

Valvular operations

164

1427

1.15

1.02

1.4

268.42

261.34

ug/g

0.19

110

861

Corneal degeneration

139

1.53

1.01

1.1

1.4

288.92

281.96

ug/g

—

Benign neoplasm: Connective and other soft tissue, unspecified

1.64

1.01

1.4

1.3

313.70

301.89

ug/g

—

N06DA Anticholinesterases

386

3326

0.91

1.00

1.4

260.75

260.31

ug/g

0.01

216

2057

Use of anticholinesterases

386

3326

0.91

1.00

1.4

260.75

260.31

ug/g

0.01

216

2057

Viral pneumonia (known virus, not influenza)

248

1.38

1.00

1.3

1.4

276.19

291.36

ug/g

0.17

141

Personal history of malignant neoplasm

673

1.22

1.00

1.4

287.35

292.90

ug/g

0.09

378

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

1.74

1.00

1.6

1.5

281.13

278.10

ug/g

—

Bullous pemphigoid

189

1.44

1.00

1.3

1.4

298.80

273.26

ug/g

—

106

Amputation of thigh

231

1.40

1.00

1.6

1.5

213.65

259.73

ug/g

0.57

138

Acute drug-induced interstitial lung disorder

1.84

1.00

1.1

1.4

261.20

303.78

ug/g

—

Other infestations

148

1.50

0.99

1.3

1.4

213.75

299.03

ug/g

1.03

Retinoschisis and retinal cysts

215

1.41

0.98

1.3

1.5

237.34

279.34

ug/g

0.57

128

Benign neoplasm: Appendix

100

1.63

0.98

1.4

185.71

283.92

ug/g

—

Crushing injury of ankle and foot

0.00

0.97

0.0

1.5

—

261.89

—

Other and unspecified corneal deformities and disorders

310

1.33

0.97

1.4

208.94

298.97

ug/g

2.07

180

Infections of genitourinary tract in pregnancy

107

904

1.19

0.97

1.3

1.4

298.31

298.44

ug/g

0.00

480

Other and unspecified injuries of wrist and hand

345

1.31

0.97

1.6

1.4

305.62

307.16

ug/g

0.02

191

Spirochaetal infections, other/unspecified

400

3674

1.09

0.97

1.4

292.62

272.91

ug/g

1.26

226

2133

Cutis laxa senilis

1.72

0.97

1.3

249.88

278.08

ug/g

—

Lyme disease

396

3636

1.09

0.97

1.4

293.27

272.95

ug/g

1.30

223

2108

Contact with sharp object, undetermined intent

182

1.44

0.97

1.4

1.5

314.06

281.25

ug/g

0.33

107

Other and specified injuries of hip and thigh

199

1.42

0.96

1.4

262.24

288.50

ug/g

0.41

117

Embedded and impacted teeth

252

1865

1.12

0.96

1.4

299.48

312.36

ug/g

0.38

125

939

Tuberculosis, IBD comorbidity

641

1.22

0.95

1.5

1.4

263.72

270.00

ug/g

0.09

378

Other benign neoplasm of uterus: Other parts/unspecified

471

1.26

0.95

1.5

1.4

284.52

274.10

ug/g

0.14

268

Dementia, including avohilmo

640

4115

1.07

0.93

1.4

269.02

259.67

ug/g

0.57

357

2537

Malignant neoplasm of prostate

295

1596

1.11

0.93

1.4

1.5

252.94

268.04

ug/g

0.57

176

975

Essential (haemorrhagic) thrombocythaemia

295

1.33

0.93

1.5

1.4

276.88

301.61

ug/g

0.35

170

HSIL lesion of the cervix uteri

188

1665

1.13

0.92

1.3

1.4

334.04

313.63

ug/g

0.55

102

847

Hirsutism in women

159

1.46

0.92

1.6

1.3

283.40

332.82

ug/g

0.49

Exposure to excessive natural cold

1.65

0.92

1.1

1.4

283.50

286.87

ug/g

—

Tarsal tunnel syndrome

1.62

0.92

1.9

1.4

189.67

331.35

ug/g

—

Tooth agenesis EXCLUDE clefts and syndromes

261

1.35

0.91

1.7

1.4

350.71

323.16

ug/g

0.37

124

Urethral stricture

482

1.25

0.91

1.5

242.75

263.01

ug/g

0.34

299

Inflammatory disorders of breast

564

1.23

0.90

1.3

310.72

306.22

ug/g

0.06

295

Left ventricular outflow tract obstruction, narrow definition

439

1.26

0.89

1.4

1.5

267.97

294.72

ug/g

0.35

264

Congenital ovarian cysts

359

1.29

0.89

1.4

1.3

357.41

331.86

ug/g

0.35

171

Complications predominantly related to the puerperium

297

2705

1.10

0.89

1.3

307.73

297.51

ug/g

0.37

152

1413

Disorders of eyelid in diseases classified elsewhere

289

1.32

0.88

1.7

1.4

298.04

281.81

ug/g

0.20

170

Later onset COPD

356

2602

1.09

0.88

1.4

249.31

255.00

ug/g

0.21

211

1618

Localized scleroderma [morphea]

144

1.48

0.88

1.5

1.4

227.08

305.92

ug/g

1.03

Liveborn infants according to place of birth

1.81

0.87

1.1

1.3

419.40

367.60

ug/g

—

Acute appendicitis, with complications

241

2175

1.11

0.87

1.5

1.4

290.31

272.27

ug/g

0.67

142

1284

Hypertrichosis

178

1.42

0.87

1.6

1.3

273.71

331.11

ug/g

0.68

Unspecific neurodegenerative disorder

507

3718

0.93

0.87

1.3

1.4

265.14

259.32

ug/g

0.28

282

2311

Other and unspecified haemorrhagic conditions

128

1.50

0.87

1.6

1.4

303.17

306.00

ug/g

—

Parkinson's disease

185

1646

1.13

0.86

1.4

274.64

261.95

ug/g

0.38

119

1007

Primary ovarian failure

170

1.43

0.86

1.5

1.3

338.87

332.66

ug/g

0.04

Lagophthalmos

112

1.54

0.86

1.5

276.92

268.74

ug/g

0.06

Malignant neoplasm of prostate, including Hilmo

305

1651

1.10

0.86

1.4

1.5

258.97

269.70

ug/g

0.36

177

1010

Graves ophthalmopathy

230

1.36

0.85

1.3

1.4

265.89

302.70

ug/g

0.42

132

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

1.65

0.85

1.4

1.3

245.29

322.73

ug/g

—

Scleritis

104

1.56

0.85

1.8

1.4

263.10

306.32

ug/g

—

Personal history of medical treatment

1.61

0.85

1.6

1.4

346.14

281.19

ug/g

—

Torsion of testis

104

1.55

0.85

1.4

1.5

109.24

311.34

ug/g

—

Burn and corrosion of head and neck

179

1.41

0.85

1.3

1.5

254.06

268.55

ug/g

0.13

104

Congenital stenosis of pulmonary valve

1.78

0.85

1.3

1.5

240.00

273.30

ug/g

—

Seropositive rheumatoid arthritis, strict definition

154

1744

0.88

0.84

1.4

286.13

278.74

ug/g

0.21

1001

Other specified disorders of external ear

327

1.29

0.84

1.3

1.5

343.21

273.48

ug/g

1.73

200

Placenta praevia

366

0.73

0.84

1.4

1.3

261.78

312.09

ug/g

0.44

186

Embolic stroke

416

1.26

0.83

1.4

197.30

272.85

ug/g

1.67

255

Mature T/NK-cell lymphomas, hilmo

113

1.52

0.83

1.8

1.5

269.83

267.75

ug/g

0.02

Other benign neoplasms of uterus

598

1.21

0.83

1.5

1.4

275.52

274.01

ug/g

0.02

346

Myeloproliferative diseases (CML excluded)

772

1.18

0.83

1.4

293.66

279.54

ug/g

0.31

452

Pedal cyclist injured in transport accident

266

2421

1.10

0.82

1.4

249.79

279.42

ug/g

1.55

157

1380

Postzoster neuralgia

138

1.47

0.82

1.3

1.4

350.42

267.92

ug/g

1.75

Other and unspecified acute skin changes due to ultraviolet radiation

223

1.36

0.82

1.4

1.5

293.62

271.34

ug/g

0.27

129

Maternal care for known or suspected fetal abnormality and damage

119

1178

0.87

0.82

1.3

358.95

311.48

ug/g

1.62

603

Golimumab

311

1.29

0.81

1.4

1.5

329.54

297.18

ug/g

0.51

177

Other disorders of breast and lactation associated with childbirth

130

1.47

0.81

1.4

1.3

283.33

342.67

ug/g

—

Struck by thrown, projected or falling objec

454

1.24

0.81

1.3

1.4

279.71

297.53

ug/g

0.24

263

Other mycoses, not elsewhere classified/unspecified

147

1.44

0.81

1.2

1.4

304.87

294.29

ug/g

0.07

Polycystic ovarian syndrome, broad definition

829

1.17

0.81

1.3

353.70

331.65

ug/g

0.39

386

Other crystal arthropathies

147

1.44

0.81

1.5

246.22

257.74

ug/g

—

Paraplegia, diplegia of upper limbs

181

1.39

0.80

1.9

1.5

253.06

288.56

ug/g

0.45

Aneurysms, operations, SAH

206

1855

1.11

0.80

1.5

1.4

297.73

272.41

ug/g

0.99

123

1106

Hodgkin lymphoma, hilmo

233

1.34

0.80

1.6

1.5

260.81

297.46

ug/g

0.50

129

Alzheimer disease

346

2744

0.92

0.80

1.3

1.4

259.19

260.50

ug/g

0.04

183

1689

Monoarthritis, not elsewhere classified

339

1.28

0.79

1.5

1.4

218.67

269.10

ug/g

0.75

198

Respiratory disorders in diseases classified elsewhere

123

1.48

0.78

1.6

1.3

292.42

292.61

ug/g

0.00

Melanocytic naevi of scalp and neck

208

1.36

0.78

1.4

257.89

304.93

ug/g

0.38

121

Tuberculosis, wide

676

1.19

0.77

1.5

270.95

270.97

ug/g

0.00

399

Malignant neoplasm of tongue

140

1.44

0.77

1.5

1.4

286.58

293.40

ug/g

0.05

Bus occupant injured in other and unspecified transport accidents

1.73

0.77

1.3

1.4

192.00

293.30

ug/g

—

Acute myringitis

1.72

0.77

1.5

1.3

198.80

315.22

ug/g

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

760

1.18

0.76

1.4

320.89

313.58

ug/g

0.12

390

Alopecia areata

235

1.33

0.76

1.5

1.4

307.71

308.94

ug/g

0.01

137

Contact with sharp glass

332

1.27

0.76

1.4

285.00

298.92

ug/g

0.18

188

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

1.67

0.76

1.6

1.4

280.00

318.35

ug/g

—

Alzheimer’s disease (Early onset), excluding more controls

254

1.30

0.76

1.2

1.4

294.64

269.46

ug/g

0.33

152

Abnormalities of forces of labour

963

0.85

0.76

1.3

1.4

316.42

300.11

ug/g

0.32

519

Myotonic disorders

1.67

0.76

1.2

1.3

245.96

292.51

ug/g

—

Pleural plaque without asbestos

306

1.28

0.75

1.5

262.62

251.88

ug/g

0.10

199

Thyrotoxicosis factitia

2.13

0.75

1.4

1.3

323.80

306.91

ug/g

—

Other parasitologically confirmed or unspecified malaria

2.13

0.75

3.0

1.5

324.80

301.83

ug/g

—

Pre-eclampsia or poor fetal growth

339

3124

1.08

0.75

1.4

1.3

306.30

303.01

ug/g

0.10

186

1631

Congenital malformations of aortic and mitral valves

369

1.25

0.75

1.4

1.5

264.32

296.29

ug/g

0.38

222

Rubella [German measles]

307

1.28

0.74

1.2

1.5

310.97

262.26

ug/g

0.64

188

Benign neoplasm: Lip

193

1.36

0.74

1.6

1.5

254.87

284.73

ug/g

0.33

114

Other retinal artery occlusion

193

1.36

0.74

1.5

204.75

276.74

ug/g

1.06

116

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

100

1.52

0.73

1.3

1.4

359.11

320.24

ug/g

—

Congenital malformations of great arteries

181

1.37

0.73

1.3

276.27

349.08

ug/g

0.85

102

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

159

1.39

0.73

1.4

252.13

298.69

ug/g

0.61

HSIL lesion of the vagina

134

1.43

0.72

1.5

1.4

259.66

311.26

ug/g

0.37

Other congenital malformations of skin

362

1.25

0.72

1.5

1.4

292.77

310.24

ug/g

0.18

200

Use of biperiden

498

1.21

0.72

1.3

1.4

280.53

285.81

ug/g

0.07

289

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

765

1.17

0.72

1.4

1.3

320.89

311.37

ug/g

0.17

392

Horner syndrome

109

1.49

0.72

1.0

1.4

456.20

279.76

ug/g

—

Erectile dysfunction

729

1.17

0.71

1.4

1.5

293.04

247.29

ug/g

1.32

475

Family history of other conditions

101

1.50

0.70

1.3

1.4

323.84

305.57

ug/g

—

Abnormal findings on antenatal screening of mother

554

1.19

0.70

1.3

335.87

327.18

ug/g

0.12

254

Macular cyst

283

1.28

0.70

1.3

1.5

268.90

281.40

ug/g

0.15

167

Cicatricial alopecia [scarring hair loss]

1.55

0.70

1.2

1.4

384.67

314.39

ug/g

—

Use of interferon beta-1a

193

0.67

0.70

1.5

1.3

278.03

326.55

ug/g

—

103

Viral conjunctivitis

337

1.25

0.69

1.2

1.4

344.68

306.91

ug/g

0.73

190

Non-small cell lung cancer

861

0.85

0.69

1.2

1.4

275.70

277.34

ug/g

0.02

526

1.66

0.69

1.5

1.4

206.40

338.68

ug/g

—

Distal bite

282

1.27

0.68

1.4

353.76

328.61

ug/g

0.30

140

Benign neoplasm: Parathyroid gland

102

1.49

0.68

1.5

1.4

300.50

299.22

ug/g

—

Traumatic ischaemia of muscle

102

1.48

0.68

1.2

1.4

281.38

286.84

ug/g

—

Other and unspecified disorders of psychological development

1.53

0.67

1.0

1.4

435.80

382.93

ug/g

—

Aphakia

119

1.44

0.67

1.9

1.5

205.50

254.11

ug/g

0.52

Chalazion

124

1099

1.13

0.67

1.4

264.73

281.93

ug/g

0.42

629

Hereditary ataxia

111

1.46

0.66

1.3

1.4

210.36

283.08

ug/g

0.81

Injury of nerves at ankle and foot level

1.60

0.66

1.7

1.4

256.83

298.39

ug/g

—

Lymphangioma, anys site

1.63

0.66

1.4

316.80

277.92

ug/g

—

Gestational diabetes (for exclusion)

373

2421

1.07

0.66

1.3

312.03

316.70

ug/g

0.15

193

1214

Malignant neoplasm of ovary, including Hilmo

679

0.84

0.65

1.5

1.4

259.95

300.96

ug/g

1.08

387

Malignant neoplasm of other and unspecified female genital organs

137

1.40

0.65

1.4

1.3

263.08

312.37

ug/g

0.80

Subacute thyroiditis

304

1.26

0.65

1.4

1.5

297.00

303.00

ug/g

0.06

169

Car occupant injured in noncollision transport accident

304

1.26

0.65

1.3

1.5

241.33

293.84

ug/g

0.90

168

Embolic stroke with flimmer

215

1.31

0.65

1.4

1.5

186.13

263.26

ug/g

0.97

126

Viral infections of central nervous system, not elsewhere classified/unspecified

1.49

0.65

1.3

1.4

365.07

303.72

ug/g

—

Etanercept

597

1.18

0.64

1.6

1.4

276.51

289.39

ug/g

0.20

329

Fourth [trochlear] nerve palsy

207

1.31

0.64

1.5

1.4

291.67

287.06

ug/g

0.04

125

Injury of muscle and tendon at ankle and foot level

216

1.31

0.64

1.4

277.30

304.39

ug/g

0.32

129

Other congenital malformations of peripheral vascular system

104

1.46

0.63

1.9

1.4

267.56

298.68

ug/g

—

Pregnancy examination and test

151

842

1.12

0.63

1.3

1.4

326.08

306.85

ug/g

0.45

426

Melanocytic naevi of ear and external auricular canal

1.66

0.63

1.0

1.3

353.38

330.30

ug/g

—

Other, unspecified and serous retinal detachments

288

1.26

0.63

1.3

1.5

301.70

284.03

ug/g

0.21

171

Abnormal spermatozoa

132

1181

1.12

0.62

1.4

1.5

294.05

244.90

ug/g

1.77

746

Chronic suppurative otitis media, including avohilmo

767

1.15

0.62

1.4

279.27

289.54

ug/g

0.18

424

Toxic effect of contact with venomous animals

388

1.22

0.62

1.4

1.5

280.90

291.36

ug/g

0.12

226

Hereditary lymphedema

0.00

0.61

0.0

1.3

—

232.83

—

Unicornuate uterus

0.00

0.61

0.0

1.2

—

350.10

—

Nystagmus and other irregular eye movements

122

1.41

0.60

1.4

227.70

337.99

ug/g

—

Vascular dementia (sudden onset)

0.00

0.60

0.0

1.6

—

222.69

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

148

1.36

0.60

1.5

1.3

228.60

352.70

ug/g

1.77

Ankylosing spondylitis, strict definition

372

1.22

0.59

1.4

279.72

307.02

ug/g

0.31

205

Hereditary lymphedema

0.00

0.59

0.0

1.3

—

255.52

—

Prophylactic surgery

1.58

0.59

1.0

1.3

251.00

315.10

ug/g

—

Premature separation of placenta [abruptio placentae]

197

0.71

0.59

1.4

1.3

263.86

317.61

ug/g

—

Eclampsia

0.00

0.59

0.0

1.2

—

380.88

—

Malignant neoplasm of rectosigmoid junction, including Hilmo

210

1.29

0.59

1.3

1.4

215.50

298.38

ug/g

1.70

127

Measles

106

1.43

0.58

1.9

1.4

212.41

318.22

ug/g

—

Bicuspidal aortic valve syndrome

319

1.23

0.57

1.4

1.5

255.43

285.65

ug/g

0.33

190

Motorcycle rider injured in other and unspecified transport accidents

484

1.18

0.57

1.5

1.4

291.46

295.80

ug/g

0.05

278

Reiter disease

1.68

0.57

1.2

1.5

161.83

302.32

ug/g

—

Open bite that required surgery (Lefort1 or BSSO)

1.52

0.56

1.0

1.3

361.94

356.10

ug/g

—

Cleft palate

1.52

0.56

1.5

1.4

439.17

311.01

ug/g

—

Maternal care for other known or suspected fetal problems

230

1345

1.08

0.56

1.3

324.00

314.69

ug/g

0.22

672

Injury of urinary and pelvic organs

168

1.32

0.55

1.3

1.5

213.73

272.59

ug/g

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

601

0.85

0.55

1.3

1.5

315.67

271.19

ug/g

0.76

369

Medical treatment for female infertility

169

1834

0.91

0.54

1.3

315.50

322.57

ug/g

0.14

918

Foreign body in ear

160

1.32

0.54

1.0

1.5

333.83

304.95

ug/g

0.33

Acute poliomyelitis

134

1.36

0.53

1.6

1.3

259.31

292.42

ug/g

0.31

Rheumatic valve diseases

169

1.31

0.53

1.6

1.4

244.53

285.77

ug/g

0.46

Polyhydramnios

359

1.20

0.53

1.3

302.35

312.19

ug/g

0.08

177

Other diseases of spinal cord

259

1.24

0.53

1.4

293.10

288.25

ug/g

0.04

149

Migraine with aura, drug-induced

0.60

0.52

1.2

1.3

351.50

311.18

ug/g

—

Outcome of delivery

133

908

0.90

0.52

1.2

1.4

332.44

307.73

ug/g

0.64

467

Malignant neoplasm of other connective and soft tissue

188

1.28

0.51

1.3

1.4

267.06

305.04

ug/g

0.40

108

Congenital malformations of breast

135

1.34

0.51

1.3

1.4

324.13

314.64

ug/g

—

LSIL lesion of the vagina

153

1.32

0.51

1.5

1.4

352.64

304.18

ug/g

0.48

Coronary artery bypass grafting

315

2205

1.07

0.51

1.4

240.12

256.41

ug/g

0.81

212

1340

Premature rupture of membranes

185

1435

0.92

0.50

1.3

360.20

309.94

ug/g

1.92

741

Benign neoplasm: Larynx

288

1.22

0.50

1.7

1.5

254.50

277.48

ug/g

0.25

166

Desensitization to allergens

426

1.18

0.50

1.4

318.86

324.03

ug/g

0.04

216

Atrial septal defect, secundum type

260

1.23

0.50

1.4

298.69

323.77

ug/g

0.30

148

Malignant neoplasm of breast, HER-negative

215

2269

0.93

0.50

1.3

1.4

279.58

294.39

ug/g

0.50

117

1288

Use of amantadine

145

1.32

0.49

1.5

1.4

317.57

302.73

ug/g

0.11

Peripheral retinal degeneration

280

1.22

0.49

1.5

1.4

273.65

299.91

ug/g

0.32

161

Retinal breaks without detachment

197

1827

1.08

0.49

1.5

1.4

278.70

274.41

ug/g

0.12

115

1068

Xanthelasma of eyelid

1.46

0.48

1.0

1.4

223.80

287.92

ug/g

—

Other specified and unspecified disorders of eyelid

119

1.36

0.48

1.4

246.10

288.87

ug/g

—

Congenital malformations of the nervous system

181

1.28

0.48

1.2

1.4

362.00

347.58

ug/g

0.12

Suppurative otitis media, unspecified

199

1.26

0.48

1.7

1.5

258.36

296.12

ug/g

0.38

113

L01XX Other antineoplastic agents

578

1.15

0.48

1.3

1.5

294.84

274.55

ug/g

0.43

346

Melanoma in situ

438

1.17

0.48

1.4

278.36

277.89

ug/g

0.01

264

Mental retardation, wide definition

389

1.18

0.47

1.3

1.4

315.83

318.36

ug/g

0.03

228

Pigmented purpuric dermatosis

1.43

0.47

2.3

1.4

279.20

305.97

ug/g

—

Benign neoplasm of brain and other parts of central nervous system

635

1.14

0.47

1.4

289.69

286.43

ug/g

0.05

366

Postpartum haemorrhage due to retained placenta

1036

0.90

0.47

1.3

301.35

326.25

ug/g

0.53

525

Noise effects on inner ear

346

1.19

0.47

1.6

1.5

285.00

260.23

ug/g

0.39

216

Arteriovenous malformation of cerebral vessels

1.40

0.46

1.8

1.6

393.63

262.78

ug/g

—

Erosion and ectropion of cervix uteri

246

1.23

0.46

1.4

1.3

275.41

273.25

ug/g

0.02

134

Vascular syndromes of brain in cerebrovascular disorders

412

1.17

0.45

1.6

1.5

286.65

274.01

ug/g

0.15

254

Respiratory tuberculosis

468

1.16

0.45

1.5

262.74

269.47

ug/g

0.09

282

Respiratory tuberculosis, confirmed and not-confirmed

468

1.16

0.45

1.5

262.74

269.47

ug/g

0.09

282

Complications of labour and delivery

789

4547

0.96

0.45

1.3

1.4

305.21

290.09

ug/g

1.17

406

2523

Benign neoplasm: Bronchus and lung

112

1.35

0.45

1.3

1.5

316.88

295.75

ug/g

—

Pregnancy hypertension

494

4232

1.05

0.45

1.4

299.56

297.42

ug/g

0.08

295

2243

Non-small cell lung cancer, squamous

297

0.81

0.44

1.0

1.4

206.86

284.96

ug/g

1.29

182

Poor fetal growth

106

961

1.10

0.44

1.4

1.3

320.69

328.44

ug/g

0.13

463

Beningn neoplasm: Meninges, unspecified

163

0.73

0.44

1.5

1.3

373.43

295.42

ug/g

—

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

157

1.28

0.43

1.3

316.00

334.71

ug/g

—

Pre-eclampsia or eclampsia

247

2322

1.07

0.43

1.4

302.05

297.55

ug/g

0.12

144

1249

Pregnancy, childbirth and the puerperium

395

1961

1.05

0.43

1.3

1.4

294.77

278.25

ug/g

0.74

211

1075

Cellulitis of external ear

104

1.36

0.43

1.2

1.3

222.08

326.10

ug/g

—

Von Willebrand disease

104

1.36

0.43

1.5

1.3

340.62

322.53

ug/g

—

Lichen planopilaris

1.59

0.43

1.0

1.2

—

295.20

—

Myocardial infarction, unclassifiable

222

2112

0.94

0.42

1.4

244.21

257.88

ug/g

0.50

132

1292

Benign neoplasm: Vagina

131

1.31

0.42

1.3

331.00

293.66

ug/g

—

Hypothyroidism due to medicaments and other exogenous substances

1.39

0.42

1.2

1.5

264.67

308.13

ug/g

—

Mental and behavioural disorders associated with the puerperium

1.39

0.42

1.1

1.3

302.17

325.04

ug/g

—

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

1.39

0.42

1.2

1.4

348.17

359.67

ug/g

—

Maxillary retrognathism

131

1.30

0.42

1.4

307.19

316.60

ug/g

0.05

Pyogenic granuloma

140

1.29

0.42

1.2

1.4

307.00

284.18

ug/g

—

Benign neoplasm: other/unspecified salivary gland

258

1.21

0.42

1.3

1.4

263.48

287.43

ug/g

0.33

159

Dermatitis herpetiformis

167

1.27

0.42

1.7

1.4

336.70

301.90

ug/g

—

101

Craniosynostosis EXCLUDE syndromes

0.00

0.41

0.0

1.5

—

347.71

—

Other retinal disorders in diseases classified elsewhere

0.00

0.41

0.0

1.5

—

299.33

—

Carcinoma in situ, bladder

286

1.19

0.41

1.4

1.5

251.78

263.64

ug/g

0.13

179

Benign neoplasm: Penis

0.00

0.41

0.0

1.6

—

296.03

—

Abnormalities of ear ossicles

0.00

0.41

0.0

1.5

—

280.54

—

Hydrocephalus

718

1.12

0.41

1.3

1.4

299.64

275.26

ug/g

0.54

431

Ankylosis of teeth

0.00

0.41

0.0

1.3

—

313.57

—

Carcinoma in situ of skin of ear and external auricular canal

105

1.34

0.41

1.5

1.6

345.13

232.23

ug/g

—

Malignant otitis externa

0.00

0.41

0.0

1.6

—

251.03

—

Disorder of thyroid, unspecified

114

1.33

0.41

1.6

1.3

252.12

313.51

ug/g

—

Postpartum haemorrhage due to anatomy

731

0.89

0.40

1.2

295.72

340.40

ug/g

0.83

329

Chondrosarcoma, including Hilmo

1.48

0.40

1.4

—

292.25

ug/g

—

Burn and corrosion of shoulder and upper limb, except wrist and hand

186

1.24

0.40

1.3

1.5

238.90

301.78

ug/g

0.55

112

Alzheimer’s disease (Early onset)

411

0.85

0.40

1.2

1.5

294.64

270.43

ug/g

0.32

253

Lumbosacral root disorders, not elsewhere classified

1.35

0.40

1.5

1.4

291.57

316.71

ug/g

—

Malignant neoplasm of mesothelium and soft tissue

306

1.18

0.40

1.4

1.5

257.93

299.56

ug/g

0.61

175

Male infertility

306

1.18

0.39

1.7

1.5

295.35

273.17

ug/g

0.23

179

Glaucoma secondary to eye inflammation

1.42

0.39

1.1

1.4

325.38

308.29

ug/g

—

L02BB Anti-androgens

812

0.90

0.39

1.2

1.5

267.33

252.99

ug/g

0.23

522

Complications following abortion and ectopic and molar pregnancy

363

1.16

0.39

1.5

1.4

241.53

294.97

ug/g

0.57

205

Pulmonary oedema

142

1.27

0.38

1.4

261.18

275.74

ug/g

0.11

Maternal care related to the fetus and amniotic cavity and possible delivery problems

481

2939

0.96

0.38

1.3

315.40

297.81

ug/g

0.91

231

1581

Burn and corrosion of wrist and hand

317

1.17

0.38

1.5

287.60

291.94

ug/g

0.04

184

Other abnormal products of conception

318

2002

1.05

0.38

1.4

1.3

317.95

307.84

ug/g

0.34

169

1047

Other renal tubulo-interstitial diseases

216

1.21

0.37

1.2

1.4

301.94

303.16

ug/g

0.01

117

Maternal care for known or suspected abnormality of pelvic organs

230

1658

0.94

0.37

1.3

314.05

305.57

ug/g

0.20

102

874

Impacted teeth

163

1354

1.07

0.37

1.4

1.3

307.44

317.95

ug/g

0.22

653

Mental retardation

372

1.15

0.36

1.3

1.4

313.93

326.78

ug/g

0.16

216

Pedal cyclist injured in noncollision transport accidents

120

1109

1.08

0.36

1.4

278.93

290.09

ug/g

0.22

620

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

263

1.18

0.36

1.4

265.77

298.02

ug/g

0.61

150

Pedal cyclist injured in collision with motor vehicle

263

1.18

0.36

1.5

199.87

288.88

ug/g

1.87

148

Adhesive middle ear disease

126

1.28

0.35

1.3

1.4

305.10

306.06

ug/g

—

Serous carcinoma of ovary, including Hilmo

341

0.85

0.35

1.2

1.4

277.19

303.38

ug/g

0.37

190

Tuberculosis of other organs

190

1.22

0.35

1.6

1.5

277.20

269.83

ug/g

0.05

109

Non-small cell lung cancer, including Hilmo

136

1375

0.93

0.35

1.3

1.4

263.12

283.60

ug/g

0.52

826

Heberden's nodes [with arthropathy]

1.33

0.34

1.6

1.4

247.83

293.66

ug/g

—

Asymptomatic human immunodeficiency virus [HIV] infection status

1.34

0.34

1.2

1.6

203.17

233.26

ug/g

—

Other disorders of amniotic fluid and membranes

127

1153

1.08

0.33

1.5

1.3

347.90

312.57

ug/g

0.79

581

Use of ropinirole

340

1.15

0.33

1.4

1.5

295.15

276.10

ug/g

0.22

207

Crystal arthropathies, rheuma endpoint

173

1.22

0.33

1.5

246.22

270.03

ug/g

—

101

Biological medicines for asthma

173

1.22

0.33

1.4

354.89

300.86

ug/g

0.48

Cholesteatoma of middle ear

477

0.88

0.33

1.3

1.5

311.32

274.18

ug/g

0.76

289

Mumps

229

1.18

0.32

1.4

1.5

324.50

275.71

ug/g

0.62

137

Viral conjunctivitis

192

1.20

0.32

1.3

1.4

352.86

291.46

ug/g

0.75

109

Communicating hydrocephalus

187

0.80

0.32

1.2

1.4

329.56

286.15

ug/g

—

103

Optic neuritis

379

1.14

0.32

1.4

320.74

310.60

ug/g

0.10

205

Benign neoplasm of male genital organs

154

0.78

0.32

1.4

1.6

188.59

264.37

ug/g

—

Other bursal cyst

128

1.26

0.32

1.4

244.50

317.05

ug/g

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

618

1.10

0.31

1.2

1.3

278.41

316.31

ug/g

0.66

292

Juvenile osteochondrosis

258

1.17

0.31

1.3

1.4

348.08

306.89

ug/g

0.47

137

Aggressive periodontitis

193

1.20

0.31

1.7

1.4

322.09

296.76

ug/g

0.22

114

Crowding of teeth, including avohilmo

582

1.10

0.30

1.2

1.4

335.38

345.23

ug/g

0.14

290

Tuberculosis of other organs, strict

212

1.18

0.30

1.5

1.4

298.11

271.51

ug/g

0.24

121

Benign neoplasm: Bones of skull and face

1.30

0.30

1.5

1.3

243.12

313.68

ug/g

—

Asymmetry of jaw

111

1.27

0.30

1.6

1.3

297.50

323.64

ug/g

—

Other and unspecified injuries of abdomen, lower back and pelvis

111

1.27

0.30

1.6

1.5

271.50

285.41

ug/g

—

Conotruncal defects

102

1.28

0.30

1.4

211.57

328.06

ug/g

—

Coarctation of the aorta

1.32

0.30

1.4

1.5

258.33

308.44

ug/g

—

Other and unspecified injuries of thorax

157

1.22

0.29

1.6

1.4

258.00

299.50

ug/g

0.42

Injury of nerves and spinal cord at neck level

194

1.19

0.29

2.0

1.5

239.94

269.93

ug/g

0.28

114

Respiratory distress of newborn

120

1.24

0.29

1.3

440.00

380.39

ug/g

—

Congenital malformations of breast

148

1.22

0.29

1.3

1.4

324.13

320.93

ug/g

—

Systemic atrophies primarily affecting the central nervous system

398

0.88

0.29

1.4

1.5

250.96

279.11

ug/g

0.43

241

Mandibular prognathia

121

1.25

0.28

1.5

1.4

278.00

332.67

ug/g

—

Delivery, wide proxy

430

2363

0.97

0.28

1.4

304.03

283.13

ug/g

1.16

231

1293

Schizoid personality disorder

149

1.21

0.28

1.3

1.5

224.05

291.05

ug/g

0.73

Cysts of oral region, not elsewhere classified

546

1.10

0.28

1.5

1.4

240.79

284.42

ug/g

0.95

318

Loose body in joint

196

1.18

0.27

1.3

1.5

237.23

278.89

ug/g

0.40

115

Malignant neoplasm of breast, HER-positive

386

3113

0.97

0.27

1.4

278.40

299.58

ug/g

1.29

238

1735

Iridocyclitis in diseases classified elsewhere

159

1.20

0.27

1.5

1.4

236.25

287.13

ug/g

—

Benign neoplasm: Peripheral nerves and autonomic nervous system

150

1.21

0.26

1.6

1.4

248.00

318.56

ug/g

0.76

Short Achilles tendon (acquired)

225

0.84

0.26

1.3

1.4

237.55

305.97

ug/g

0.84

128

Viral infections of central nervous system, not elsewhere classified/unspecified

132

1.22

0.26

1.3

1.4

363.29

308.09

ug/g

—

Use of selegiline

425

1.11

0.25

1.4

1.5

290.81

273.34

ug/g

0.25

256

Gestational [pregnancy-induced] hypertension

269

2582

1.04

0.25

1.4

1.3

314.43

306.23

ug/g

0.25

158

1321

Enterobiasis

159

0.81

0.25

1.2

1.4

251.80

337.98

ug/g

—

Traumatic amputation of wrist and hand

382

0.89

0.25

1.6

1.5

253.18

264.58

ug/g

0.10

226

Malignant neoplasm of breast, ER-positive, including Hilmo

395

3142

0.97

0.24

1.4

278.96

299.43

ug/g

1.25

241

1749

Other obstetric trauma

434

0.90

0.24

1.3

1.4

364.98

315.06

ug/g

0.65

213

Malignant neoplasm of corpus uteri

900

1.07

0.24

1.4

247.56

294.08

ug/g

1.28

526

Injury of muscle and tendon at forearm level

152

1.19

0.24

1.3

1.5

242.73

296.93

ug/g

0.43

Other operation for atrial fibrillation

1.36

0.23

1.6

248.00

257.04

ug/g

—

Foreign body or object entering through skin

552

1.09

0.23

1.6

1.5

303.80

286.84

ug/g

0.27

317

Mandibular retrognathia AND surgery (BSSO)

222

0.85

0.23

1.3

1.4

312.47

311.16

ug/g

—

125

Abnormal findings on diagnostic imaging of breast

143

1.20

0.23

1.1

1.4

328.52

297.96

ug/g

—

Disorders of acoustic nerve

256

1.14

0.23

1.3

1.5

307.50

280.31

ug/g

0.34

162

Dementia due to Parkinson's disease

209

1.15

0.23

1.4

291.67

269.07

ug/g

0.18

124

Congenital malformations of eye, ear, face and neck

553

1.09

0.23

1.4

255.33

308.91

ug/g

0.84

298

Otosclerosis

787

1.07

0.22

1.3

1.4

308.23

272.19

ug/g

0.83

448

Burkitt lymphoma, helper endpoint

0.00

0.22

0.0

1.7

—

264.60

—

Haemolytic disease of fetus and newborn

0.00

0.22

0.0

1.4

—

317.20

—

Mild mental retardation

199

0.85

0.21

1.5

304.80

307.69

ug/g

—

113

Other and unspecified hereditary haemolytic anaemias

0.00

0.21

0.0

1.1

—

250.80

—

Other histiocytosis syndromes

0.00

0.21

0.0

1.6

—

160.80

—

Arthropathy in hypersensitivity reactions classified elsewhere

0.00

0.21

0.0

1.0

—

461.40

—

Drowning to ice

0.00

0.21

0.0

1.3

—

234.67

—

Corrosions classified according to extent of body surface involved

0.00

0.21

0.0

1.7

—

227.60

—

Exposure to high and low air pressure and changes in air pressure

0.00

0.21

0.0

1.7

—

142.04

—

Benign neoplasm: Spinal cord

126

1.20

0.21

1.5

1.4

213.33

295.07

ug/g

—

Actinic reticuloid

0.00

0.21

0.0

1.6

—

163.00

—

Degenerative diseases of the nervous system

442

3162

1.03

0.21

1.4

257.77

260.44

ug/g

0.10

239

1948

Dislocations, sprains and strains involving multiple body regions

0.00

0.21

0.0

1.4

—

358.46

—

Lens-induced iridocyclitis

0.00

0.21

0.0

1.5

—

258.57

—

Exposure to other specified electric current

198

0.86

0.20

1.6

1.4

332.33

318.60

ug/g

—

118

Chronic mastoiditis

230

1.13

0.20

1.4

369.22

283.19

ug/g

—

134

Accident to watercraft causing drowning and submersion

0.00

0.20

0.0

1.5

—

251.55

—

Carcinoma in situ of oral cavity and pharynx

0.00

0.20

0.0

1.6

—

304.88

—

Venous complications and haemorrhoids in pregnancy

136

1.18

0.20

1.4

314.48

322.06

ug/g

0.04

Occlusion and stenosis of arteries, not leading to stroke

1.22

0.19

1.7

1.5

201.67

276.74

ug/g

—

Nontraumatic intracranial haemmorrhage

216

2237

0.96

0.19

1.4

264.00

264.91

ug/g

0.02

124

1347

Polycythaemia vera

279

1.11

0.19

1.5

299.88

300.44

ug/g

0.00

165

Pre-eclampsia

219

2115

1.04

0.19

1.4

304.67

300.00

ug/g

0.11

125

1117

Contact with nonpowered hand tool

385

1.09

0.19

1.4

1.5

291.56

278.13

ug/g

0.16

225

Benign neoplasm of other and unspecified female genital organs

453

1.08

0.19

1.3

1.4

334.37

304.22

ug/g

0.42

256

Tuberculosis

540

1.08

0.19

1.5

265.33

269.24

ug/g

0.05

322

Carcinoma in situ of other and unspecified genital organs

194

1.14

0.18

1.2

1.4

336.09

319.55

ug/g

0.08

109

Multiple gestation

793

1.06

0.18

1.4

1.3

346.79

311.26

ug/g

0.76

410

Mental and behavioural disorders of puerperium, not classified elsewhere

100

1.21

0.18

1.1

1.4

302.17

329.96

ug/g

—

Other congenital malformations of face and neck

248

0.88

0.18

1.4

1.5

229.68

306.44

ug/g

—

146

Overjet

184

1.14

0.18

1.3

1.5

338.14

341.66

ug/g

—

Postpartum care and examination

124

750

1.05

0.17

1.3

1.4

350.27

312.34

ug/g

1.03

374

Perioral dermatitis

195

1.13

0.17

1.4

340.67

308.96

ug/g

0.31

109

Routine general health check-up of defined subpopulation

110

1.18

0.17

1.4

1.2

318.83

315.53

ug/g

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

413

0.92

0.17

1.8

1.5

287.00

286.99

ug/g

0.00

245

Any dementia

499

3395

1.02

0.17

1.4

270.12

260.09

ug/g

0.52

272

2107

Malignant neoplasm of breast, HER2-negative

512

3417

0.98

0.16

1.3

1.4

279.13

301.09

ug/g

1.61

302

1888

Sequelae of poliomyelitis

1.16

0.16

1.3

1.5

186.50

273.59

ug/g

—

Failed induction of labour

437

1.08

0.16

1.2

1.3

327.75

324.37

ug/g

0.03

207

Alzheimer’s disease, strict definition

273

2310

0.97

0.16

1.3

1.4

257.61

261.41

ug/g

0.12

140

1430

Twin gestation

769

1.05

0.16

1.4

1.3

346.38

310.02

ug/g

0.76

395

Unspecified human immunodeficiency virus [HIV] disease

1.16

0.15

1.4

1.6

172.36

270.56

ug/g

—

Carcinoma in situ of breast, intraductal

106

1015

1.05

0.15

1.3

1.4

306.18

284.66

ug/g

0.56

586

Malignant neoplasm of vulva, including Hilmo

121

1.16

0.15

1.3

268.83

311.30

ug/g

—

Malignant neoplasm of breast, ER-negative, including Hilmo

253

2473

0.97

0.15

1.3

1.4

279.77

295.21

ug/g

0.62

143

1388

Other puerperal infections

605

0.94

0.15

1.2

1.3

339.35

324.85

ug/g

0.20

276

Small cell lung cancer

150

1.14

0.14

1.4

295.45

299.22

ug/g

0.02

Small cell lung cancer, including Hilmo

150

1.14

0.14

1.4

295.45

299.22

ug/g

0.02

Malignant neoplasm of breast

519

3445

0.98

0.14

1.3

1.4

280.34

301.15

ug/g

1.49

305

1900

Unspecified dementia

108

932

1.04

0.14

1.3

1.5

296.89

260.64

ug/g

1.13

575

Dementia

570

3856

1.02

0.14

1.4

268.77

258.44

ug/g

0.61

320

2396

Other disorders of prostate

227

1.10

0.14

1.4

1.6

240.67

236.89

ug/g

0.04

156

Supervision of high-risk pregnancy

186

1153

0.97

0.14

1.3

1.4

319.41

305.48

ug/g

0.34

598

MS-disease / Multiple Sclerosis

633

0.95

0.13

1.5

1.4

278.14

303.33

ug/g

0.36

325

Melanoma in situ of other and unspecified parts of face

113

1.16

0.13

1.2

1.5

190.84

263.50

ug/g

—

Thyroiditis, unspecified

113

1.15

0.13

1.2

1.4

193.71

320.33

ug/g

—

Keratoconus

211

0.90

0.13

1.5

325.52

296.95

ug/g

—

122

Melanocytic naevi of other and unspecified parts of face

540

1.06

0.13

1.4

316.16

296.38

ug/g

0.27

289

Benign neoplasm: Vulva

221

0.90

0.13

1.2

1.4

340.22

302.85

ug/g

—

128

malignant neoplasm of female genital organs

181

1752

1.03

0.12

1.4

263.35

298.04

ug/g

1.57

101

999

Other disorders of thyroid

133

1.13

0.12

1.6

1.3

252.13

312.37

ug/g

—

Carcinoma in situ of cervix uteri

797

1.04

0.12

1.2

1.3

333.28

316.16

ug/g

0.25

390

Use of other anti-dementia drugs

312

2535

1.02

0.11

1.3

1.4

266.15

258.16

ug/g

0.31

167

1554

Use of memantine

312

2535

1.02

0.11

1.3

1.4

266.15

258.16

ug/g

0.31

167

1554

Divergent concomitant strabismus

700

0.96

0.11

1.4

265.06

301.25

ug/g

0.61

381

Malignant neoplasm of brain, including Hilmo

393

0.94

0.10

1.2

1.4

281.09

308.71

ug/g

0.40

234

Circumscribed brain atrophy

202

1.09

0.10

1.2

1.4

251.07

277.38

ug/g

0.35

118

Scissor bite

181

1.09

0.10

1.3

1.4

274.11

336.08

ug/g

—

Undefined dementia

109

974

1.03

0.10

1.3

1.4

296.89

261.82

ug/g

1.08

596

Malignant neoplasm of eye, brain and central nervous system

339

1.06

0.10

1.4

291.52

308.83

ug/g

0.25

197

Benign neoplasm of ovary

217

2126

1.02

0.10

1.4

265.15

288.40

ug/g

0.97

138

1202

Impacted maxillary molar

412

0.95

0.09

1.3

304.80

330.60

ug/g

0.22

186

Benign neoplasm: Cranial nerves

281

1.07

0.09

1.3

1.5

307.94

291.18

ug/g

0.19

166

Myocardial infarction, with ST-elevation

180

1839

0.98

0.09

1.4

1.5

256.55

257.14

ug/g

0.01

117

1125

Slow fetal growth and fetal malnutrition

1.03

0.09

1.6

1.4

396.80

328.07

ug/g

—

Demyelinating diseases of the central nervous system

763

1.04

0.09

1.5

1.4

290.21

299.46

ug/g

0.13

396

Other congenital malformations of tongue, mouth and pharynx

106

1.13

0.09

1.7

1.4

267.43

366.55

ug/g

—

Bilateral sagittal split ramus osteotomy operation

292

1.06

0.08

1.3

1.4

287.30

314.46

ug/g

0.27

155

Vaginal lichen planus

1.05

0.08

1.2

1.4

286.00

299.91

ug/g

—

Lung cancer and mesothelioma

189

1650

0.98

0.08

1.4

265.38

258.26

ug/g

0.19

114

999

Malignant neoplasm of corpus uteri, including Hilmo

108

1052

1.03

0.08

1.5

1.4

252.97

293.93

ug/g

1.17

614

Mixed conductive and sensorineural hearing loss

135

1320

1.02

0.08

1.4

277.26

266.51

ug/g

0.24

815

Intracerebral haemorrhage

126

1289

0.98

0.08

1.4

1.5

222.76

267.25

ug/g

1.69

800

Melanocytic naevi of upper limb, including shoulder

205

1.08

0.08

1.7

1.4

319.73

302.58

ug/g

0.20

114

Certain zoonotic bacterial diseases

264

1.06

0.07

1.7

1.4

210.11

302.16

ug/g

1.44

152

Benign neoplasm of thyroid gland

333

1.05

0.07

1.5

1.4

267.00

294.19

ug/g

0.33

191

Sequelae of poliomyelitis

1.04

0.07

1.3

1.5

186.50

268.59

ug/g

—

Small cell lung cancer, helper endpoint

183

0.93

0.06

1.4

1.5

295.45

257.36

ug/g

0.30

113

Endovascular or surgical operations to intracerebral aneurysms

639

0.97

0.06

1.6

1.4

291.01

282.63

ug/g

0.11

376

Other conjunctival vascular disorders and cysts

217

1.06

0.06

1.6

1.5

274.41

291.12

ug/g

0.14

127

Benign neoplasm: Skin of scalp and neck

227

1.06

0.06

1.4

247.64

294.20

ug/g

0.42

127

Obstructed labour due to maternal pelvic abnormality

172

1746

0.98

0.06

1.2

1.4

297.70

285.80

ug/g

0.34

984

Schizophrenia

163

1605

1.02

0.05

1.3

1.4

299.39

280.52

ug/g

0.52

909

Hypertrophic cardiomyopathy

395

0.96

0.05

1.4

1.5

226.83

273.69

ug/g

0.74

236

Vascular dementia (subcortical)

273

0.95

0.05

1.6

1.4

190.69

257.20

ug/g

1.30

167

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

222

0.94

0.05

1.2

1.5

335.75

285.59

ug/g

0.35

138

Use of galantamine

743

1.02

0.05

1.4

263.15

264.78

ug/g

0.03

456

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

252

0.95

0.05

1.5

217.88

265.90

ug/g

0.65

146

Benign neoplasm: Skin of lip

120

1.09

0.05

1.5

1.4

176.13

302.85

ug/g

—

Other benign neoplasms of connective and other soft tissue

1008

0.98

0.04

1.5

1.4

308.84

287.92

ug/g

0.47

566

Non-small cell lung cancer, adenocarcinoma

496

1.03

0.04

1.3

1.5

315.67

289.08

ug/g

0.38

303

Alzheimer’s disease (Atypical or mixed)

906

1.02

0.04

1.3

1.4

243.76

263.40

ug/g

0.47

571

Disorders of globe

219

1.05

0.04

1.3

1.4

283.29

290.18

ug/g

0.06

125

Subarachnoid haemorrhage

103

1047

0.98

0.04

1.4

302.51

275.32

ug/g

0.67

630

Third [oculomotor] nerve palsy

160

0.94

0.04

1.5

1.4

247.75

296.13

ug/g

—

Polyarteritis nodosa and related conditions

121

1.08

0.03

1.2

1.4

340.60

289.02

ug/g

—

L02BX Other hormone antagonists and related agents

472

0.97

0.03

1.4

1.5

270.47

251.77

ug/g

0.26

304

Family history of certain disabilities and chronic diseases leading to disablement

391

0.97

0.03

1.4

236.55

294.07

ug/g

0.67

202

LeFortI or BSSO operation

350

1.03

0.03

1.4

297.15

313.89

ug/g

0.16

182

Sequelae of tuberculosis

132

1.06

0.02

2.2

1.4

253.22

270.45

ug/g

—

Normal-pressure hydrocephalus

470

0.98

0.02

1.4

1.5

283.61

269.18

ug/g

0.17

281

Benign neoplasm: Skin of upper limb, including shoulder

182

1.05

0.02

1.2

1.4

323.68

297.94

ug/g

0.33

Alzheimer’s disease (Late onset)

255

2133

1.01

0.02

1.3

1.4

260.30

259.42

ug/g

0.02

128

1329

Maternal care for known or suspected malpresentation of fetus

162

1182

0.99

0.02

1.3

319.21

314.98

ug/g

0.08

596

Other disorders of optic disc

123

1.06

0.01

1.4

1.3

182.57

309.81

ug/g

—

Labour and delivery complicated by umbilical cord complications

443

1.02

0.01

1.4

360.27

301.79

ug/g

1.01

227

Malignant neoplasm of breast, including Hilmo

537

3483

1.00

0.01

1.4

276.95

301.66

ug/g

2.04

319

1923

Malignant neoplasm of breast, HER2-negative, including Hilmo

537

3483

1.00

0.01

1.4

276.95

301.66

ug/g

2.04

319

1923

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

116

0.95

0.00

1.5

339.60

285.94

ug/g

—

Ventricular septal defect, a heart condition

214

0.98

0.00

1.8

1.4

282.19

362.02

ug/g

1.20

117

Other diseases of appendix

115

1.04

0.00

1.5

1.6

90.39

295.50

ug/g

—

Wegener granulomatosis

134

0.97

0.00

1.8

1.5

280.13

287.86

ug/g

—

Use of glatiramer acetate

144

0.97

0.00

1.6

1.3

281.14

323.92

ug/g

—

Cleft lip, lip and palate or palate

124

0.97

0.00

1.5

1.4

405.14

305.94

ug/g

—

Hydatidiform mole

123

0.98

0.00

1.0

1.3

308.33

346.13

ug/g

—

Ovarian hyperstimulation (induction)

133

0.98

0.00

1.2

1.3

369.50

366.09

ug/g

—

Benign neoplasm: Brain, supratentorial

133

0.98

0.00

1.5

1.4

300.29

307.92

ug/g

—

Heart failure and hypertrophic cardiomyopathy

163

0.98

0.00

1.3

1.4

248.55

267.60

ug/g

0.14

Pedestrian injured in other and unspecified transport accidents

118

1.02

0.00

1.3

1.4

216.00

303.77

ug/g

—

Infections of breast associated with childbirth

302

0.99

0.00

1.1

1.3

377.69

330.13

ug/g

0.59

146

Other obstructed labour

732

1.00

0.00

1.4

280.57

295.91

ug/g

0.29

405

Benign neoplasm: Skin of lower limb, including hip

251

1.00

0.00

1.8

1.5

285.79

283.77

ug/g

0.02

147

Use of levodopa decarbox-comt-inhibitor

301

1.00

0.00

1.3

1.5

274.98

272.49

ug/g

0.02

184

Other demyelinating diseases of the central nervous system

319

1.00

0.00

1.5

1.4

313.66

307.91

ug/g

0.05

176

Complications of the puerperium, not elsewhere classified

317

1.01

0.00

1.5

1.3

332.03

335.02

ug/g

0.03

147

Other congenital malformations of tongue, mouth and pharynx

150

0.99

0.00

1.6

1.4

247.13

364.33

ug/g

—

Malignant neoplasm of brain

255

1.02

0.00

1.3

1.4

297.33

311.77

ug/g

0.14

151

Respiratory tuberculosis, not confirmed

350

1.00

-0.00

1.5

237.82

269.17

ug/g

0.44

204

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Elastase.pancreatic [Mass/mass] in Stool

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS